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It has been estimated that by 2020 nearly one-third of all Americans (almost 160 million 
people) will have at least one chronic disease to manage and the cost of health care will consume 
over 20 percent of the GDP. The Obama Administration responded to this pending crisis by 
passing the Patient Protection and Affordable Care Act (PPACA) in 2010. This major legislation 
aims to instill patient-centered, accountable care into the health care delivery system. 
Specifically, the United States government is on a mission to reduce the utilization of expensive 
inpatient care, while increasing access to primary care for all Americans, thereby lowering the 
total cost of health care. 
Primary care practices organized around the principles of the patient-centered medical 
home (PCMH) can better manage their patients, especially their patients with chronic conditions; 
 and become accountable for their care. In 2008, the National Committee for Quality Assurance 
(NCQA) released practice-level recognition standards based on the seven Joint Principles of the 
PCMH, to aid doctors seeking to transform their practices into effective patient-centered delivery 
systems. 
The results of several published studies have touted the successes (e.g., reduced 
emergency department visits, reduced hospitalizations) of the PCMH model at individual 
practice sites. These localized successes demonstrated that the principle tenets of the PCMH 
model—care coordination, team-based care, population management—helped lower utilization 
of more expensive health care services within the specific practice settings evaluated. However, 
there has been no study to determine if these core tenets are having a broader impact on the 
health care delivery system within a community. 
One hypothesized outcome of a health care system centered on the PCMH care model is 
better care coordination and more effective, whole-person care management across the 
continuum of health care; resulting in a more efficient system that can prevent avoidable 
hospitalizations. 
This dissertation proposal seeks to understand if the increasing numbers (density) of 
recognized PCMH practices in communities affect avoidable hospitalizations related to 
ambulatory care sensitive conditions (ACSC), as measured by the AHRQ Composite Prevention 
Quality Indicators (PQI). The research has two purposes: 
1. Establish constructs and hypotheses to measure the effect of the increasing numbers of 
NCQA-Recognized PCMH practices in communities (counties). 
2. Using an outcomes-based measurement approach, investigate the relationship between 
growing densities of NCQA-Recognized PCMH practice doctors among all primary 
  
 
care doctors (PCD) in a community and the associated impact on the utilization of 
inpatient care, specifically related to ACSCs, as measured by the AHRQ Composite 
PQIs. 
The research is quasi-experimental in design and is based on a retrospective (2008–2011) 
analysis of existing data from the NCQA PCMH program, the AHRQ Composite PQI and the 
Centers for Medicare & Medicaid Services (CMS) National Provider Identification (NPI) 
databases. Analysis will link NCQA-Recognized PCMH practices (independent variable), 
AHRQ Risk Adjusted Composite PQIs (dependent variable), and the CMS NPI (total PCDs) on 
Federal Information Processing Standard (FIPS) identifiers across 114 state and county-level 
geographical areas in Vermont and North Carolina. The research will inform the following 
hypotheses: 
1. Does the research literature support the measurement construct proposed in this 
study? 
2. Communities with concentrations of recognized PCMH practices among primary care 
practices will have lower risk-adjusted avoidable hospital admission rates. 
3. The use of technology and care coordination will have a greater predictive correlation 
on risk-adjusted avoidable hospital admission rates than other PCMH capabilities. 
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Chapter 1: Introduction 
 
 
Overview 
One of the central tenets of an effective patient-centered medical home (PCMH) is 
whole-person primary care management via team-based care coordination across the continuum 
of health care delivery. United States health reform efforts count on the widespread 
transformation of primary care around the core principles of the PCMH in an effort to break 
away from the fragmented fee-for-service (FFS) model and develop Accountable Care 
Organizations (ACO).  
In 2010 the Patient Protection and Affordable Care Act (PPACA) was passed, with the 
major goals of increasing access to affordable ambulatory primary care and reducing the 
prevalence of chronic disease and subsequent utilization of expensive inpatient care. The current 
care delivery model rewards doctors for using a volume-over-value delivery model that does not 
hold them accountable for the overall health of the patient. A paradigm shift toward an 
accountable care delivery model hinges on the effectiveness of the patient’s entry point (primary 
care practices) into the larger health care system.  
This research concentrates on two main aims: 
1. Establish constructs and hypotheses to measure the impact of the increasing 
concentrations of NCQA-Recognized PCMH practices in communities (counties).
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2. Investigate the relationship between growing densities of NCQA-Recognized PCMH 
practice doctors among total primary care doctors (PCD) in a community and the 
associated impact on the utilization of inpatient care, specifically related to 
ambulatory-sensitive conditions as measured by the AHRQ Composite Prevention 
Quality Indicators (PQI) … an outcomes-based measure. 
Understanding the impact of these associations at the community level will help to 
inform policymakers on the effects and broader implications of the PCMH model and its impact 
on the goals of health care reform initiatives aimed at lowering overutilization of more costly 
inpatient care (bending the total cost of health care downward), while improving the overall 
health of citizens. 
Background 
In the 1960s, the concept of the patient medical home was introduced by the American 
Academy of Pediatrics (AAP) as a place where a care team would manage all aspects of a child’s 
care. In the late 1990s, Ed Wagner and the McCall Institute evaluated the core functions of 
primary care practices that experienced better chronic disease outcomes. Their findings were 
published as the chronic care model (CCM). The success of the CCM findings spurred a renewed 
interest in the importance of well-managed primary care as a better care delivery model. In 2000, 
several primary care associations incorporated the CCM and the initial AAP model to jointly 
release the seven principles of the PCMH. The PCMH has at its core a team-based, whole-person 
approach at delivering complete care coordination across the health care continuum. It is 
believed that implementing the PCMH on a broad scale (nationally) will increase access to 
higher quality care and reduce total health care costs. Furthermore, it is hypothesized by some 
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inside health care industry experts that establishing ACOs is the pathway to successful health 
care reform. 
The United States health care system is often heralded as one of the finest in the world 
when it comes to lifesaving or acute care intervention (Atlas, 2009); simultaneously, it has the 
dubious distinction of being the most expensive health care system in the world. Some claim the 
US health care delivery model does not function as a system at all, pointing to the prevalence of 
fragmentation and the perversely incentivized FFS payment model. On a per capita basis, the US 
is ranked among the lowest of all industrialized countries in most measures of health care 
outcome indicators. In particular, indicators of chronic disease (diabetes, obesity, asthma, heart 
disease) prevalence in the US are among the highest in the world. (Davis, Schoen, & Stremikis, 
2010).  
Chronic disease is well documented as the leading cause of total health care expenditures 
(Carpenter, 2008; Garrett & Martini, 2007; Scopelliti & Spinelli, 2011). As we age, we are more 
likely to become diagnosed with a chronic disease—by 2020, nearly one-third of all Americans 
(nearly 160 million) will have at least one chronic disease to manage (Bodenheimer, Chen, & 
Bennett, 2009). And it is estimated that by 2023, the aging American population will consume 
nearly 80 percent of the total health care dollars spent (Bodenheimer et al., 2009).  
In addition to the increasing number of people reaching age 65 (Bodenheimer et al., 
2009), millions more are already without adequate access to health care (Berwick, Nolan, & 
Whittington, 2008). Communities are unable to provide access to primary care for the expanding 
populations of the poor and the uninsured (Pear, 2011). Even though the US economy has been 
slow to recover from an economic recession that began in 2008, health care premiums have 
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continued to rise, and outpace inflation by a factor of four (Commins, 2010). These economic 
trends are unsustainable. 
Purpose of the Study 
The purpose of this research is to measure the impact of recognized PCMH practices on 
utilization of hospital care related to ambulatory care sensitive conditions (ACSC). According to 
several demonstration projects sponsored by various payers across the US, the PCMH model has 
been successfully demonstrated (within individual practice locations) to reduce hospital 
admissions and emergency room visits for a range of diseases (Averill et al., 2009; Dusheiko, 
Doran, Gravelle, Fullwood, & Roland, 2011; Gilfillan et al., 2010; Slowik, 2011; Wade, Furney, 
& Hall, 2009). But although results have been promising, they are potentially biased due to 
payment incentives; moreover, they are not generalizable across the fragmented care delivery 
system. More important, the studies focused primarily on the effectiveness of the individual 
practice with an assigned patient cohort. To date, studies do not demonstrate the aspects of the 
PCMH model that actually drive care coordination on a broader scale and result in improved 
population health outcomes and lower utilization of more expensive inpatient care within a 
community’s health care continuum.  
Other studies articulate the importance of the PCMH “neighbor,” such as care 
coordination among specialists and hospitals, to effectively manage care across the continuum 
(Wade et al., 2009). We have yet to develop an outcomes-based approach to measuring the wider 
impact of the growing numbers of PCMH practices within geographic areas, and their numbers 
may now be sufficient to affect the health of the broader population, as envisioned by the chronic 
care model and desired by policymakers intent on reforming the state of health care in the 
country. 
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This study aims to build on prior research demonstrating that geographic areas with 
higher concentrations of PCDs experienced reduced utilization of hospital admissions (David 
Bradley & Thomas, 2010). This study will determine if communities with higher concentrations 
of PCMH-recognized PCDs experience a lower rate of risk-adjusted composite ACSC hospital 
admissions compared with communities with lower concentrations of PCMH-recognized PCDs. 
It is hypothesized that communities with higher PCMH-recognized concentrations will have 
lower avoidable hospital admissions, as measured by using AHRQ’s risk-adjusted Composite 
PQIs. 
Significance of the Study 
The key construct of this proposed study is that better primary care ( a subsystem of the 
overall health care system) that follows the Chronic Care Model (CCM), as measured by NCQA 
PCMH evaluation standards, leads to better population health and less use of more costly 
medical care, such as hospitalizations. Other studies have concluded that the best primary care 
delivery model is one that practices the PCMH principles, which are based on the CCM of team-
based, whole-person, primary care (Clark, 1995; Gilfillan et al., 2010; Stange et al., 2010). The 
PCMH standards go much farther than the CCM in that they not only define the functions of the 
care delivery model, but also describe the necessary infrastructure that supports PCMH 
functions, such as patient registries and electronic communication (cyber infrastructure). 
With the national interest to achieve the triple aim and the legislative action to reform the 
US health care system through ACOs and electronic health records (EHR), there is a significant 
need to monitor the success of these legislative reforms. Much of the anticipated rationale for 
moving forward with legislative initiatives was based on localized successes of PCMH 
demonstrations or pilot projects (e.g., within a health system, within a group practice), not on a 
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broad scale (communitywide). Thus, it is unclear how the localized successes will affect 
comprehensive implementations like ACOs or if meaningful use of EHRs will help achieve the 
intended national agenda of bending the cost curve downward while increasing access to care 
and improving quality of care: the triple aim. 
Introduction to the Theoretical Framework 
This study will employ the PCMH constructs from the perspective of the classical health 
services research effectiveness described by Aday, et al. (2004): effectiveness of the health care 
delivery system (quality measurement), as prescribed by Donabedian and Kane, can be divided 
into three compartments—structure, process and outcomes. This model supports research 
activities to determine the effectiveness of the PCMH as a subsystem of the US health care 
system as it relates to the General Systems Theory. It is a widely held belief that the 
effectiveness of a system is the degree to which improvements to the inputs into the system are 
attainable (Aday et al., 2004). The theoretical framework supports this study’s research 
hypothesis as follows: 
1. Structure of effective primary care delivery: PCMH is a team-based, whole-person 
approach to delivering primary care that is based in principle on the CCM and acts as 
a foundational subset of the larger US health care system. 
2. Processes of effective primary care delivery: Interventions (PCMHs) manage 
wellness of enrolled patients to prevent avoidable hospital admissions. 
3. Outcomes of effective primary care delivery: Increasing numbers of recognized 
PCMH practices can reduce preventable ACSC hospital admissions as defined and 
measured by the risk-adjusted AHRQ Composite PQIs. 
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This study intends to build on the General Systems science theory as applied to health care. 
In this context, the US health system has been defined as an incomplete system that operates in 
the zone of chaos (Janecka, 2009). General Systems Theory thinking postulates that laws 
(principles) governing biological open systems can be applied to systems of any form, as 
follows: 
1. Parts (subsystems) that make up the system are interrelated 
 The primary care practice is the “subsystem,” interrelated with the overall health 
care system 
2. The health of the overall system is contingent on how well the subsystems perform 
 The overall performance of the health care system operates more efficiently if the 
subsystems (primary care) operate more efficiently 
3. Open systems import and export material from and to the environment 
 Patients of primary care become patients of hospitals, and vice versa 
4. Boundaries are permeable (materials can pass through) 
 Patients can access both hospitals and primary care practices 
5. There is relative openness (the system can regulate permeability) 
 Primary care practices and hospitals can “regulate” (coordinate) care between and 
among each other for their patients 
Building on Janecka’s research, this study proposes to establish that outcome-based 
measures of ACSC risk-adjusted composite PQI rates are affected by increasing concentrations 
of well-structured primary care delivery subsystems: PCMHs. In this context, this study 
postulates that the effectiveness of the overall health care system, as measured by the outcomes 
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of hospital admission rates (AHRQ composite PQIs), is affected by the intervention of increased 
PCMH concentrations among PCDs within communities (Figure 1).   
 
 
 
Summary of Data Sources 
The dependent variables in this study are the Agency for Healthcare Research and 
Quality (AHRQ) Composite PQIs, which have been shown to be effective as an outcome 
measure of effective primary care’s role in avoiding unnecessary hospital admissions. Each of 
the three composite PQIs (90 [Overall], 91 [Acute], and 92 [Chronic]) are based from the 13 
individual disease-specific conditions PQIs. PQI 90 represents all 13 PQIs; whereas PQI 91 is an 
amalgam of the acute disease-specific conditions, and PQI 92 is an amalgam of the 10 chronic 
disease-specific conditions. 
The independent variables for this study are the PCD concentrations, PCMH 
concentrations and the PCMH capability composites. The PCD concentrations or each county 
was developed from the CMS National Provider Identification (NPI) dataset for total doctors and 
the population demographics were taken from the population files within the AHRQ PQI 
Figure 1: PCMH Intervention Framework 
 
PCMH Model of Care (IV) 
PCMH 
Principles 
Practiced 
Healthier 
Patients 
Recognized 
PCMHs in 
Community 
Reduced 
Composite PQI 
Hospitalizations 
Comp. Risk Adj. PQI Rates (DV) 
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programming logic. This study utilized the AHRQ PQI SAS (Version 5, March 2015) 
programming logic to run the 2008 (pre) and 2011 (post) State Inpatient Data (SID) from 
Vermont and North Carolina. These data will be matched to the NCQA PCMH dataset and CMS 
NPI datasets based on the state/county FIPS identifiers. 
 The PCMH capabilities composites were derived from the 160 PCMH elements by 
grouping them into the 10 capabilities mapping established by the Center for Health System 
Change, a Meaningful Use (MU) composite based on a NCQA crosswalk mapping, and a Must-
Pass (MP) composite based on the NCQA must-pass elements.  
Chapter Summary and Overview of Remaining Chapters 
The indicators are clear: the US health care system is producing increasingly unhealthy 
citizens at a much higher total cost per patient than any other industrialized country in the world. 
The value proposition (Total Quality/Total Cost = Total Value) is inversely proportionate from 
what it should be for the dollars invested in the system. Given that the US population is 
increasingly aging and that chronic disease prevalence will continue to grow at untenable levels, 
the US Legislative Branch enacted laws to shake up the fee-for-service (FFS) medical care 
system and promote a more accountable health system. 
Unlike the current FFS model, where volume-over-value is the care delivery model 
driving the patient/provider interaction, an ACO is focused on value over volume. An ACO is a 
provider-led team of clinicians that accepts responsibility for the whole-person management of 
the patient population. It is postulated that an ACO can only be effective if the foundation of the 
subsystem of care (primary care) is organized in a team-based and patient-centered structure to 
deliver optimal care based on the CCM.  
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The NCQA PCMH Recognition program has evaluated ~4,800 primary care practices 
across the country. Some areas have higher densities (concentrations) of recognized practices 
than others. The intent of this paper is to study these communities with various recognized-
PCMH practice concentrations and their impact, as measured by the outcome of hospital 
utilization related to chronic conditions. In addition, this study will evaluate functions in 
recognized PCMH practices to understand which of the 160 standards correlate to hospital 
utilization. 
Chapter Two of this proposal will focus on establishing the validity of the proposed 
measurement constructs, based on prior research in the areas of General Systems Theory, 
Donabedian ’s quality improvement construct, the CCM, PCD concentration, PCMH 
concentration, and avoidable hospital admission rates.  
Chapter Three will leverage the literature review results and apply them to a theoretical 
framework based on the hypothesis that primary care as a subsystem of the total health care 
system, when organized around the CCM as measured by the NCQA PCMH Recognition 
program, will positively impact (reduce) the communitywide utilization of inpatient care, 
particularly for patients with chronic conditions.  
Chapter Four provides the details of the research methodology to test the theoretical 
constructs presented in Chapter Three.  
Chapter Five provides the results of the statistical analysis described by the 
methodological approach in Chapter Four.  
And finally, Chapter Six provides an assessment, implications, and conclusions supported 
by the statistical analysis and results from Chapter Five. 
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Chapter 2: Literature Review 
 
 
Overview 
Central tenets of an effective PCMH are care coordination and whole-person care 
management across the continuum of care. The intent of this proposal is to conduct a literature 
review to support the constructs of a model that will use a risk-adjusted outcome measure to 
evaluate the impact of PCMH concentrations among PCDs in various communities. The model 
will then be used to conduct a retrospective analysis of NCQA-Recognized PCMH practices and 
hospital admission rates for select chronic disease conditions in a community (using FIPS 
designations).  
This study will inform the extent to which the PCMH model can determine differences in 
risk-adjusted ACSC chronic disease condition composite rates in various communities. 
Evaluation elements in the PPC-PCMH standards will also be reviewed for correlations with the 
risk-adjusted ACSC rates. Understanding the effect of these associations at the community level 
will inform policymakers about the effects and broader implications of the PCMH model’s 
ability to bend the total cost of health care downward. 
Background 
Although much literature has been published regarding the success of the PCMH model 
in reducing costs in specific practice settings, within specific patient populations and for specific 
conditions, no study measures the impact of these localized phenomenon on a broader scale. 
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Health care reform has moved forward with major legislation that places effective 
primary care at the center of the path toward a more efficient system of care.  
This study will research current literature for evidence to support a model that can 
demonstrate the effect of the primary care subsystem at the community level, to inform the 
national reform agenda. 
General Systems Theory postulates that laws (principles) governing biological open 
systems can be applied to systems of any form, as follows: 
1. Parts (subsystems) that make up the system are interrelated 
2. The health of overall system is contingent on subsystem performance 
3. Open systems import and export material from and to the environment 
4. Boundaries are permeable (materials can pass through) 
5. There is relative openness (the system can regulate permeability). 
Building on Janecka’s research, this study proposes to establish the effectiveness of 
primary care (as measured by the PCMH) as a subsystem of the overall US health care system 
(Figure 1). In this context, the vigor of the overall system is contingent on the PCMH functioning 
as a subsystem, as measured by the outcomes of risk-adjusted ACSC hospital admission rates in 
various communities. 
Models of Primary Care Delivery 
The chronic care model. In the late 1990s, via the MacColl Institute, Ed Wagner 
published his findings on interventions used to treat various chronically ill patients (Coleman, 
Austin, Brach, & Wagner, 2009). His review of interventions noted that four categories of 
practice changes led to the greatest improvements in health: increasing doctors’ expertise and 
skill; educating and supporting patients; making care delivery more team based and planned; and 
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making better use of registry-based information systems (Coleman et al., 2009). These findings 
formed the basis of the CCM, whose overall goal is to enhance the patient/provider relationship 
through engagement that transforms patients into proactive participants in their health care. The 
CCM delivery of primary care requires physicians to manage the care of their patient population 
by leveraging patient registries and other clinical information systems to support a team-based 
practice. 
Over a decade after the CCM, Coleman, et al. (2009) published findings on a literature 
review from more than 80 articles citing results of using one of the 6 areas of the CCM. “To be 
defined as CCM-based, an intervention had to integrate changes that involved most or all of the 
six areas of the model: self-management support, decision support, delivery system design, 
clinical information systems, health care organization, and community resources” (Coleman et 
al., 2009, p. 76). The evaluation concluded that chronic care was improved when one or more 
CCM areas were implemented; when higher-performing practices implemented multiple 
elements in an integrated delivery model, there were even stronger results of better outcomes—
but results were inconclusive regarding the effect of CCM-based care on reducing the total cost 
of care. 
It is well documented that patients with chronic disease conditions, particularly multiple 
chronic conditions, utilize more health care resources than patients with no chronic disease 
conditions (Bodenheimer et al., 2009; Garrett & Martini, 2007; Hamar et al., 2011; Lewis, 2009; 
Scopelliti & Spinelli, 2011). A study (Hamar et al., 2011) conducted in Germany on a senior 
population (>65) evaluated the effect on hospital admission rates when practices implemented a 
proactive chronic care management program for patients with chronic disease conditions. The 
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results of this study demonstrated a 6% decrease in overall admission rates for the control group, 
compared to an 18% increase in the uncontrolled group—a 24% difference. 
Bodenheimer, et al., (2010) identified that the health care reform of 2009–2010 is poised 
to highlight the current shortage of PCDs in the US. They contend that the number of patients 
with complex chronic disease conditions, requiring more frequent visits and visit duration (time) 
from PCDs, is increasing. Although they conclude that the uneven geographic distribution of 
practitioners should be addressed by the government at a macro level, they also determined that 
several micro-level adjustments could achieve better access to care. They suggested micro-level 
changes to the primary care practice setting to align with the team-based CCM and PCMH 
delivery of care principles. 
The patient-centered medical home. Although the PCMH concept was introduced by 
the American Academy of Pediatrics (AAP) more than 40 years ago, it recently became the 
nation’s foundational health reform initiative. Four of the nation’s premier primary care 
associations came together in 2007 to promulgate the seven joint principles of the PCMH 
(Stange et al., 2010): 
1. Personal Physician: All patients know their personal physician. 
2. Physician-Led: The physician leads a team-oriented practice; collectively, the team is 
responsible for the ongoing care of patients across the health care continuum. 
3. Whole-Person Accountability: The personal physician is accountable for coordinating 
all of the patient’s health care needs among and across the complete health care 
continuum. 
4. Coordinated/Integrated Care: All elements of care are coordinated through the use of 
patient registries and other management structures to ensure that the patient navigates 
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the continuum of the health care system (e.g., specialty care, home care, inpatient 
care). 
5. Quality and Safety: Practice performance is measured against clinical guidelines to 
ensure that the team uses evidence-based interventions for all patients. 
6. Enhanced Access: Access to the practice team is improved through extended operating 
hours or digital access (e.g., e-mail), to facilitate the patient/provider relationship. 
7. Payment: Practices are supported with fiscal incentives to promote value of care over 
volume of care (FFS model).  
This study will build on research indicating that higher concentrations of PCDs in a 
geographic area may lower the utilization of more costly and preventable inpatient care; focusing 
on a model that will utilize risk-adjusted outcome measures specific to ACSCs. The research will 
extend the PCD concentration construct by examining primary care delivery functions (as 
measured by NCQA’s PCMH Recognition results) to determine which aspects of the PCMH 
model have the greatest impact on reducing preventable ACSC hospital admissions. 
The PPC-PCMH model incorporates the CCM principle domains and gives the industry a 
roadmap for transforming the primary care delivery structure and measuring the extent to which 
practices achieve optimal care delivery for their patient populations (Figure 2). Flottemesh, et al. 
(2011) used multivariate analysis to examine the impact of the PPC-PCMH on total cost of care. 
Using 2008 data, the research examined the relationship of 21 practices on total costs, against the 
practice’s score on the PPC-PCMH Readiness Survey. Although the readiness scores reflected 
insignificant changes in total cost of care (outpatient and inpatient), higher functioning PCMHs 
(Level 3) showed significant decreases in cost, particularly among more complex (costly) 
patients (Flottemesch et al., 2011).  
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Figure 2: The CCM Domain Measured by the PPC-PCMH Elements. Reprinted from 
“Relationship of Clinic Medical Home Scores to Health Care Costs,” by T. J. Flottemesch, et al., 
2005, J Ambulatory Care Manage Vol. 34, No. 1, pp. 78–89. Copyright 2011 by Wolters Kluwer 
Health Lippincott Williams & Wilkins. Reprinted with permission.
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Gaps in Knowledge 
The literature review (Table 1) indicates that when primary care is managed in a team-
based, whole-person primary care setting (vs. practices that do not utilize PCMH principles), 
there is improvement in the quality of care and a reduction in the utilization of more expensive 
health care resources. The majority of the literature, however, is focused on the aspects of a 
single practice site location vs. the broader communitywide impact within the health care 
continuum; and the outcomes being measured were typically specific to a disease condition or 
fiscal incentive program.  
 
Table 1: Literature Review Summary 
Article Intent/Approach Results Conclusions Limitations 
General Systems Theory: Health Care Delivery System 
“Is U.S. health 
care an 
appropriate 
system? A 
strategic 
perspective from 
systems 
science” 
(Janecka, 2009) 
Comparative study using 
the general systems 
science theory against 
the US health care 
system. 
The US health care 
system currently 
operates in the zone of 
chaos (an incomplete 
system). 
If the US health care 
system complied 
with general 
systems science, it 
would improve its 
value creation for 
society as a whole. 
This is a theoretical study 
lacking in concrete 
examples to demonstrate 
how the US health care 
system might evolve to 
achieve improved benefits. 
Primary Care Practice (PCP)—Subsystem of Health Care Delivery System 
“Health Care 
Utilization and 
the Proportion 
of Primary Care 
Physicians” 
 
A retrospective cross-
sectional analysis with 
generalized estimating 
equations to determine if 
measures of health care 
utilization (inpatient  
Higher proportions of 
PCDs were associated 
with significantly 
decreased utilization, 
with each 1% increase 
in proportion of PCDs  
Increased 
proportions of PCDs 
appear to be 
associated with 
significant 
decreases in  
Definition of primary care 
capabilities is generally 
assumed (primary care = 
preventive care); there are 
no defined standards or 
evaluations of primary care  
(Kravet et al., 
2008) 
admissions, outpatient 
visits, ED visits, 
surgeries) were 
associated with the 
proportion of PCDs to 
total physicians in 
metropolitan statistical 
areas. These 
relationships were 
consistent each year 
studied. 
associated with 
decreased yearly 
utilization for an 
average-sized 
metropolitan statistical 
area of 503 admissions, 
2,968 ED visits and 
512 surgeries. 
measures of health 
care utilization 
across the 1990s. 
delivery practice 
effectiveness. The general 
assumption is that greater 
access to primary care of 
any capability will reduce 
hospitalizations. 
“Re-examining 
the impact of the 
primary care 
physician 
workforce on  
Re-examine the 
association between the 
proportion of PCDs and 
health care utilization 
rates in an area. This  
Higher proportions of 
PCDs in the area’s 
physician supply is 
associated with a 
decreased number of  
There is some 
evidence that a 
higher concentration 
of PCDs is 
associated with a  
It is unclear what factors 
caused the aggregation 
affect. This study looks at 
proportion of primary care  
 18 
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Article Intent/Approach Results Conclusions Limitations 
health care 
utilization 
rates”(Wright & 
Ricketts, 2010) 
study focuses on health 
care utilization in the US 
using inpatient 
admissions, outpatient 
visits, ER visits and total 
(both inpatient and 
outpatient) surgeries as 
dependent variables in 
separate regressions. 
Several community-level 
control variables are also 
included. 
inpatient admissions at 
the MSA level, but not 
at the county level, and 
a decreased number of 
ER visits at the county 
level, but not the MSA 
level. Outpatient visits 
and total surgeries are 
not associated with the 
proportion of PCDs. 
decrease in health 
care utilization, but 
these findings 
depend on the level 
of aggregation. 
Investigators should 
be aware of the 
implications of 
aggregating data 
and acknowledge 
resultant limitations. 
to specialty care without 
measuring impact on 
specific disease conditions 
(e.g., ACSCs). 
Primary Care Practice (PCP)—Subsystem of Health Care Delivery System 
“Estimating a 
Reasonable 
Patient Panel 
Size 
for Primary 
Care Physicians 
With Team- 
Based Task 
Delegation” 
(Altschuler, 
Margolius, 
Bodenheimer, & 
Grumbach, 
2012) 
Growth of team-based 
primary care is 
growing. Study aimed 
to measure the extent of 
team panel size under 
different models of task 
delegation. 
Under the various 
delegation models 
analyzed, the authors 
obtained results ranging 
from 1,300–1,900 
patient panel sizes for 
the teams to adequately 
deliver preventive and 
chronic care services. 
Under the different 
models, the authors 
concluded that the 
current primary care 
workforce could 
provide 
recommended 
preventive and 
chronic care 
services. 
The authors cited that the 
average panel sizes in the 
US in 2009 were 2,300 on 
average, but no evidence of 
a range or geographic 
differences. The authors 
present and accept that 
current primary care 
practices only provide 55% 
of the recommended 
preventive and chronic care 
services. This study is 
based on a fictitious panel 
and not on actual 
performance of a given 
practice or practice model. 
“Networks of 
primary and 
secondary care 
services: how to 
organise 
services so as to 
promote 
efficiency and 
quality in access 
while reducing 
costs” (Farinha, 
Duarte Oliveira, 
& de Sá, 
2008)Duarte 
Oliveira, & de 
Sá, 2008) 
Three simulations 
(using Simul8) modeled 
within a national health 
system (Portugal) to 
demonstrate the effect 
of various policy 
decisions on primary 
and secondary (e.g., 
hospitals, specialty 
care) networks of care 
utilization.  
Scenario I simulated a 
10% increase in 
demand for primary 
care services in a 
specific region of 
Portugal, indicating that 
the current system 
cannot sustain such an 
increase. Scenario 2 
simulated a 50/50 ratio 
of primary to specialty 
care (currently at 
37/63), resulting in the 
expected result of 
decreasing demand on 
specialty care.  
Scenario 3 simulated 
the closure and shift of 
ER services to primary 
care services, resulting 
in an unchanged 
demand in specialty 
care with an overall 
total decrease in cost of 
care by ~8%. 
Using a simulation 
model is cost-
effective to aid 
policymakers in 
devising more 
efficient use of 
resources that can 
nudge the health 
care system toward 
more appropriate 
uses of health care 
resources. 
This simulation 
demonstrated the “system-
ness” between the primary 
and secondary care 
networks (e.g., changes in 
one affect the other) and 
associated utilization/costs 
of each, but it did not 
address the quality of care 
(or health outcomes) of the 
simulated changes on the 
patient populations within 
modeled areas of care. 
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Article Intent/Approach Results Conclusions Limitations 
Chronic Care Model (CCM) 
“The Impact of 
Proactive 
Chronic Care 
Management on 
Hospital 
Admissions in a 
German Senior 
Population” 
(Hamar et al., 
2011) 
Determine if proactive 
CCM results in reduced 
hospital admissions. 
A 6% reduction in hospital 
admissions within the 
control group vs. an 18% 
increase in the compare 
group. 
Demonstrated that 
proactive CCM can 
reduce hospital 
admissions in older 
populations, 
especially those with 
multiple chronic 
conditions. 
Target population 
(>65) limits the 
generalizability of 
results to other age 
groups with similar 
conditions. Regression 
to the mean is a cited 
concern, given the 
target population had 
several comorbidities. 
The evaluation of 
proactive care 
management was not 
assessed against a 
standard model (e.g., 
PCMH recognition) 
“Translating the 
Chronic Care 
Model Into the 
Community” 
(Piatt et al., 
2006) 
To determine whether 
using the chronic care 
model (CCM) in an 
underserved community 
leads to improved 
clinical and behavioral 
outcomes for people 
with diabetes. This 
multilevel, cluster-
design, randomized 
controlled trial 
examined the 
effectiveness of a 
CCM-based 
intervention in an 
underserved urban 
community.  
A marked decline in HbA1c 
was observed in the CCM 
group but not in the other 
groups. The magnitude of 
the association remained 
strong after adjustment for 
clustering. The CCM group 
also showed improvement 
in HDL cholesterol, 
diabetes knowledge test 
scores, and empowerment 
scores. 
These results suggest 
that implementing the 
CCM in the 
community is 
effective in 
improving clinical 
and behavioral 
outcomes in patients 
with diabetes. 
This study focused on 
a specific chronic 
disease condition 
without consideration 
of co-morbidities or 
risk adjustments 
within a narrow 
population which 
limits generalizability 
of the results.  
“Evidence On 
The Chronic 
Care Model In 
The New 
Millennium” 
(Coleman et al., 
2009) 
Retrospective lit review 
of articles published 
about the impacts of 
CCM care delivery on 
ambulatory health 
practice/system 
effectiveness. 
In most studies, there was 
improvement in both 
international and U.S. 
based practices.  
More research is 
needed on CCM cost-
effectiveness, but 
these studies suggest 
that redesigning care 
using the CCM leads 
to improved patient 
care and better health 
outcomes. 
Most of the studies 
reflected the results of 
highly performing 
practices without 
consideration of how 
other practices may 
perform using the 
CCM and limits the 
generalizability of the 
results. 
“Improving 
Primary Care 
for Patients 
With Chronic 
Illness”  
(Bodenheimer, 
Wagner, & 
Grumbach, 
2002) 
This article reviews 
research evidence 
showing the extent to 
which the CCM can 
improve management of 
chronic conditions 
(using diabetes as an 
example) and reduce 
health care costs. 
Thirty-two of 39 studies 
found that interventions 
based on CCM components 
improved at least 1 process 
or outcome measure for 
diabetic patients. Regarding 
whether chronic care model 
interventions can reduce 
costs, 18 of 27 studies 
concerned with 3 examples 
of chronic  
Even though the 
CCM has the 
potential to improve 
care and reduce costs, 
several obstacles 
hinder its widespread 
adoption. 
Unclear which aspects 
of the CCM were 
evaluated. 
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  conditions (congestive 
heart failure, asthma, 
diabetes) demonstrated 
reduced health care 
costs or lower use of 
health care services. 
  
Patient-Centered Medical Home (PCMH): Process and Structure 
“Practice Systems 
Are Associated With 
High-quality Care for 
Diabetes” (Solberg, 
Asche, Pawlson, 
Scholle, & Shih, 
2008) 
Determine if evidence 
of practice systems 
affected quality of care 
related to diabetes 
using the PPC-RS 
questions and scores. 
Evidence suggests 
(correlated at 0.31 to 
0.52 [P <.05]) that 
practice systems (as 
measured by the PPC-
RS) can affect the 
quality of care for 
diabetes. 
The PPC-RS tool 
(measuring structure/ 
process) suggests 
usefulness in guiding 
practices to attain 
quality improvement 
for patients with 
diabetes. 
Focused on a specific 
disease across a cohort 
of 40 practices 
participating in a 
statewide quality 
improvement 
initiative. The PPC-RS 
was self-administered 
by each practice site 
participating. 
“Relationship of 
Clinic Medical Home 
Scores to Health Care 
Costs” 
(Flottemesch et al., 
2011) 
Determine PCC-
PCMH effects on total 
cost of care. 
A reduction in costs 
was noted for higher 
performing PPC-PCMH 
practices among the 
most complex patients 
(>11 medications). 
Results only suggest, 
given the limitations 
of the evaluation 
methodology. In 
addition, the patient 
sample population 
came from groups of 
high continuity of 
care with low 
fragmentation. 
Practice sites included 
were assessed against 
a readiness assessment 
version of the PPC-
PCMH and not 
recognized practices. 
In addition, all practice 
sites were part of one 
institution located in 
one geographic region. 
“Illness Care: 
Findings From a 
National Study of 
Care Management 
Processes in Large 
Physician Practices” 
(Rittenhouse, 
Shortell, & Fisher, 
2009) 
Evaluate patient 
outcomes in the 
Demonstration Project 
(NDP) of practices’ 
transition to PCMHs. 
Quasi-experimental 
design to assess 
differences between 
facilitated and self-
directed practices  
Facilitated practices 
adopted more NDP 
components than self-
directed practices. 
After two years, there 
was small 
improvement in 
condition-specific 
outcomes of care and 
no differences in 
patient-rated 
outcomes.  
Focus on condition-
specific outcomes of 
care that were not 
consistent among the 
practices electing to 
transform into 
PCMHs. 
Patient-Centered Medical Home (PCMH): Process and Structure 
“Vermont Blueprint 
for Health” 
(Vermont Blueprint 
for Health Report: 
2013 Annual Report, 
2014) 
Using its all payer 
claims database, VT 
evaluated the 
effectiveness of its 
statewide health 
services model, which 
is based on 
incentivizing primary 
care practices to 
transform into NCQA-
Recognized PCMH 
practices. The quality 
of care was measured 
by using NCQA 
HEDIS performance 
measures. 
Reduction in annual 
expenditures; a shift to 
more primary care 
utilization and less 
specialty care; reduction 
in hospital utilization 
and pharmacy services; 
increase in utilization of 
nonmedical services by 
Medicaid patients. 
The PCMH model of 
care continues to be a 
more cost effective 
primary care delivery 
model than more 
traditional primary 
care delivery. 
Patients seen in 
PCMH-recognized 
practices were 
healthier, as 
measured by NCQA 
HEDIS rates, than 
patients seen in non-
PCMH practices. 
While this study is one 
of a few in the 
literature that analyzes 
cost and quality 
impact of PCMH 
practices, it is difficult 
to ascertain the impact 
that the additional 
support from the 
community health 
team (CHT) has on the 
state’s success vs. the 
PCMH model of care 
alone. 
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“The Patient-
Centered Medical 
Home: A Systematic 
Review” (Jackson et 
al., 2013) 
Literature review of 
articles describing 
PCMH 
implementation and 
effect on patient and 
staff experiences, 
process of care and 
clinical and 
economic outcomes. 
Mixed results from 19 
comparative studies. 
There was a small 
positive effect on 
patient/staff experiences.  
Evidence of reduction in 
utilization of ED visits, 
but not in hospital 
admissions in older 
adults. No evidence of 
total cost savings. 
Current evidence 
appears insufficient to 
determine effects on 
clinical and most 
economic outcomes, 
but the PCMH model 
holds promise for 
improving experiences 
of patients/staff; and 
potentially for 
improving care 
processes. 
Given that there was 
no standard definition 
used for PCMH in this 
study, the results are 
severely limited, 
making evaluation 
across studies 
susceptible to bias 
selection in terms of 
comparisons/conclusio
ns drawn. 
“Total Cost of Care 
Lower among 
Medicare Fee-for-
Service Beneficiaries 
Receiving Care from 
Patient-Centered 
Medical Homes” 
(van Hasselt, 
McCall, Keyes, 
Wensky, & Smith, 
2014) 
Compare cost to care 
for Medicare 
patients in practices 
that were PCMH 
recognized against 
practices that were 
not. 
Results demonstrated 
that the cost of care and 
utilization of ER visits in 
PCMH practices was 
lower than practices not 
recognized (compare 
group). 
This study provides 
additional evidence 
that the PCMH model 
of care may lower the 
total cost of care.  
This study focused on 
Medicare patients 
only. It was also 
limited in determining 
the gross total cost 
savings vs. total net 
cost of care (cost to 
become PCMH and 
associated savings). 
There was evidence 
that more savings 
occurred for “sicker” 
patients, but no quality 
measures were 
evaluated to determine 
if health care quality 
is/was affected. 
Ambulatory Care Sensitive Conditions (ACSC): AHRQ Preventable Quality Indicators (PQI)—Outcome Measure 
“Expanding the uses 
of AHRQ's 
prevention quality 
indicators: Validity 
from the clinician 
perspective” 
(Davies S.M., 2009) 
Validate the 
appropriate uses of 
the AHRQ PQI 
Measures, via an 
expert clinical panel. 
Not all the indicators 
received expert panel 
consensus for use as a 
comparison measure. 
The risk-adjusted 
composite (PQI) received 
consensus by the clinical 
expert panel to have 
comparability at the 
geographic/regional 
level. 
The panel concluded 
that regional 
comparisons were 
more appropriate than 
facility comparisons. 
There was consensus 
that the PQIs were not 
appropriate for use as 
pay-for-performance 
standards on 
individual doctors. 
Limited number of 
research studies using 
PQIs to measure 
system effectiveness. 
Use of PQIs as a 
measure of system 
effectiveness is 
supported, but not as a 
comparative measure 
for provider-level 
effectiveness of care or 
payment incentives. 
“Trends in 
Potentially 
Preventable Hospital 
Admissions among 
Adults and Children, 
2005–2010” (Torio, 
Elixhauser, & 
Andrews, 2013) 
Analyze the AHRQ 
NIS dataset to 
determine trends in 
hospitalizations. 
Overall, potentially 
preventable hospital 
(AHRQ PQIs) 
admissions for adults and 
children trended 
downward nationally for 
selected conditions 
monitored during the 
period analyzed (2005–
2010), with greater 
decreases in the pediatric 
community (<18 years 
old). 
The report provides no 
conclusions; this is not 
a study of potential 
associations or 
causality of why PQI 
rates declined overall 
or specifically to each 
condition. However, 
downward trends can 
signal possible 
improvement in the 
primary care delivery 
system. 
This statistical brief 
provides descriptive 
data on the overall 
national trending of 
the AHRQ PQIs 
during the 5-year 
period observed. It is 
limited in its use 
because there are no 
rationale or probable 
conditions provided, 
which may have 
affected the downward 
trend.  
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There are mixed conclusions about the PCMH model’s ability to realize actual savings or 
reduce health care utilization on a broader scale; therefore, this study intends to address the gap 
in the literature by focusing on the community-level effect of PCMH-recognized practices, as 
measured by the communitywide utilization of more expensive inpatient care related to ACSCs. 
This study will also address the impact of the PCMH delivery model capabilities, as measured by 
the points achieved on each NCQA Recognition program evaluation element that correlates to 
the measurement outcome of the AHRQ ACSC Risk-Adjusted Composite PQIs. 
Chapter Summary 
The literature provides several examples that the PCMH model of primary care has a 
positive effect on patient populations managed by general primary care practices, but there is 
inconclusive evidence that increasing numbers of PCMH practices in a community reduces the 
total cost of care and improves health, as suggested by the ACA legislation. Although the 
literature supports the hypothesis that practices organized around PCMH principles can affect 
cost reduction and quality of care, there has not been a study to establish if greater concentrations 
of PCMH practices provide better quality of population health than higher concentrations of 
PCDs alone.  
Research indicates that higher concentrations of PCDs can help reduce utilization of ER 
and inpatient services, but studies did not indicate how PCDs functioned within their practices or 
if the reduction in hospitalizations where specific to disease conditions. This study intends to 
close the gap in understanding how the structure and processes within a primary care subsystem 
may have an impact on disease-specific conditions within community populations, as measured 
by the risk-adjusted AHRQ ACSC composite PQIs.  
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The results of this study will provide an outcomes-based model for policymakers and 
decision makers to measure the impact that healthcare reform legislation is having on a 
community-wide scale; and could serve to inform community leaders about the progress of the 
triple aim—whether its goals of increased access, reduced cost and improved quality of care are 
on track. 
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Chapter 3: Theoretical Framework 
 
 
Introduction 
The key theoretical assumption of this proposed study is that better primary care follows 
the chronic care model (CCM) and leads to better population health, less chronic disease and less 
use of costly medical care such as hospitalizations. Earlier studies concluded that coordinated 
primary care management of patient populations by specific practice location can reduce costs of 
care, particularly for patients with chronic disease conditions (David Bradley & Thomas, 2010; 
Dusheiko et al., 2011; Jaén et al., 2010; Liss et al., 2011).  
Other studies concluded that the best care delivery model is defined and widely accepted 
as practicing the PCMH principles, which are fundamentally based on the CCM of team-based, 
whole-person primary care (Clark, 1995; Gilfillan et al., 2010; Stange et al., 2010). The PCMH 
standards go much farther than the CCM in that they not only define the functions of the care 
delivery model, but also include the necessary infrastructure that supports PCMH functions, such 
as patient registries and electronic communication. 
Background 
With the national interest to achieve the triple aim and the legislative action to reform the 
US health care system through ACOs and EHRs, there is a significant need to monitor the 
success of healthcare reform legislation on attaining the triple aim. Much of the anticipated 
rationale for moving forward with legislative initiatives was based on localized successes of 
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PCMH demonstrations or pilot projects (e.g., within a health system, within a group practice), 
not on a broad scale (communitywide). Thus, it is unclear how the localized successes will affect 
comprehensive implementations like ACOs, or if meaningful use of EHRs will help achieve the 
intended national agenda of bending the cost curve downward while increasing access to care 
and improving quality of care. 
Therefore, the significance of this study is to highlight the progress of national health 
reform with regard to the PCMH model and use of EHR technologies. 
This study will employ the PCMH constructs from the perspective of the classical health 
services research effectiveness described by Aday, et al. (2004), that effectiveness of the health 
care delivery system (quality measurement), as prescribed by Donabedian and Kane, can be 
divided into three compartments of structure, process and outcomes. This model supports 
research activities to determine the effectiveness of the PCMH as a subsystem of the US health 
care system as it relates to the General Systems Theory. It is a widely held belief that the 
effectiveness of a system is the degree to which improvements in the inputs to the system are 
attainable (Aday et al., 2004). The theoretical framework (structure, process, outcome) supports 
this study’s research hypothesis as follows: 
1. The structure of the primary care delivery model (PCMH): Team-based, whole-person 
approach to delivering care 
2. PCMH processes: Interventions to manage wellness of enrolled patients to reduce 
chronic conditions 
3. Outcomes: Reduced ACSC hospital admissions related to chronic conditions 
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General Systems Theory 
This study intends to build on the General Systems Theory, as applied to health care. In this 
context, the US health system has been defined as an incomplete system that operates in the zone 
of chaos (Janecka, 2009). General Systems Theory thinking postulates that laws (principles) that 
govern biological open systems can be applied to systems of any form, as follows: 
1. Parts (subsystems) that make up the system are interrelated 
2. The overall health of the system is contingent on subsystem functioning 
3. Open systems import and export material from and to the environment 
4. Boundaries are permeable (materials can pass through) 
5. Relative openness (system can regulate permeability) 
Building on the research of Janecka and the General System Theory, this study proposes 
to establish the effectiveness of the PCMH as a subsystem of the overall US health system 
(Figure 4). In this context, the effectiveness of the overall health system is largely contingent on 
PCMH functioning as a subsystem. Effectiveness can be measured by the outcomes of hospital 
admission rates among ACSCs. The primary care subsystem can regulate the input (patients) to 
hospitals by keeping healthy patients healthy and sick patients (chronic conditions) better 
managed at home. 
Health care delivery system. Shi and Singh (2008) describe US health care as a 
“kaleidoscope of financing, insurance, delivery, and payment mechanisms that remain 
unstandardized and loosely coordinated” (p. 4). Adding to this kaleidoscope of payment 
mechanisms are the capitalistic incentives of a complex, market-oriented system that attracts a 
variety of entrepreneurs seeking innovative ways to maximize profits. “A complex system 
exhibits several major characteristics: a large number of interacting parts; interactive complexity; 
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and self-organization” (Tan, Wen, & Awad, 2005, p. 3). Perrow’s Framework of Complexity 
categorizes system (organization) complexity by its degree of “coupledness” (tightly or loosely) 
and interactivity (simple or complex). The more loosely coupled and highly interactive an 
organization is, the more highly complex it is (Tan et al.). Given that the US spends nearly twice 
as much per capita for its current health care system and produces far less healthy outcomes, as 
measured by the increasing numbers of patients with multiple chronic conditions, it is fair to 
conclude that the current system is ineffective and loosely coupled, with a high degree of 
complex interactivity among its various subsystems. 
Subsystems of health care delivery. Although organizational entities within the US 
health care system vary in ownership type (e.g., for profit, not for profit), management structure 
(e.g., board of directors, board of trustees) and size and scope of services, each operates within 
its own boundaries as a hierarchical structure of units forming microsystems of care delivery. 
The American health care system’s level of complexity is underscored by more than 10 million 
workers spread geographically among nearly 6,000 hospitals, more than 16,000 nursing homes, 
more than 4,000 mental health institutions and thousands of physician practices, all managed 
under a variety of organizational structures (Shi & Singh). 
Based on the data, we can conclude that the US health care system has a variety of 
hierarchical entities that comprise highly interactive and loosely coupled (complex) 
microsystems (subsystems) operating on the basis of fiscal incentives that induce optimization of 
payment vs. optimization of health care. As such, a health care organization (HCO) functions as 
a complex adaptive system (CAS) composed of diverse agents (health care doctors) serving in 
various roles and exchanging information nonlinearly during the delivery of health care services 
(McDaniel, Lanham, & Anderson, 2009).  
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But several studies indicate a more effective health care delivery model—specifically, 
primary care—can result in better outcomes for patients and reduced total health care costs. 
The Chronic Care Model 
Over a decade after the Chronic Care Model (CCM) (Figure 3), Coleman, et al. (2009) 
published their findings of a literature review from more than 80 articles citing evidence of using 
one of the 6 areas of the CCM. “To be defined as CCM-based, an intervention had to integrate 
changes that involved most or all of the six areas of the model: self-management support, 
decision support, delivery system design, clinical information systems, health care organization, 
and community resources” (Coleman et al., 2009, p. 76). Their evaluation concluded that chronic 
care improved when one or more CCM areas were implemented—and when higher-performing 
practices implemented multiple elements in an integrated delivery model, there were even better 
outcomes—but results were inconclusive regarding the effect of CCM-based care on reducing 
the total cost of care. 
 
Figure 3: The Chronic Care Model (CCM). Reprinted from the Improving Chronic Illness Care 
Web site. Retrieved September 16, 2015, from http://www.improvingchroniccare.org. Copyright 
The MacColl Center. Reprinted with permission.   
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The patient-centered medical home. The PPC-PCMH model incorporates the CCM 
principle domains and gives the industry a roadmap for transforming and measuring the care 
delivery model. Four of the nation’s premier primary care associations came together in 2007 to 
promulgate the seven joint principles of the PCMH (Stange et al., 2010): 
The Physician Practice Connections—Patient-Centered Medical Home (PPC-PCMH) 
model incorporates the CCM principle domains and gives the industry a roadmap for 
transforming and measuring the care delivery model. Four of the nation’s premier primary care 
associations came together in 2007 to promulgate the seven joint principles of the PCMH 
(Stange et al., 2010): 
1. Personal Physician: All patients know their personal physician. 
2. Physician-Led: The physician leads a team-oriented practice; collectively, the team is 
responsible for the ongoing care of patients across the health care continuum. 
3. Whole-Person Accountability: The personal physician is accountable for coordinating 
all of the patient’s health care needs among and across the complete health care 
continuum. 
4. Coordinated/Integrated Care: All elements of care are coordinated through the use of 
patient registries and other management structures that ensure the patient navigates 
the continuum of the health care system (e.g., specialty care, home care, inpatient 
care). 
5. Quality and Safety: Practice performance is measured against clinical guidelines to 
ensure that the team uses evidence-based interventions for all patients. 
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6. Enhanced Access: Access to the practice team is improved through extended 
operating hours or digital access (e.g., e-mail), to facilitate the patient/provider 
relationship. 
7. Payment: Practices are supported with fiscal incentives to promote value of care over 
volume of care (FFS model).  
Although the PPC-PCMH standards do not mandate the use of EHRs as “must-pass” 
elements to achieve PCMH recognition, the standards are closely aligned with the meaningful 
use of electronic health record technologies outlined in the Health Information Technology for 
Economic and Clinical Health (HITECH) Act. 
The HITECH Act legislation—released in 2009 as part of the American Recovery and 
Reinvestment Act (ARRA)—is designed to energize the adoption and meaningful use of certified 
EHR systems (McLeod, 2009). Meaningful use (not just implementation) is defined in that 
legislation as an eligible provider’s use of EHR system functionalities that demonstrate the 
following (Blumenthal, 2010): 
1. Use of a certified EHR in a meaningful manner (e.g., e-prescribing) 
2. Use of certified EHR technology for electronic exchange of health information to 
improve quality of health care 
3. Use of certified EHR technology to submit clinical quality and other measures 
By the end of 2011, the adoption of basic EHR technologies in the doctor’s office had 
doubled (16% to 33%) as a result of the monetary incentives provided by the HITECH act (Hsiao 
& Hing, 2014). In addition to more practices having a basic EHR technology, there was a 15% 
increase (from 42% to 57%) in practices having any form of EHR technology to manage clinical 
care. Many practices that adopted EHR technologies during 2008–2011 were positioned to 
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achieve higher PCMH recognition scores, given that over 50% of the evaluation elements benefit 
from some form of cyber-infrastructure.  
The HITECH meaningful use criteria and PCMH recognition standards are closely 
aligned. Twenty-one of the 26 MU program objectives can be measured by the NCQA PCMH 
Recognition program (Table 2). The 5 areas of the MU program not measured by PCMH  
 
Table 2: Crosswalk Meaningful Use (Stage) 1 to PPC-PCMH Standards (2008) 
Stage 1 Objectives 
Eligible 
Professionals (EP) Stage 1 Measures 
NCQA PPC-PCMH 
Standard 
Degree of Alignment 
Comments 
NCQA Recognition 
Evaluation Points 
Available 
Use CPOE (computerized 
physician order entry) 
For EPs, CPOE 
(computerized physician 
order entry) is used for at 
least 80% of all orders.  
PPC-PCMH 5: 
Electronic Prescribing, 
Element A 
 Practice uses electronic 
Rx writer. 
 (100% = ≥75% of new 
prescriptions written in 
last 3 months written 
linked to patient 
information). 
 Practice uses electronic 
system. 
High 
PCMH does not require 
transmittal. 
3 
Generate and transmit 
permissible prescriptions 
electronically (eRx) 
At least 75% of all 
permissible prescriptions 
written by the EP are 
transmitted electronically 
using certified EHR 
technology. 
Maintain an up-to date 
problem list of current and 
active diagnoses based on 
ICD-9-CM or SNOMED 
CT® 
At least 80% of all unique 
patients seen by the EP 
have at least one entry or 
an indication of none 
recorded as structured 
data. 
PPC-PCMH 2: Patient 
Tracking and Registry, 
Element A, Practice uses 
electronic data to 
document current and past 
diagnoses 
(100% =12-18 items 
entered for 75% of 
patients)  
Medium 
 ICD 9 or SNOMED not 
specified. 
 Factor 13, “Current and past 
diagnoses” not required. 
2 
Record demographics At least 80% of all unique 
patients seen by the EP 
have demographics 
recorded as structured 
data. 
High 
Check insurance eligibility 
electronically from public 
and private payers 
Insurance eligibility 
checked electronically for 
at least 80% of all unique 
patients seen by the EP. 
Medium 
Eligibility not necessarily 
checked electronically 
Maintain active medication 
list 
At least 80% of all unique 
patients seen by the EP 
have at least one entry (or 
an indication of “none” if 
the patient is not currently 
prescribed any medication) 
recorded as structured 
data. 
PPC-PCMH 2: Patient 
Tracking and Registry 
Functions, Element D, 
Practice uses paper or 
electronic charting tools, 
including prescribed 
medications. 
Medium 
 Not required to be electronic. 
 Prescribed medications do not 
have to be one of the tools or 
care management. 
6 
Implement drug-drug, 
drug-allergy, drug 
formulary checks 
The EP has enabled this 
functionality 
PPC 5: Electronic 
Prescribing, 
Elements B, C 
 System has general 
and/or patient specific 
information and alerts at 
the point of care: drug-
drug interactions, drug-  
High  
5 
 32 
Table 2: Continued 
Stage 1 Objectives 
Eligible 
Professionals (EP) Stage 1 Measures 
NCQA PPC-PCMH 
Standard 
Degree of Alignment 
Comments 
NCQA Recognition 
Evaluation Points 
Available 
  disease interactions, 
drug-allergy alerts.  
(100% = 8 or more alerts) 
 Electronic system has 
generic and formulary 
checks. 
(100% = both checks) 
 
 
Report ambulatory quality 
measures to CMS or to 
state. 
For 2011, provide 
aggregate numerator and 
denominator through 
attestation. 
PPC-PCMH 8: 
Performance Reporting 
and Improvement, 
Element F: Practice 
reports performance 
electronically. 
High 1 
Incorporate clinical lab-
test results into EHR as 
structured data. 
At least 50% of all clinical 
lab tests ordered whose 
results are in a positive/ 
negative or numerical 
format are incorporated in 
certified EHR technology 
as structured data. 
PPC-PCMH 6: Test 
Tracking, Element B: 
Practice uses electronic 
system to retrieve lab and 
imaging results. 
High 
Lab tests not necessarily 
completed field 
6 
Implement 5 clinical 
decision support rules 
relevant to specialty 
or high clinical priority, 
including diagnostic test 
ordering, along with the 
ability to track compliance 
with those rules. 
Implement 5 clinical 
decision support rules 
relevant to the clinical 
quality metrics the EP is 
responsible. 
PPC-PCMH 3: Care 
Management, Element A 
Practice adopts and 
implements evidence-
based guidelines for 3 
important conditions  
(100% = Guidelines for 3 
conditions) 
High 
Each guideline will contain 
multiple decision support rules 
3 
Provide clinical summaries 
for patients for each office 
visit. 
Clinical summaries are 
provided for at least 80% 
of all office visits 
PPC-PCMH 4: Self-
Management Support, 
Element B: Practice 
provides written care plan 
(100% = 3 of 7 activities 
for ≥75% of patients with 
3 important conditions) 
Low 
 Not necessarily electronic 
 Written care plan not 
necessarily required 
 Population measured is those 
with 3 important conditions 
4 
Record smoking status for 
patients 13 years old or 
older. 
At least 80% of all unique 
patients 13 years old or 
older seen by the EP have 
“smoking status” recorded 
PPC-PCMH 3: Care 
Management, Element B 
 Practice uses paper or 
electronic system for 
guideline-based 
reminders, including age 
appropriate risk factors 
(smoking) and 
counseling for smoking 
cessation  
(100% = reminders for all 
4 situations) 
Medium 
 Paper or electronic 
 Age-appropriate risk factors 
not necessarily required 
 PPC-PCMH 3, Element B 
 
4 
Generate lists of patients 
by specific conditions to 
use for quality 
improvement, reduction of 
disparities, and outreach. 
Generate at least one 
report listing patients of 
the EP with a specific 
condition. 
PPC-PCMH 2: Patient 
Tracking and Registry, 
Element F: Practice uses 
electronic information to 
generate lists of patients. 
High 
3 
Send reminders to patients 
per patient preference for 
preventive/follow up care. 
Reminder sent to at least 
50% of all unique patients 
seen by the EP that are age 
50 or over. 
Perform medication 
reconciliation at relevant 
encounters and each 
transition of care. 
Perform medication 
reconciliation for at least 
80% of relevant 
encounters and transitions 
of care. 
PPC-PCMH 3: Care 
Management, Element 
D: Practice reviews 
medication lists with 
patients. 
Medium 
 Not electronic 
 Important conditions (3) 5 
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Table 2: Continued 
Stage 1 Objectives 
Eligible 
Professionals (EP) Stage 1 Measures 
NCQA PPC-PCMH 
Standard 
Degree of Alignment 
Comments 
NCQA Recognition 
Evaluation Points 
Available 
Provide patients with an 
electronic copy of their 
health information 
(including diagnostic test 
results, problem list, 
medication lists, allergies), 
upon request 
At least 80% of all patients 
who request an electronic 
copy of their health 
information are provided it 
within 48 hours. 
PPC-PCMH 9: Advanced 
Electronic 
Communication, Element 
A: Patients have access to 
interactive Web site to 
make appointments, 
request referrals, test 
results and prescription 
refills, see parts of medical 
record and import 
elements into PHR. 
High 
1 Provide patients with 
timely electronic access to 
their health information 
(including lab results, 
problem list, medication 
lists, allergies) within 96  
hours of the information 
being available to the EP 
At least 10% of all unique 
patients seen by the EP are 
provided timely electronic 
access to their health 
information. 
Submit claims 
electronically to public and 
private payers. 
At least 80% of all claims 
filed electronically by the 
EP.  
Not in 2008 standards None None 
Capability to exchange key 
clinical information among 
doctors of care and patient 
authorized entities 
electronically 
Performed at least one test 
of certified EHR 
technology's capacity to 
electronically exchange 
key clinical information. 
Capability to submit 
electronic data to 
immunization registries 
and actual submission 
where required and 
accepted 
Performed at least one test 
of certified EHR 
technology's capacity to 
submit electronic data to 
immunization registries. 
Capability to provide 
electronic syndromic 
surveillance data to public 
health agencies and actual 
transmission according to 
applicable law and practice 
Performed at least one test 
of certified EHR 
technology's capacity to 
provide electronic 
syndromic surveillance 
data to public health 
agencies. 
Protect electronic health 
information created or 
maintained by the certified 
EHR technology through 
the implementation of 
appropriate technical 
capabilities 
Conduct or review a 
security risk analysis per 
45 CFR 164.308 (a)(1) and 
implement security 
updates as necessary. 
 
evaluation are specific to the capability of the electronic system being implemented (e.g., system 
capability to submit claim, system capability on privacy/security) and are not directly related to 
the functional capabilities of delivering care.  
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The PCMH capability composites were formed by mapping specific PCMH elements to 
each of the capability categories and then averaging the points earned by each of the recognized 
practices within each FIPS area being evaluated. 
AHRQ Preventable Quality Indicators (PQI) 
For this study, the 16 AHRQ PQIs are used as outcome measures to ascertain the effect 
of PCMH-recognized primary care practices on managing the communitywide population of 
patients admitted for ACSCs. ACSC measures have been shown to be sensitive to the 
concentration of PCDs (Scopelliti & Spinelli, 2011; Slowik, 2011); however, a review of the 
literature indicates a gap in knowledge about which primary care practice models or functions of 
primary care delivery affect hospital utilization in a community. This study will expand on these 
validated AHRQ PQI measures as an indicator of primary care effectiveness among counties in 
Vermont and North Carolina.  
In 2009, responding to the concern that quality measures can be used for provider pay-
for-performance initiatives, AHRQ convened an expert panel to review the use of PQIs as 
comparative measures. The panel concluded that PQIs are effective when they compare health 
care system delivery performance at an area level (e.g., regional, health system), but not when 
they are used as individual provider-based comparative measures (Davies S.M., 2009). The 
intent of this study is to compare the health care delivery system as a “total system” of care 
networks in geographic areas (counties) within a state.  
Two states were used in this study to control and limit the research scope, yet include 
sufficient measured communities to strengthen the study’s statistical analysis and 
generalizability. To conduct comparative analysis with statistical validity, the AHRQ SAS PQI 
program requires the complete set of discharges from each hospital in a comparison/study. 
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Vermont has ~50K discharges for each year in the study and North Carolina has ~1.1M; each 
state represents sufficient numbers of PCMH-recognized practices, with varying concentrations 
among the counties for variation and statistical validity. 
Delivery System Reform 
In March 2010, President Obama signed the Patient Protection and Affordable Care Act 
(PPACA) into law, with the goals of widening access to care for 32 million uninsured 
Americans, creating a more healthy population and providing an affordable health care system to 
all Americans (Doherty, 2010). Several of its many provisions were aimed at key issues plaguing 
the current health care delivery system and its failure to achieve the triple aim of increased 
access, improved care and reduced costs. However, there is widespread debate about the 
potentially adverse economic consequences the provisions may have on individuals and 
communities, because PPACA fails to fundamentally reform the fragmentation and volume-
over-value incentives that currently plague the system (Staff, 2010).  
Some of PPACA’s more controversial provisions are the mandate for individuals to 
purchase insurance coverage, the mandate for states to establish health insurance exchanges and 
the mandate for states to provide universal access to care (Staff, 2010). However, there is a 
provision to fund voluntary efforts that may offer incentives to health care delivery systems to 
reorganize into ACOs. 
“An ACO is a provider-led organization whose mission is to manage the full continuum 
of care and be accountable for the overall costs and quality of care for a defined population” 
(Rittenhouse et al., 2009). The aim of the ACO concept is to reform financing and delivery of 
care into structures where there is shared responsibility and accountability for the total cost and 
quality of the care delivered. Shortell and Casalino (2007) introduced the concept of an 
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accountable care system that could take five forms, with variations of the degree of strengths 
among the seven core capabilities (Figure 4).  
 
Figure 4: Accountable Care System Models and Core Capabilities. Reprinted from the Policy 
Archive Web site. Retrieved September 17, 2015, from http://research.policyarchive.org. 
Copyright 2015 CGS and Policy Archive. Reprinted with permission. 
 
The intent of recognizing the various forms of the ACO model is to enable the current 
fragmented delivery care system to form provider-led arrangements (e.g., group practice, 
hospital, health plan provider network) through which to coordinate all patient care. Although 
they are uniquely different models of care, each model must practice the core principles of the 
PCMH to a varying degree. Figure 4 illustrates each different ACO arrangement and the degree 
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(high, medium, low) to which each core capability has a concentration of PCMH-like core 
capability. 
The importance of the ACO model to this research study is that the ACO model builds 
from the core concept of a well-coordinated primary care home for patients—the PCMH is the 
ACO’s foundational building block. “The PCMH model emphasizes the creation of a strong 
primary care foundation for the health care system, and the ACO model emphasizes the 
alignment of incentives and accountability for doctors across the continuum of care” 
(Rittenhouse et al., 2009, p. 3). 
In theory, the PCMH care delivery model should produce healthy patients and reduce the 
prevalence of chronic diseases; the ACO model rewards those outcomes with fiscal incentives. 
Some would argue that these models are no different from health maintenance organizations 
(HMO), in that they attempt to give the health care delivery system an incentive to manage care. 
Others contend that the difference between the failed insurance-led (HMO) attempts of the 1990s 
and the most recent attempts of today’s PCMH/ACO model is that the latter are “provider-led” 
(Rittenhouse et al., 2009).  
Arguments aside, legislative mandates make it clear that the government is moving 
forward with health care reform. An important aspect of this study is to inform policymakers of 
about a framework to measure the impact of the PCMH model of care at a community-wide level 
(Doherty, 2010).  
If, after several years of transforming primary care around the principle PCMH tenets, 
there is no correlational effect on the utilization of inpatient care directly related to ambulatory 
sensitive care conditions, the probability that ACOs will be more effective than current delivery 
models is likely to be in jeopardy. 
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Although PPC-PCMH standards do not mandate the use of EHRs as must-pass elements 
to achieving PCMH recognition, the standards are strongly aligned with the meaningful use of 
electronic health record technologies, as outlined in the HITECH Act. Released in 2009 as part 
of the ARRA, it is designed to energize the adoption and meaningful use of certified EHR 
systems (McLeod, 2009). Meaningful use (not just implementation) is defined in that legislation 
as an eligible provider’s use of EHR system functionalities that demonstrate the following 
(Blumenthal, 2010): 
1. The use of a certified EHR in a meaningful manner (e.g., e-prescribing) 
2. The use of certified EHR technology for electronic exchange of health information to 
improve quality of health care 
3. The use of certified EHR technology to submit clinical quality and other measures 
Conceptual Framework 
Figure 1 illustrates how the various theories described in this chapter form the hypothesis 
of this research paper, beginning with the broader concept of the General Systems Theory, which 
postulates that the primary care setting is a subsystem of the US health care system, through the 
Donabedian theory of quality improvement (QI), whereby structure and processes used in the 
subsystem beget better health care outcomes.  
With a focus on the primary care setting as a regulator of care within the total care 
continuum, the CCM defines a model of practice for primary care. It postulates that primary care 
practices should use a team-based, whole-person delivery of care construct to manage patient 
populations effectively to avoid the onset of chronic conditions, as well as to manage patients 
with chronic conditions efficiently. The NCQA PCMH standards are a tool for measuring a 
practice’s delivery of care capabilities and use of cyber-infrastructure to transform into an 
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effective and efficient delivery model, as described by the CCM. The NCQA PCMH standards 
and elements define and further evaluate primary care team capabilities (Table 3 and Figure 5).  
Table 3: Primary Care Capabilities Mapped to the PCMH Elements (2008 Version) 
Percent 
of 
Elements 10 PCMH Capability Composites* Element 
Pts 
Avail** 
46% 1. Information Technology (IT): 
19 items on e-prescribing 
 
18 items on electronic data system for patient demographic data 
14 items on the use of email, e-communication, interactive Web site, 
electronic patient notification, e-care management support 
 
11 items on electronic system for basic clinical data 
8 items on electronic system for managing tests  
7 items on electronic system for population management 
5A# 
5B# 
5C# 
2A#  
9A#  
9B  
9C  
2B  
6B#  
2F# 
3 
3 
2 
2 
1 
2 
1 
3 
6 
3 
Total: 26 
14% 2. Condition Specific Care (CSC): 
Care for three specific conditions that the practice identifies as important to their 
patient panel, e.g. including identifying those patients, use of condition specific 
guidelines, care management and self-management support. 
2E^ 
3A^ 
3D# 
4B^# 
4 
3 
5 
4 
Total: 16 
13% 3. Coordination of Care (COC):  
1 item on scheduling visits to different doctors into 1 trip 
4 items on referral-tracking 
6 items on test tracking and follow-up 
10 items assess information continuity across settings (e.g. care transitions) 
 
1A^ 
7A^ 
6A^ 
3E# 
 
4 
4 
7 
5 
Total: 20 
9% 4. Accessibility (ACC) 1A^ 
1B^ 
4 
5 
Total: 9 
5% 5. Performance Reporting (RPT) 8A^ 
8C^ 
8D 
3 
3 
3 
Total: 9 
4% 6. Clinical Data Tools (CDT) such as problem lists and medication lists 2D^# 4 
2% 7. Use of Non-Physician Staff (NON) 3C 3 
2% 8. Patient Experience (PXP) With Care  
1 item on access to care 
1 item on physician communication  
1 item on patient confidence in self-care 
1 item on satisfaction with care 
 
8B 
 
3 
1% 9. Preventive Services (PVS) 3B# 4 
1% 10. Patient Communication (PTC) Preferences  4A 2 
*Table adapted from concept mappings developed by the Center for Health System Change (O'Malley, Peikes, & Ginsburg, 
2008). The term “items” refers to the underlying factors (questions) within each element of the NCQA evaluation tool. 
**Points available do not total 100 because some elements not used in mapping—only 97% of elements mapped 
^Must-Pass (MP) Elements 
#Meaningful Use (MU) Elements (Note: Some MU-related Elements 2C, 3A, 8F are displayed in MU crosswalk table – not 
this table above.) 
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Figure 5: PCMH Capability Composite Mapping to PCMH Elements 
MU MP IT CSC CoC ACC RPT CDT NoN PXP PVS PTC
PCMH1* 9
PCMH1_A 4 X X X
PCMH1_B 5 X X
PCMH2* 21
PCMH2_A 2 X X
PCMH2_B 3 X
PCMH2_C 3 X
PCMH2_D 6 X X X
PCMH2_E 4 X X
PCMH2_F 3 X X
PCMH3* 20
PCMH3_A 3 X X X
PCMH3_B 4 X X
PCMH3_C 3 X
PCMH3_D 5 X X
PCMH3_E 5 X X
PCMH4* 6
PCMH4_A 2 X
PCMH4_B 4 X X X
PCMH5* 8
PCMH5_A 3 X X
PCMH5_B 3 X X
PCMH5_C 2 X X
PCMH6* 13
PCMH6_A 7 X X
PCMH6_B 6 X X
PCMH7* 4
PCMH7_A 4 X X
PCMH8* 15
PCMH8_A 3 X X
PCMH8_B 3 X
PCMH8_C 3 X X
PCMH8_D 3 X
PCMH8_E 2
PCMH8_F 1 X
PCMH9* 4
PCMH9_A 1 X X
PCMH9_B 2 X
PCMH9_C 1 X
Total Pts Avail 100 51 43 26 16 20 9 9 6 3 3 4 2
PCMH Capability CompositesScored PCMH 
Elements
Pts 
Avail
*=PCMH Standard Level (aggregations and sub score of each PCMH elemental category)
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Study Hypotheses 
The results of this study and each specific aim will advance our understating of the 
impact that PCMH-recognized practices have in their communities. This study will inform 
policymakers where we are in the journey to achieving the triple aim—increasing access to care, 
improving quality of care, reducing total cost of care—through propagation of PCMHs and 
meaningful use of EHRs. 
Specific Aim 1, with its associated sub-aims, seeks to inform the hypothesis that delivery 
of primary care in communities (as defined by counties within a state) are affected by the 
increasing densities of recognized PCMH practices within communities. The structure- and 
process-based evaluation of the NCQA PCMH Recognition program is the basis for determining 
achievement of PCMH transformation at each PCD practice location. Each sub-aim of Specific 
Aim 1 looks at the relationships of PCD (Sub-Aim 1) and PCMH (Sum-Aim 2) densities on risk-
adjusted PQI composite rates within communities.  
Specific Aim 2 investigates the effect of various PCMH capabilities composites; 
composites derived from the scores that PCMH practices attained on their respective NCQA 
recognition. The MU and MP composite capabilities are evaluated via a correlation and 
regression analysis of the effect that each composite has on risk-adjusted PQI rates (Sub-Aim 1). 
Each of the 10 capability composites are evaluated as in a simple regression model to determine 
which of them predict the effect of the PCMH structure and process capabilities within 
communities (Sub-Aim 2).  
Table 4 illustrates the mapping of each aim and hypothesis with each aim’s independent 
variables (IV) and dependent variables (DV) of interest.
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Table 4: Mapping Specific Aims/Hypothesis to Variables and Analysis 
Aims/Hypothesis 
Intervention: 
Independent 
Variable (IV) 
Response: 
Dependent 
Variable (DV) Analysis 
Measurement 
Outcome 
SPECIFIC AIM 1: 
Define a model to measure 
the community-level 
impact of recognized 
PCMHs. 
Studies related to 
primary care 
structure and 
Recognized PCMHs 
Studies related to 
ACSC AHRQ PQI 
rates  
Literature 
Review 
Literature supports 
model to measure 
PCMH impact using 
Composite PQIs 
HYPOTHESIS (H1): Literature exists to support the proposed measurement framework. 
SPECIFIC AIM 2: Determine correlation of hospital admission rates for risk-adjusted ACSC Composite PQIs 
within a community when PCMH-recognized practices increase in number. 
SUB AIMS: 
1. Are risk-adjusted PQI 
rates affected by the 
PCD density among the 
114 FIPS areas? 
Concentration (ratio) 
of Primary Care 
Doctors (PCD) 
within a FIPS 
Delta (2008-2011) 
and the 2011 AHRQ 
risk-adjusted PQI 
composite rates by 
FIPS Area and by 
Age (Table 5) 
Multiple 
Regression 
R-Square of the 
overall regression 
and p-value of each 
correlation and beta 
coefficient 
2. Are risk-adjusted PQI 
rates affected by the 
PCMH density among 
the 114 FIPS areas? 
Concentration (ratio) 
of Recognized 
PCMH Doctors 
among FIPS 
population 
HYPOTHESIS (H2): Communities with PCMH-recognized practice concentrations among PCP practices will 
have lower avoidable ambulatory care sensitive condition hospital admission rates.  
SPECIFIC AIM 3: Determine which attributes of PCMH-recognized practices correlate with ACSC risk-
adjusted Composite PQIs. 
SUB-AIMS: 
1. Do the 10 PCMH 
capability composites 
(Table 3) effect risk-
adjusted PQI rates? 
Average of the 10 
PCMH Capabilities 
grouped PCMH 
practice element 
scores within a FIPS 
Delta (2008-2011) 
and the 2011 AHRQ 
risk-adjusted PQI 
composite rates by 
FIPS Area and by 
Age (Table 5) 
Multiple 
Regression 
R-Square of the 
overall regression 
and p-value of each 
correlation and beta 
coefficient 
 
2. Do MU (Table 2) 
capability composites 
effect risk-adjusted PQI 
rates? 
Average of the MU-
grouped PCMH 
practice element 
scores within a FIPS  
3. Do MP (Table 3) 
capability composites 
effect risk-adjusted PQI 
rates? 
Average of the MP-
grouped PCMH 
practice element 
scores within a FIPS 
   
HYPOTHESIS (H3): The use of EHR technologies and care coordination will affect avoidable ambulatory care 
sensitive condition hospital admission rates.  
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Chapter Summary 
This chapter presents the theoretical framework that will provide the majority of content 
for Specific Aim 1, defining a framework to measure the effect of the increasing concentration of 
PCMH-recognized primary care practices. Starting with the General Systems Theory, the 
research expands on the concept that various subsystems of primary care are central to the total 
health care system and can be organized optimally to improve the health of communities in 
which they operate, as measured by reduction in the utilization of more expensive inpatient care.  
The research is also based on Donabedian QI framework theory that the CCM provides 
the structure, the PCMH recognition program provides the practice transformation (processes) 
and the AHRQ ACSC Composite PQIs provides the outcome used to measure the impact of the 
intervention (recognized PCMH practices).  
Using these theories, the author established two main themes that will be analyzed in in 
Specific Aims 2 and 3. For Specific Aim 2, the author will focus on data analysis of the primary 
hypothesis that greater concentrations of recognized PCMHs will inform a decrease in utilization 
of inpatient care specific to the AHRQ ACSC risk-adjusted Composite PQIs. In addition to the 
primary aim, the author presents additional sub-aims to support the validity of the research 
design. In Specific Aim 3, the author will focus data analysis on determining which PCMH 
capabilities correlate with a reduction in the AHRQ ACSC risk-adjusted Composite PQIs. 
The research results of the three Specific Aims will provide community planners, health 
care decision makers (e.g., purchasers, employers, health plans) and state/federal government 
with a framework for measuring health care reform efforts. 
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Chapter 4: Methodology 
 
 
Introduction 
The intent of this study is to measure the effect of PCMH-recognized practices on 
hospitalizations related to ambulatory care sensitive conditions within a community. The 
hospitalization of patients with ACSCs has been consistently used in research studies as a 
reliable and valid outcomes-based proxy of health care resource utilization where increased 
utilization results in an increased total cost of care (Berry-Millett, Bandara, & Bodenheimer, 
2009; Bodenheimer, 2011; Bodenheimer et al., 2009; Gilfillan et al., 2010; Scopelliti & Spinelli, 
2011). This quasi-experimental research intends to utilize the AHRQ state inpatient dataset (SID) 
and the AHRQ ACSC Risk-Adjusted Composite PQIs to measure the impact of the increasing 
concentration NCQA-recognized PCMH practices among the communities (counties) within the 
states of Vermont (VT) and North Carolina (NC). This study will measure 2008 PQI rates (pre) 
and compare them to 2011 PQI rates (post) within each of the 114 counties within VT and NC. 
Furthermore, the study will evaluate correlations of the PCMH elements against the PQI rates 
within each of the counties being analyzed to determine effect. 
Research Design 
The author will establish the theoretical constructs, Specific Aim 1, through literature 
review and subsequent identification of knowledge gaps, leading to the rationale for studying 
Specific Aims 2 and 3. The methodology for addressing Specific Aim 2 builds upon the 
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established research that primary care concentrations effect utilization of more expensive health 
care (e.g., hospitalizations). Kravet et al., (2008) conducted a retrospective cross-sectional 
analysis of area resource use files from the 1990s to establish the primary care geographic 
concentration construct. This study will adapt the concentration construct to establish and 
demonstrate the effect of PCMH-recognized provider concentrations among primary care 
practices. Assuming there is an association, the author infers that the current direction of health 
care reform is likely on the right course; however, a lack of association may be cause for a 
course correction. Either way, this study will inform policy makers, community planners, and 
health care decision makers if the PCMH model is impacting community-level inpatient 
utilization, which accounts for 35% of the total health care expenditure.  
The evaluation of Specific Aims 2 and 3 begins with a descriptive analysis of the ~4,800 
NCQA PCMH-recognized practice database by geographic area which will demonstrate which 
communities within Vermont and North Carolina have experienced the greatest concentration of 
PCMH-recognized practices over a three-year period (2008–2011). Because the NCQA PCMH 
recognition program began in 2008, it is the intent of this study to use 2008 as a baseline (pre-
intervention) of PCMH recognized practices and the growth of PCMH recognized practices over 
a three-year period (2008-2011). An analysis of the NCQA PCMH recognition dataset will 
provide the number of recognized PCMHs, by zip code (grouped into FIPS), and by practice size 
(number of physicians) as of Dec 2011 (NCQA, 2011). In addition to the number of recognized 
practices and physicians within each community (FIPS area), the analysis will also provide a 
ratio of doctors-to-population per the overall population census within that community (FIPS). 
This study utilizes all hospital discharges from two points in time (2008 and 2011) from 
the Vermont State Inpatient (SID) database. The 2008 and 2011 Vermont SID was obtained by 
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submitting an application to the AHRQ HCUP program administrator (HCUP, 2011). The author 
will utilize the AHRQ PQI SAS program on each year (2008/2011) of the Vermont and North 
Carolina SID files to determine risk-adjusted Composite PQIs for each of the 114 FIPS (by age 
category) within each state. 
According to the Agency for Health care Research and Quality (AHRQ), chronic disease 
conditions account for nearly 35 percent of total US health care expenditures (HCUP, 2011). 
Several studies have indicated that by providing patients with chronic disease a designated 
primary care team that provides whole-person management (e.g., PCMH care), that the total 
costs of managing these patients can be reduced, primarily through the reduction of 
hospitalizations or readmissions as a result of those patients not properly managing their 
condition (Berry-Millett et al., 2009; Bodenheimer, 2011; Bodenheimer et al., 2009; Carpenter, 
2008; Gilfillan et al., 2010; Scopelliti & Spinelli, 2011). 
It is anticipated that the number of recognized physicians within a given community will 
provide increased access to PCMH care that could potentially affect the health of the population 
and their utilization of hospital services related to ambulatory care sensitive conditions (ACSCs). 
Based on this assumption, this study proposes to measure the correlation of the predictor 
variables in Table 3 on the expected hospitalization rates (response variable). A multiple linear 
regression analysis will be used to establish correlation of hospitalization among these disease 
conditions in communities with various concentrations of recognized PCMH practices.  
After establishing PCD/Population and PCD/PCMH ratios for each of the communities 
(FIPS counties), the communities will be compared in 2008 and again in 2011 to determine any 
change and/or correlation with the AHRQ ACSC risk-adjusted Composite PQIs. 
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In 2008, on average across the US, the ratio of primary care doctors was 100 for every 
100,000 people (1:1,000) in cities (urban communities) and 46 for every 100,000 people 
(1:2,174) in rural areas (Bodenheimer & Pham, 2010).  
In addressing Specific Aim 3, the author intends to build upon work by the Center for 
Studying Health System Change (CSHSC) regarding their categorization/grouping of the NCQA 
PPC-PCMH evaluation standards (Table 5). As a result of their study, they released a policy 
perspective regarding the heavy reliance (nearly 50% of the 160 elements) that the NCQA PPC-
PCMH evaluation program places on health information technology (cyber infrastructure), like 
electronic health record capabilities (O'Malley et al., 2008). The CSHSC study concluded that 
the PPC-PCMH evaluation criteria was heavily weighted on the information technology aspects 
and most practices would likely not be able to meet these evaluation elements. However, several 
studies conducted at individual practice sites have validated the importance of health information 
technology (HIT) and the cyber infrastructure necessary for an effective team-based, whole-
person approach at delivering PCMH-based primary care (Finkelstein, Barr, Kothari, Nace, & 
Quinn, 2011; Hunt et al., 2009). The HITECH meaningful use criteria strongly support the 
construct that EHRs are a necessary infrastructure enabling the planned (PPACA) health care 
reform legislation.  
In summary, the research methodology approach for Specific Aim 3 is to establish which 
of the PCMH capabilities impact the risk-adjusted PQI rates. As well, this study will establish a 
correlation coefficient equation that will predict the level of directional correlation the 
implementation/use of PCMH capabilities impact avoidable hospital admission rates. 
The strengths of this research design are its simplicity, data availability, and relevance to 
the current environmental climate regarding the national agenda to assess the impact of the 
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PCMH model, EHR technology use, and the foreshadowing of the ACO model potential/success. 
The study design is appropriate for the level of assessment at a community-wide level. There are 
limitations in making an inferential conclusion that increasing PCMH recognition alone is the 
cause of declining ACSC hospital admission rates. The author would not anticipate such a literal 
and direct interpretation. There are other environmental factors that could also impact hospital 
admission rates. In particular, the United States has recently experienced one of the worst 
economic downturns in recent history. There is an attempt to control for such environmental 
factors by using admissions per 1,000. Although attempts to control extraneous variables/factors 
may not entirely negate effects on admission rates, the analysis will establish the degree to which 
variance is explained in the model. As a result of potentially confounding factors, the statistical 
analysis will be supported with significance testing to support the strength of the statistical 
relationships. 
Research Design Validity 
This is a quasi-experimental, quantitative research design that leverages existing 
secondary data. The strengths in this research design are its use of existing data sources and its 
reproducibility from the county to state level as an outcomes-based measurement framework. 
The NCQA recognition data source will serve as the valid source of the intervention, 
independent variable (PCMH Recognition). In addition to using the existing data on PCMH 
recognitions and the validity of that measurement program, this study will leverage a tested and 
valid outcomes measurement dataset—the AHRQ Risk Adjusted Composite PQIs. As well, the 
accessibility of the data makes for a fiscally practical research design. However, there are threats 
to the internal and external validity of this study to consider.  
 49 
Threats to Internal Validity 
History. This study occurs between the years of 2008 (pre) and 2011 (post). During this 
time period, the country experienced an economic downturn. Such an economic shift would 
signal a probable downturn in healthcare utilization as more people are more likely to be without 
jobs and without healthcare insurance/access to care. As a result, a decrease in PQI rates could be 
impacted by this economic downturn. However, the economic event occurs across all FIPS, so 
the difference between the two measure points should be uniformly distributed. 
Maturation. This study is susceptible to the threat that practices, although not recognized 
by NCQA, may be utilizing the PCMH concepts to manage their populations. Meaning, PQI 
rates may be affected by better primary care practices that are not recognized by NCQA as 
having transformed. As well, this study is based on the earliest version of the PCMH evaluation 
standards which have been changed two times since its introduction to account for noted 
weaknesses in how the standards were written/evaluated. 
Testing. There is no knowledge of the actual practice “status”. This study assumes that 
all practices in all counties were not practicing the PCMH principles. As indicated with the 
maturation threat to internal validity, the testing threat poses the challenge that none of the 
practices were “pre-tested” to determine actual practice “status” before the intervention of 
PCMH recognition. 
Instrumentation. The validity/reliability of the PCMH recognition standards and the 
AHRQ PQI rates have been determined by each respective owner of the measurement tool. The 
strength of this study is in leveraging these existing measurement tools to test the research 
hypothesis. 
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There was a change in PCMH standards in 2011. So, this study only includes practices 
recognized on the 2008 NCQA standards. There is a possible threat in terms of instrumentation 
or construct validity of the PQI measures. Although the use of the PQI rate has been shown to be 
an effective measure of quality in terms of a population, there are no studies to date that attempt 
to tie PQI rates directly to the practice capability scores, or actual density of “practice type” by a 
recognition status. There is also the possibility that the outcome measurement (AHRQ PQI rates) 
may not necessarily be attributed to the specific actions of the recognized PCMH practices 
within the NCQA dataset (measurement/performance attribution). However, this research is 
testing the theory that the PCMH practice is a subsystem of the overall health care system and 
that changes to its delivery model extend into the community and can be measured by changes in 
the population’s utilization of inpatient services related to their potentially preventable 
hospitalizations (ambulatory-specific). Based on prior research that an individual PCMH 
recognized practice did better on treating patients with specific disease conditions after the 
intervention of transforming into a PCMH, there is a reasonable expectation that increasing 
concentrations of these recognized practices would have a broader community-wide impact.  
Statistical regression. There is a potential threat that the “floor effect” or “halo effect” 
may occur in terms of the practices that do or do not attempt NCQA recognition. For example, 
practices that may elect to become recognized may have already been practicing the PCMH 
principles, so that county would show smaller improvement (halo effect). There is also the 
possibility that a majority of practices in a county are performing very poorly and only a couple 
achieve NCQA recognition. Therefore, that county may appear to be performing poorly in 
relative comparison because the very poorly performing practices mask the improvements of the 
two practices that are NCQA recognized PCMHs (floor effect). 
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Selection of subjects. There is inherent selection bias in using the NCQA PCMH 
recognized practices because there is no randomized selection of which practices become 
recognized or not. As well, practices that decided to become recognized by NCQA may have 
already been “transformed” into PCMH practices prior to their formal recognition. However, 
prior research also indicates that practices often “think” they are practicing as a PCMH, only to 
be informed by the process of going through recognition that they find otherwise (Torda, Han, & 
Scholle, 2010).  
Threats to External Validity 
Population validity. This study uses all discharges in the entire state, so it includes the 
entire population within a state. It also uses all recognized practices within a state. So, this study 
is representative of all populations. In addition, this study uses data from two different states to 
ensure heterogeneity of the counties evaluated. This approach strengthens the design of this 
study. 
Ecological validity. There is a strong degree of validity to which the results of this study 
are reproducible across counties within the 46 states participating in the AHRQ HCUP state 
inpatient data submission process. 
 Interaction Effect of Testing. This study utilizes existing data (secondary data use), so 
there is no knowledge by the participants that “testing” of any sort is occurring. 
 Interaction Effect of Selection Bias. This study is susceptible to this threat because 
there is no way to know if practices were already practicing PCMH principles prior to 
the study, and no way to determine if the practices in counties without recognized 
PCMHs are actually practicing the principles of PCMH. 
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 Reactive Effects of Experimental Testing. As with the interaction effect of testing, this 
study is not susceptible to the “Hawthorne Effect” because there is no knowledge of 
the practices that there is a study. 
 Multiple Treatment Interference. This study is not susceptible to this potential threat to 
validity because the “treatment” is the achievement of PCMH recognition and the 
“subjects” are self-selecting to participate in the recognition program. 
Data Sources 
There are four primary data sources (and two derived from the four primary) used in this 
study to derive the variables of primary interest. Figure 6 illustrates the various data sources and 
how they are used to derive the variables used in this study.  
 
 
 
 Data Source A: State Inpatient Dataset (SID). The SID data files were obtained from 
the AHRQ HCUP Web site for each state (VT and NC) for each year, 2008 and 2011 
(HCUP, 2011). 
 Data Source B: Population by ages were provided by the AHRQ PQI SAS program 
that contains a population file to establish the PQI rates by FIPS, by age. 
Figure 6: Datasets used in study 
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 Data Source C: The AHRQ risk-adjusted PQI rates were derived by processing the 
four SID files for each state (VT and NC) for each year, 2008 and 2011. (DV) 
 Data Source D: The PCD ratio was derived from the CMS NPI dataset which provided 
the total primary care doctors with family practice (FP), internal medicine (Int Med), or 
general practice (GP) as their credential. The total population was then divided by the 
total primary care doctor within each FIPS to obtain the resultant PCD ratio. (IV) 
 Data Source E: The PCMH ratio was derived from the total NCQA-recognized 
primary care doctors divided by the total PCDs (Source D) within a FIPS. (IV) 
 Data Source F: The PCMH capability composites were derived from mapping each 
PCMH element to a defined practice capability and the scores of each practice within a 
given FIPS were averaged to obtain the PCMH capability composite for each FIPS 
area. 
In 2000, the Agency for Health care Research and Quality (AHRQ) developed a 
population-based outcome measure of potentially preventable hospital admissions affected by the 
effectiveness of outpatient care. Based on over a decade of work, the Prevention Quality 
Indicators (PQIs) and have been shown to effectively demonstrate use as an outcome of 
ambulatory care sensitive conditions (ACSCs). Based on hospital discharge data, the PQIs 
consist of 13 individual disease conditions ranging from acute (e.g., urinary tract infection) to 
chronic conditions (e.g., diabetes).  
For this study, the AHRQ Composite PQIs are used as an outcome measure to ascertain 
the impact of PCMH-recognized primary care practices in managing the community-wide 
population of patients admitted as a result of a preventable ambulatory care sensitive condition 
(ACSC). ACSC-related measures have been shown to be sensitive to the concentration of 
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primary care doctors (PCDs) (Scopelliti & Spinelli, 2011; Slowik, 2011); however, literature 
review indicates a gap in knowledge as to what primary care practice capabilities affect these 
ACSC hospital utilization rates within a community. Table 5 provides a complete listing of all 16 
PQIs, including the composites (overall, acute, chronic) that are based on a grouping of the 
individual measures. 
 
Table 5: AHRQ Prevention Quality Indicators (PQIs) 
PQI Title 
PQI 01 Diabetes Short-Term Complications Admission Rate 
PQI 02 Perforated Appendix Admission Rate 
PQI 03 Diabetes Long-Term Complications Admission Rate 
PQI 05 Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate 
PQI 07 Hypertension Admission Rate 
PQI 08 Heart Failure Admission Rate 
PQI 10 Dehydration Admission Rate 
PQI 11 Bacterial Pneumonia Admission Rate 
PQI 12 Urinary Tract Infection Admission Rate 
PQI 13 Angina Without Procedure Admission Rate 
PQI 14 Uncontrolled Diabetes Admission Rate 
PQI 15 Asthma in Younger Adults Admission Rate 
PQI 16 Rate of Lower-Extremity Amputation Among Patients With Diabetes 
PQI 90* Overall Composite (PQI 1, 3, 5, 7, 8, 10, 11, 12, 13, 14, 15 and 16) 
PQI 91* Acute Composite (PQI 10, 11 and 12) 
PQI 92* Chronic Composite (PQI 1, 3, 5, 7, 8, 13, 14, 15 and 16) 
*=PQI Composite rates used in this study 
 
In 2009, given the concern that quality measures may be used for provider-based pay for 
performance initiatives, AHRQ convened an expert panel to review the use of PQIs as 
comparative measures. The expert panels concluded that the PQIs are effective at comparing 
health care system delivery performance at an area level (regional, health system, etc.), but not as 
individual provider-based comparative measures or pay for performance (Davies S.M., 2009). 
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As of December 2014, NCQA had recognized nearly 4,800 primary care-based practices 
across the country as meeting the 2008 Physician Practice Connections Patient Centered Medical 
Home (PPC-PCMH) standards (NCQA, 2011) out of approximately 161,000 practice locations 
across the United States (Hing & Burt, 2007).  
Based on the NCQA recognized PCMH practice data and the AHRQ Composite PQI 
patient population file, the author conducted a preliminary analysis (Table 3) of PCMH 
provider/patient ratios within select communities in the state of Vermont where PCMH-
recognized practices exist. 
In order for a practice to be recognized by NCQA as a Patient-Centered Medical Home 
(PCMH), a primary care practice must meet several standards. Although there are only 10 must-
pass elements of the PPC-PCMH standards, there are over 160 elements that a primary care 
practice can attain points.  
There are 3 levels of “PCMH-ness” that a primary care practice can attain as a result of 
submitting their documentation for review by NCQA; however, the levels are not used as a 
variable in this study and only provided to understand how PCMH recognition is awarded: 
 Level 1: 25–49 points and 50% of points on 5 of the 10 must-pass elements 
 Level 2: 50–74 points and 50% of points on 10 of the 10 must-pass elements 
 Level 3: ≥75 points and 50% of points on 10 of the 10 must-pass elements 
The following descriptive data analysis is provided to confirm that there are enough geographic 
locations with varied provider/patient ratios from which to conduct the complete study. The areas 
selected for this observational study are based on the convenience of readily available data from 
the National Committee for Quality Assurance PCMH recognition database (NCQA, 2011), the 
Agency for Health care Research and Quality (AHRQ) Prevention Quality Indicators (Composite 
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PQI) database (HCUP, 2011), and the CMS National Provider Identifier datasets. According to a 
review of the NCQA PCMH dataset, there are approximately 1000 cities across the United States 
that have at least one PCMH recognized practice (Figure 7).  
 
Figure 7: NCQA PPC-PCMH Standards. Reprinted from the National Committee for Quality 
Assurance (NCQA) Web site. Retrieved September 17, 2015, from http://www.ncqa.org. 
Copyright NCQA. Reprinted with permission. 
 
As of 2012, NCQA had recognized ~4,800 practices across the country as meeting the 
2008 Physician Practice Connections Patient Centered Medical Home (PPC-PCMH) standards 
(NCQA, 2011). Based on this data, the author conducted a preliminary analysis of PCMH 
provider/patient ratios within select communities where PCMH-recognized practices exist. From 
this robust dataset, the author will be able to study a substantial number of PCMH-recognized 
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practices from which to understand the broader impact this delivery model is having within their 
respective communities.  
Table 6 depicts provider-to-population and NCQA recognized provider ratios within 
Vermont to illustrate the variation of ratios (concentrations) within the counties (FIPS). 
Table 6: PCMH Recognized Doctor-to-Population Ratios in Vermont 
 
  
Based on this data, the author conducted an analysis of PCMH provider/patient ratios 
within select communities where PCMH-recognized practices exist. From this robust dataset, the 
author will be able to study a substantial number of PCMH-recognized practices from which to 
understand the broader impact this delivery model is having within their respective communities. 
Although the author does not have preliminary studies directly related to this research, a 
preliminary data analysis of the PCMH provider/patient ratios illustrates variance among the 14 
FIPS areas within the state of Vermont. This descriptive analysis is provided to confirm that 
there exists varied provider/patient ratios and PCMH concentrations from which to conduct the 
complete study. The communities (FIPS areas) selected for this observational study are based on 
ST FIPS
Total 
Docs
Rec 
Docs
Pop-
2011
Rec Doc 
Den
Doc 
Den
VT 50017 9 9    23,093 1.00    2,566 
VT 50021 36 17    49,518 0.47    1,376 
VT 50015 8 8    19,266 1.00    2,408 
VT 50005 21 21    24,347 1.00    1,159 
VT 50003 22 12    29,546 0.55    1,343 
VT 50009 3 3      5,154 1.00    1,718 
VT 50001 16 16    29,051 1.00    1,816 
VT 50025 18 6    35,706 0.33    1,984 
VT 50023 46 33    47,456 0.72    1,032 
VT 50007 194 73  124,795 0.38       643 
VT 50027 54 24    45,985 0.44       852 
VT 50019 12 10    21,663 0.83    1,805 
VT 50013 0 0      5,608 0.00    5,608 
VT 50011 15 8    36,812 0.53    2,454 
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the convenience of readily available data from the National Committee for Quality Assurance 
PCMH recognition database (NCQA, 2011), and the Agency for Health care Quality and 
Research Health care Cost and Utilization Project (HCUP) database (HCUP, 2011). According to 
a review of the NCQA PCMH dataset, there are approximately 1000 cities that have at least one 
PCMH recognized practice. Table 3 depicts the preliminary analysis of NCQA PCMH 
recognized provider-to-population ratios and PCMH/PCP concentrations (data pulled from the 
2011 NCQA recognized PCMH directory). The preliminary analysis demonstrates there are 
representative practices from various geographic locations with various PCD/Population and 
PCMH/PCD concentration ratios. Table 6 illustrates the various PCMH-recognized/PCD and 
PCD/population ratios among the 14 communities (FIPS) within Vermont. 
This study proposes a retrospective analysis of PCMH practice concentrations within 
communities; the intervention is the PCMH recognition. Several studies have conducted similar 
evaluations where there is an evaluation of the practice performance after PCMH-like 
transformation. Gilfillan and colleagues conducted a retrospective observational study using 
regression modeling of data from 11 interventional and 75 non-interventional (control group) 
practice sites where data was evaluated to determine effectiveness (quality, cost, access) of the 
practices pre/post intervention of the Proven Health Navigator (a model based on PCMH 
capabilities) transformation (2010). Their study found that the Proven Health Navigator (PHN) 
intervention resulted in a statistically significant drop in inpatient admissions (18% at p<.01) and 
a readmissions (36% at p<.02) over the control group that did not implement PHN (Gilfillan et 
al., 2010). This proposed study builds upon the work of Gilfillan and colleagues by conducting a 
retrospective observational study using multiple regression and ANOVA to determine the 
community-wide impact of PCMH-recognized practices on the hospital admission rates of select 
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chronic disease conditions. The intervention this research study is the concentration of 
recognized PCMH practices among PCDs within a community. 
Secondary Data Use 
The secondary data used for this analysis has the inherent limitations of not accounting 
for other variables that may or may not be affecting the hospitalization rates in the selected 
communities. Given this limitation, the information provided in these databases will be sufficient 
to imply associations between variables and not causality (Aday et al., 2004). This novel study 
design is based on the two perspective view of population and clinical system effectiveness of 
the health services research evaluation model. The effectiveness of population health outcomes 
and the PCMH-recognized clinical practice is represented by measuring hospital admissions 
based on the AHRQ ACSC Composite PQI rates. This novel approach is supported by numerous 
studies (as previously cited) validating the use of hospital admissions as a measure of system 
effectiveness and population health outcomes. The reliability of this measurement approach will 
be supported by the NCQA research staff review of the methodology and statistical analysis 
performed by an expertly trained statistician. It is anticipated that this study can be replicated and 
made generalizable to any community within the United States using this study design, data, and 
methodology. 
Power Analysis 
Using a freely available a-priori sample size calculator for multiple regression from the 
Internet (Lenth, 2006-9), it is estimated that to achieve statistical power of .8 using two (2) 
predictors (PCD and PCMH densities) and obtain a .05 probability level with medium effect size 
(.15) requires a minimum of 67 FIPS as an appropriate sample size for Specific Aim 2. For 
Specific Aim 3, the two sub-aims require different power analysis consideration. For Sub-Aim 1, 
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there are two predictors (PCD density and MU or MP composite capability scores); so, the same 
power analysis result of 67 FIPS is required in the sample size. However, Sub-Aim 2 of Specific 
Aim 3 uses 11 predictors (PCD density and the 10 PCMH capability composites); so, the effect 
size has to be adjusted to .35 to obtain a statistical power of .8 and a .05 probability level with a 
sample size of 59. 
Variables and Measurement 
The intent of measuring the variables of interest in this study is to determine if there is a 
correlation between the PCMH physician/population ratios within a community (FIPS) and the 
rate of hospitalization for the AHRQ ACSC risk-adjusted Composite PQI rates. Due to the sheer 
number of total regression models and resultant tests (300), the author did consider the need for a 
Bonferroni correction. 
Aim 2 tests three composite PQIs and their deltas (2008-2011) for 5 times, summary-
level plus 4 age-specific groups (total 15 times). There are only two predictors (PCD and PCMH 
density) and they are examined together. This study does include two analysis of the hypotheses 
in that it does look at all 114 FIPS in a model and then only the 67 FIPS with PCMHs. This 
additional analysis would be testing the same hypothesis twice; but again, they are stated as 
separate hypotheses where one is not tested as a result of the significance of the other.  
Aim 3 tests the same DVs, but against the PCD density and 12 PCMH capability 
predictors. Again the study starts with separate hypotheses for the 15 DVs (3 PQIs (summary-
level, plus 4 age-specific PQIs (3*4=12)) for a total of 15 DVs). For example, there is no 
relationship between PQI 90 for age category 1 and PCD plus PCMH categories for the 114 
counties (FIPS).  
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The author determined there is no need for a Bonferroni correction, due to potential false 
positive correlations; in essence, this study asks 300 different research questions all independent 
of each other and does not test multivariate correlations of the IVs/DVs (Table 7). 
Table 7: Study Variables 
Variable Name 
Variable 
Type Data Type 
Specific Aim 2 
Ratio of PCP Doctors/Population by FIPS  Predictor Continuous 
Ratio of PCMH/PCD Physicians by FIPS  Predictor Continuous 
AHRQ Risk Adjusted Composite PQIs by FIPS and by Age Category Response Continuous 
Specific Aim 3 
Ratio of PCP Doctors/Population by FIPS Predictor Continuous 
Average (by FIPS) Composite PCMH Capability Scores (10 Individual, MU, and MP) Predictor Continuous 
AHRQ Risk Adjusted Composite PQIs by FIPS and by Age Category Response Continuous 
 
Table 8 depicts the measurement outcomes established as a result of the analysis 
conducted to evaluate Specific Aim 2. Of note, specific aim 2 is focused on determining if 
concentrations of providers alone or ratio of recognized providers affected the change in PQI 
rates and/or has correlation with the resultant (post) risk-adjusted PQI rates (DV). 
Table 8: Measurement Outcomes for Specific Aim 2 
Sub-Aims of Specific Aim 2: Independent 
Variables (IV) (Underlined/Bold) Delta PQI Rates 2011 PQI Rates 
1. Are risk-adjusted PQI rates affected by the PCD 
density among the 114 FIPS areas? Dependent Variables 
(DV): AHRQ Risk 
Adjusted Composite 
PQI Rates 
Dependent Variables 
(DV): AHRQ Risk 
Adjusted Composite 
PQI Rates 
2. Are risk-adjusted PQI rates affected by the 
PCMH density among the 114 FIPS areas? 
 
For Specific Aim 3, it is anticipated that the technology-specific and care coordination 
composite capabilities will emerge as stronger directional correlations to the dependent variable 
of ACSC risk adjusted hospital admission composite rates. Table 5 depicts the grouping of 
PCMH evaluation elements into 10 PCMH capabilities that serve as the independent variables in 
a multiple regression analysis for one of several sub-aims. It is hypothesized that the clinical 
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information systems grouping of the six domains will correlate highly to a reduction in the 
outcome measure of reduced inpatient utilization (Table 9). 
 
Table 9: Measurement Outcomes for Specific Aim 3 
Sub-Aims of Specific Aim 3: Independent 
Variables (IV) (Underlined/Bold) Delta PQI Rates 2011 PQI Rates 
1. Do the 10 PCMH capability composites 
(Table 3) effect risk-adjusted PQI rates?  
Dependent Variables (DV): 
AHRQ Risk Adjusted 
Composite PQI Rates by 
FIPS and by Age 
Dependent Variables (DV): 
AHRQ Risk Adjusted 
Composite PQI Rates by 
FIPS and by Age 
2. Do MU (Table 2) capability composites 
effect risk-adjusted PQI rates? 
3. Do MP (Table 3) capability composites effect 
risk-adjusted PQI rates? 
 
Data Analysis 
In 2000, the Agency for Health care Research and Quality (AHRQ) developed a 
population-based outcome measure of potentially preventable hospital admissions affected by the 
effectiveness of outpatient care. Based on over a decade of work, the Prevention Quality 
Indicators (Composite PQIs) and have been shown to effectively demonstrate use as an outcome 
of ambulatory care sensitive conditions (ACSC). Based on hospital discharge data, the PQIs 
consist of 13 individual disease conditions ranging from acute (e.g., urinary tract infection) to 
chronic conditions (e.g., diabetes). See Table 2 for a complete listing of all 16 PQIs, including 
the composites (overall, acute, chronic) that are based on a grouping of the individual PQIs. 
For this study, the author will use all hospital discharges in the states of Vermont and 
North Carolina for baseline year 2008 and post intervention year 2011. The author will conduct a 
descriptive analysis of both state inpatient data files obtained from the AHRQ HCUP program 
office. Then the author will run the SID data files through the AHRQ PQI SAS programming 
logic to obtain risk-adjusted Composite PQIs by FIPS and age strata. There are 14 FIPS in the 
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state of Vermont and 100 FIPS areas in North Carolina. The AHRQ PQI SAS (Version 5.0) 
program uses four age strata as follows: (1) 18–39; (2) 40–64; (3) 65–74; (4) 75+.  
The author will analyze the NCQA PCMH recognition program database by first 
conducting a data completeness and descriptive analysis. Then the author will prepare an 
extraction of the data to align with the FIPS counties from the Vermont and North Carolina 
composite PQI results. The author will use the AHRQ PQI SAS program to obtain total 
population within each FIPS by age strata previously described. The author will then use the 
CMS NPI dataset to obtain the number of primary care doctors (PCD) by FIPS area.  
The author will use these three data points (PCDs, Population, and PCMH recognized 
practices) to develop two ratios as the predictor variables in analyzing the AHRQ composite 
PQIs by FIPS … the responder variable. These data will form the variables of analysis for 
Specific Aim 2 (Table 8). The author will use regression analysis to determine any statistically 
significant directional correlation and predictive strength of the predictor variables on the Delta 
and 2011 PQI rates Table 8. 
For Specific Aim 3, the author will utilize the same AHRQ Composite PQI rates as the 
responder variables, but then use the PCMH capability composites to determine which of them 
has any statistically significant directional correlation and predictive strength on the risk-adjusted 
Delta and 2011 composite PQIs (Appendix B).  
For this data analysis, the author will use SAS Version 9.4 licensed to Virginia 
Commonwealth University (VCU) via the VCU App-2-Go Citrix Platform. To prepare the data 
for analysis (averages and ratios) the author will use Microsoft Excel Version 2013. To prepare 
the responder variable (risk-adjusted AHRQ Composite PQI rates) for this analysis, the author 
will utilize the Version 5.0 (March 2015) AHRQ PQI SAS program (HCUP, 2011).  
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Chapter Summary 
Chapter 4 provides an outline of the methodology, data, and analysis used to study the 
phenomenon in question: “Are increasing numbers of recognized PCMHs having an impact on 
ambulatory care sensitive conditions as measured by the risk-adjusted AHRQ composite PQI 
rates?” This chapter defines the specifics of the convenience data available to conduct the 
analysis. The strength of this study is its use of existing datasets and the use of validated 
instruments: the PCMH recognition program, the AHRQ Composite PQIs, and the CMS NPI 
data files. As well, this study is strengthened by its generalizability and replicability. In addition 
to the aforementioned strengths, this study is also simple in its methodological approach by 
utilizing regression and ANOVA analysis to determine associations and effect between the 
predictor (PCP, PCMH recognized PCDs, and PCMH element/factor scores) and responder 
(AHRQ Composite PQIs) variables. The results of this study are reported in Chapter 5. 
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Chapter 5: Analysis and Synthesis 
 
 
The purpose of this chapter is to present the results of the statistical analysis, beginning 
with the descriptive statistics of each dataset used in this study. Then the author presents results 
from the data analysis of interactions between the independent and dependent variables through 
means comparisons and correlation/regression analysis. SPSS version 22 was accessed via the 
VCU App2Go (Citrix) servers to conduct all means comparisons, correlations, and regression 
analysis used in this study. The authored also used a combination of Microsoft Excel 2013 and 
Microsoft Access 2013 software to prepare data for analysis and present results in charts, figures, 
and tables. 
Descriptive Statistics 
Beginning with the population by age category within each state from which the hospital 
discharges are a subset, Table 10 illustrates that there was a small change (+4% or ~313K 
increase) in overall population from 2008–2011 in the total population of both states combined. 
Within that change, there was (as expected) an increase of ~18% in the aging of the population 
as more of the population moved (aged) into the over 65 category. North Carolina represents 
~94% of the total population between the two states. However, the age distribution within each 
state is about the same, with 18–64 representing over 82%–84% of the population in each state. 
The Medicare-eligible population (65+) represents ~18% of the population within each state. 
 66 
Table 10: State Population by Age Category 
 
For purposes of this study, the population under the age of 18 is not included because the AHRQ 
PQI SAS program does not use that age group in the adult PQI rates. 
The author established risk-adjusted composite prevention quality indicators (composite 
PQIs 90 (Overall); 91 (Acute); and 92 (Chronic)) for each state (Vermont (VT) and North 
Carolina (NC)) by using each State Inpatient Data (SID) file obtained from the Agency for 
Healthcare Research and Quality (AHRQ) Health Care Utilization Program (HCUP).  
Given that North Carolina represents ~94% of the population between the two states, it 
also represents ~96% of all the discharges between the two states. Although the proportion of 
males (~40%) and females (60%) is about the same within each state, the proportion of race is 
much different with Vermont having ~92% white and North Carolina at ~68%. The proportion of 
the population living in metro versus urban areas is also much different within each state. Within 
North Carolina, ~63% of the population live in urban areas and only 27% for Vermont residents; 
a 36% difference. However, there is an even greater proportion (~24%) of the Vermont 
population living in isolated rural areas (where access to health care resources can be very 
scarce) versus less than ~6% for North Carolina. In terms of payers, both states tend to have 
about the same private payer coverage at ~32% and similar Medicaid populations at ~21%. The 
Medicare population in Vermont is slightly higher at ~42% versus 38% in North Carolina. 
Age Cat 2008 % 2011 % Delta % 2008 % 2011 % Delta % 2008 % 2011 % Delta %
18-39 170,692 0.35 168,731 0.34 -1,961 -0.01 2,811,233 0.40 2,846,507 0.39 35,274   0.01 2,981,925 0.40 3,015,238 0.38 33,313   0.01
40-64 232,444 0.47 235,147 0.47 2,703 0.01 3,074,900 0.44 3,237,897 0.44 162,997 0.05 3,307,344 0.44 3,473,044 0.44 165,700 0.05
65-74 46,242   0.09 51,889   0.10 5,647 0.12 651,838    0.09 726,650    0.10 74,812   0.11 698,080    0.09 778,539    0.10 80,459   0.12
75+ 41,000   0.08 42,233   0.08 1,233 0.03 518,859    0.07 552,136    0.07 33,277   0.06 559,859    0.07 594,369    0.08 34,510   0.06
Totals 490,378 0.06 498,000 0.06 7,622 0.02 7,056,830 0.94 7,363,190 0.94 306,360 0.04 7,547,208 1.00 7,861,190 1.00 313,982 0.04
Vermont North Carolina Totals
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Of interest, the overall discharges in Vermont (-4%) went down at twice that of North 
Carolina (-2%) from 2008–2011. In other demographic categories, the overall changes in 
discharges for females (-9%) was three times that of males (-3%) and increasing by four times 
the rate for minority groups (~4%) than whites (<1%); however, the rate of missing and other 
categories fell at nearly 3% and could explain this Delta. Table 11 illustrates the total number of 
discharges by state with selected demographics (race, age, sex, payer, and geography). 
 
Table 11: State Inpatient Dataset (Hospital Discharges) 
 
In addition to the AHRQ state inpatient dataset (SID) files, this study utilized the AHRQ 
SAS-based software program that is designed to provide users a series of ambulatory care 
N % N % N % N % N % N % N % N % N %
Toal Discharges 54,670 0.05 52,214 0.04 -2,456 -0.04 1,134,014 0.95 1,111,961 0.96 -22,053 -0.02 1,188,684 1.00 1,164,175 1.00 -24,509 -0.02
Race
Missing 3,380   6.18 2,585   4.95 -795 -0.24 356,109    31.4 9,725        0.87 -346,384 -0.97 359,489 0.30 12,310 0.01 -347,179 -1.21
White 50,352 92.10 48,266 92.44 -2,086 -0.04 525,288    46.32 738,566    66.42 213,278 0.29 575,640 0.48 786,832 0.68 211,192 0.25
Black 389      0.17 461      0.88 72 0.19 167,181    14.74 269,313    24.22 102,132 0.38 167,570 0.14 269,774 0.23 102,204 0.56
Hispanic 100      0.18 84        0.16 -16 -0.16 -            0 47,751      4.29 47,751 1.00 100 0.00 47,835 0.04 47,735 0.84
Asian/Pacific Islander 214      0.39 361      0.69 147 0.69 6,895        0.61 10,755      0.97 3,860 0.36 7,109 0.01 11,116 0.01 4,007 1.05
Native American 65        0.12 161      0.31 96 1.48 15,545      1.37 17,853      1.61 2,308 0.13 15,610 0.01 18,014 0.02 2,404 1.61
Other 170      0.31 296      0.57 126 0.74 62,996      5.56 17,998      1.62 -44,998 -2.50 63,166 0.05 18,294 0.02 -44,872 -1.76
Sex
Male 23,324 42.66 22,678 43.43 -646 -0.03 466,670    41.15 463,889    41.72 -2,781 -0.01 489,994 0.41 486,567 0.42 -3,427 -0.03
Female 31,341 57.33 29,532 56.56 -1,809 -0.06 667,297    58.84 647,932    58.27 -19,365 -0.03 698,638 0.59 677,464 0.58 -21,174 -0.09
Age
0-17 8,315   15.21 7,631   14.62 -684 -0.08 187,703    16.55 171,789    15.45 -15,914 -0.08 196,018 0.16 179,420 0.15 -16,598 -0.17
18-39 11,064 20.24 10,106 19.36 -958 -0.09 241,010    21.25 227,090    20.42 -13,920 -0.06 252,074 0.21 237,196 0.20 -14,878 -0.14
40-64 14,773 27.03 14,474 27.73 -299 -0.02 327,203    28.85 331,413    29.81 4,210 0.01 341,976 0.29 345,887 0.30 3,911 -0.01
65-75 7,438   13.61 7,398   14.17 -40 -0.01 157,931    13.93 163,317    14.69 5,386 0.03 165,369 0.14 170,715 0.15 5,346 0.03
75+ 13,064 23.90 12,589 24.12 -475 -0.04 220,145    19.41 218,271    19.63 -1,874 -0.01 233,209 0.20 230,860 0.20 -2,349 -0.04
Primary Payor
Missing 34        0.06 375      0.72 341 10.03 3,050        0.27 4,572        0.41 1,522 0.50 3,084 0.00 4,947 0.00 1,863 10.53
Medicare 22,667 41.46 21,895 41.93 -772 -0.03 416,831    36.76 419,866    37.76 3,035 0.01 439,498 0.37 441,761 0.38 2,263 -0.03
Medicaid 11,042 20.20 11,210 21.47 168 0.02 243,691    21.49 236,509    21.27 -7,182 -0.03 254,733 0.21 247,719 0.21 -7,014 -0.01
Private 18,150 33.20 16,685 31.96 -1,465 -0.08 365,314    32.21 346,667    31.18 -18,647 -0.05 383,464 0.32 363,352 0.31 -20,112 -0.13
Self-Pay 1,739   3.18 1,053   2.02 -686 -0.39 71,100      6.27 68,596      6.17 -2,504 -0.04 72,839 0.06 69,649 0.06 -3,190 -0.43
No Charge 219      0.40 162      0.31 -57 -0.26 -            0.00 -            0.00 0 0.00 219 0.00 162 0.00 -57 -0.26
Other 816      1.49 834      1.60 18 0.02 34,028      3.00 35,751      3.22 1,723 0.05 34,844 0.03 36,585 0.03 1,741 0.07
Geography
Missing 2,456   4.49 2,285   4.38 -171 -0.07 31,880      2.81 29,148      2.62 -2,732 -0.09 34,336 0.03 31,433 0.03 -2,903 -0.16
Urban 15,128 27.67 14,225 27.24 -903 -0.06 712,907    62.87 707,431    63.62 -5,476 -0.01 728,035 0.61 721,656 0.62 -6,379 -0.07
Large town (rural) 13,000 23.78 12,463 23.87 -537 -0.04 243,059    21.43 235,454    21.17 -7,605 -0.03 256,059 0.22 247,917 0.21 -8,142 -0.07
Small town (rural) 11,438 20.92 10,695 20.48 -743 -0.06 81,220      7.16 77,878      7.00 -3,342 -0.04 92,658 0.08 88,573 0.08 -4,085 -0.11
Isolated (rural) 12,648 23.14 12,546 24.03 -102 -0.01 64,949      5.73 62,050      5.58 -2,899 -0.04 77,597 0.07 74,596 0.06 -3,001 -0.05
DeltaDelta Delta2008 2011
Vermont North Carolina
2008 2011
Totals
2008 2011
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sensitive condition (ACSC) quality of care outcomes measures based on inpatient (hospital 
discharge) data files. This study used the AHRQ PQI SAS Version 5 (March 2015) software 
program to run against each of the state inpatient datasets (SID) for each year in this study (2008 
and 2011). Table 12 represents the PQI rate means by year (2008 and 2011), and the change 
(Delta) in the risk-adjusted composite rates between the two years. 
 
Table 12: Dependent Variable Means (PQI Rates) 
 
There are 14 counties (FIPS) within Vermont and 100 within North Carolina for a total 
114 counties in this study. Table 12 represents the descriptive statistics of the composite PQI 
rates for all 114 counties. There are four (4) age categories (Cat 1 (18-39), Cat 2 (40-64), Cat 3 
(65-74), and Cat 4 (75+)) used in this study for each of the three risk-adjusted PQI composites: 
PQI 90 (Overall); PQI 91 (Acute); and PQI 92 (Chronic). Table 12 includes the overall PQI rates 
by age for all 114 counties, as well as a representation of rates for FIPS (counties) with NCQA-
recognized PCMHs (67; NC=54, VT=13). 
PQI Age Cat
(1) >18<39 -0.102 0.423 -0.180 0.539 -0.048 0.311 1.008* 0.439 1.067 0.468 0.967 0.417 1.110** 0.484 1.247 0.563 1.015 0.397
(2) >40<64 -0.140* 0.298 -0.214 0.384 -0.088 0.207 0.960* 0.380 0.933 0.364 0.978 0.392 1.100 0.439 1.147 0.490 1.067 0.399
(3) >65<74 -0.214* 0.306 -0.283 0.373 -0.166 0.240 0.967 0.372 0.907 0.357 1.010 0.378 1.181 0.409 1.189 0.453 1.176 0.379
(4) 75+ -0.164 0.267 -0.214 0.350 -0.129 0.182 0.958 0.310 0.907 0.295 0.993 0.318 1.122 0.317 1.120 0.366 1.123 0.281
(1) >18<40 -0.233** 0.501 -0.397 0.614 -0.117 0.366 0.958 0.513 1.023 0.624 0.913 0.417 1.193** 0.617 1.432 0.775 1.026 0.405
(2) >40<65 -0.156 0.372 -0.232 0.497 -0.103 0.242 1.016 0.392 1.030 0.413 1.006 0.380 1.188 0.475 1.267 0.547 1.133 0.413
(3) >65<75 -0.216 0.392 -0.262 0.490 -0.184 0.306 1.011 0.369 0.985 0.386 1.029 0.358 1.254 0.493 1.261 0.575 1.249 0.430
(4) 75+ -0.202* 0.339 -0.283 0.449 -0.145 0.220 1.023 0.369 0.978 0.364 1.054 0.372 1.233 0.442 1.255 0.517 1.217 0.383
(1) >18<41 -0.018 0.505 -0.046 0.655 0.001 0.369 1.042 0.518 1.098 0.527 1.003 0.511 1.062 0.560 1.137 0.671 1.010 0.466
(2) >40<66 -0.135* 0.306 -0.210 0.380 -0.083 0.229 0.934 0.414 0.890 0.395 0.965 0.427 1.063 0.485 1.097 0.526 1.039 0.457
(3) >65<76 -0.226* 0.316 -0.309 0.368 -0.168 0.261 0.945 0.416 0.866 0.391 1.000 0.427 1.157 0.454 1.169 0.485 1.149 0.434
(4) 75+ -0.171 0.278 -0.204 0.359 -0.147 0.202 0.907 0.330 0.852 0.323 0.945 0.332 1.073 0.335 1.063 0.353 1.081 0.324
-0.002* 0.004 -0.003 0.005 -0.002 0.003 0.015 0.005 0.014 0.005 0.015 0.005 0.017** 0.004 0.020 0.003 0.016 0.004
-0.001 0.002 -0.002 0.002 -0.001 0.002 0.006 0.002 0.006 0.002 0.006 0.002 0.007 0.002 0.007 0.003 0.007 0.002
-0.002 0.002 -0.002 0.003 -0.001 0.002 0.009 0.003 0.008 0.003 0.009 0.003 0.010 0.004 0.010 0.004 0.010 0.003
N=47        
(no PCMH)
*=p<.05 & **=<.01
Mean SD Mean SD
N=47        
(no PCMH)
PQI 92 (Chronic)
90 
(Overall)
Dependent Variables
Mean SD
Delta PQI Rates
N=47        
(no PCMH)
Mean SD SD
91 
(Acute)
92 
(Chronic)
PQI 90 (Overall)
PQI 91 (Acute)
N=67 
(w/PCMH)
Mean SD Mean SD
2008 PQI Rates
Mean SD
N=67 
(w/PCMH)
Mean SDMean
2011 PQI Rates
N=114                 
(all FIPS)
N=114           
(all FIPS)
N=67 
(w/PCMH)
N=114           
(all FIPS)
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All three composite PQI mean rates across all age categories decreased from 2008 to 
2011, as did the mean rates of each PQI regardless of age [PQI 90 (-.002), PQI 91 (-.001), PQI 
92, (-.001)]. Among the age-specific mean differences for PQI 90, age category 3 (65-74) 
showed the greatest decrease among all FIPS (-.21) and the PCMH FIPS (-.17). As well, that 
same age category showed the highest risk-adjusted PQI over all others at 1.18 for all and 
PCMH-only FIPS. The 47 FIPS with no PCMHs showed the greatest decrease from 2008 to 
2011 across all three PQI composite rates; however, the same 47 FIPS started in 2008 with the 
highest PQI mean rates. These mean rates indicate that the 67 FIPS where PCMH concentrations 
increased were already performing better than the 47 FIPS where no PCMH concentrations 
existed, even though the FIPS without PCMH concentrations decreased more significantly over 
the same time period than the FIPS with PCMHs (Figure 8). 
 
Figure 8: Mean PQI Rates (Chart) 
In Figures 9–11, the age-specific rate means are charted. The younger age category 
(>18<39) show the highest rates in 2008 and also the greatest drops in PQIs 90 and 91 in 2011.  
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Figure 9: PQI 90 (Overall) Mean Rates by Age (Chart) 
 
Figure 10: PQI 91 (Acute) Mean Rates by Age (Chart) 
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Figure 11: PQI 92 (Chronic) Mean Rates by Age (Chart) 
For PQI 92, the older age category (>65<76) show the highest rates in 2008 and greatest 
drop in 2011. These two results make sense in terms of acute rates being higher for younger ages 
and chronic rates being higher for older age categories. 
The NCQA PCMH recognition program standards were released in 2008. By 2012, the 
program had assessed ~4,800 practices. In 2011, NCQA released an updated version of the 
recognition program. The primary changes to the 2008 evaluation criteria were more explicit 
language in terms of alignment with the ONC MU program requirements for the use of EHRs.  
For the purposes of this study, the focus is only those practices recognized under the 2008 
standards, even though several more practices within both states (VT and NC) continued to 
become recognized under the new/updated standards. 
After extracting data from the NCQA dataset for recognized primary care practices 
(Internal Medicine, General Practice, and Family Practice) recognized on the 2008 standards, the 
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resultant dataset included 1,421 doctors within 393 practices across NC (Doctors=1,181, 
Practices=322) and VT (Doctors=240, Practices=71); VT and NC represented ~30% of the total 
NCQA recognized doctors/practices at that time.  
See Appendices A, B, and C for the results of the NCQA recognition data matched to the 
CMS NPI data and AHRQ SAS PQI population data to establish the primary care doctor (PCD) 
per population, PCMH per PCD ratios, PQI rates, and the PCMH capability composites used in 
this study.  
Table 13 depicts that North Carolina (93%) represents the majority of recognized PCMH 
doctors versus Vermont at (7%); however, the overall percentage of recognized doctors in terms 
of density in Vermont counties (53%) is nearly three times that of North Carolina (18%). 
 
Table 13: Population, Provider, Ratio Summary Chart 
 
 
Means of the PCD and PCMH densities, as well as the PCMH capability composites are 
shown in Table 14. As would be expected, the PCMH density mean for all 114 FIPS areas was 
lower (~23%) when compared to the 67 FIPS areas with PCMHs (~39%), by a difference of ~16 
percent. As well, the PCD density mean for the 67 FIPS areas was better at ~2400:1 than all 114 
FIPS areas at ~3900:1, indicating the 67 FIPS areas with NCQA-recognized practices had better 
doctor-to-population ratios. It is also noted in Table 14 that the means of the PCD and PCMH  
  
Rec 
Prac
Total 
Docs
Pct of Tot 
Docs Rec Docs
Pct of Tot 
Rec Docs
Total Pop 
>17 (2011)
Pct of Tot 
Pop PCMH/PCD PCD/Pop
VT Totals 71         454       7% 240          17% 498,000       6% 53% 1,097      
NC Totals 322       6,423    93% 1,181       83%     7,363,190 94% 18% 1,146      
Grand Totals 393       6,877    100% 1,421       100%     7,861,190 100% 21% 1,143      
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Table 14: Independent Variable Means (PCD/PCMH Densities and PCMH Cap Comp) 
  
 
density rates are statistically significantly different between FIPS with PCMHs versus FIPS 
without PCMHs. 
Directional Correlation and Predictive Strength Analysis 
With regard to Specific Aim 2—that PCMH density rates within FIPS areas impact the 
risk-adjusted composite PQI rates—the author tested for correlation of the predictor variables 
PCD/population and PCMH/PCD density ratios (IVs) against the response variables, 2011 and 
Delta (2008-2011) PQI composite 90, 91, and 92 rates.  
PCD and PCMH densities were used in a simple multiple regression analysis to predict 
2011 and Delta (2008-2011) risk-adjusted avoidable hospital admission rates (PQIs) among the 
counties with PCMH practices within Vermont and North Carolina. The results are reported in 
Mean SD Mean SD Mean SD
3938** 4330 6119 5755 2408 1805
0.227** 0.320 0.386 0.336
IT 10.452 9.299 17.783 3.963
CSC 8.176 7.075 13.911 2.171
CoC 10.292 8.900 17.512 2.695
ACC 3.986 3.479 6.782 1.213
RPT 4.372 3.858 7.439 1.526
CDT 3.397 2.884 5.780 0.511
NoN 1.280 1.230 2.178 0.777
PxP 1.534 1.403 2.611 0.719
PVS 2.097 1.837 3.569 0.670
PTC 0.903 0.880 1.537 0.581
MU 23.989 20.705 40.817 0.332
MP 21.824 18.626 37.134 4.105
N/A
*=p<.05 & **=<.01
N=114                
(all FIPS)
Independent Variables
PCD Den
PCMH Den
N=47        
(no PCMH)
N/A
P
C
M
H
 C
a
p
a
b
il
it
ie
s
N=67 
(w/PCMH)
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the following four tables and demonstrate varying strength of the correlations with each of the 
PQI rates.  
The results in Table 15 indicate no statistical significance in any of the full models for 
PCD and PCMH density on any of the overall or age-specific Delta PQI rate means for all FIPS 
(n=114). The analysis of the PQI rates was done at two levels: 1) FIPS Summary-Level (no age 
categories), and 2) by four age-specific categories. 
 
Table 15: Delta PQI Regression—All FIPS—PCD/PCMH Density 
 
 
In addition, Table 16 indicates no statistical significance in any of the full models for 
PCD and PCMH density on any of the overall or age-specific Delta PQI rate means for the FIPS  
Corr Sig Corr Sig Beta Sig Beta Sig
(1) >18<39 -0.061 0.259 0.076 0.212 -0.050 0.600 0.068 0.481 0.455 0.008 0.663
(2) >40<64 0.008 0.466 0.067 0.238 0.019 0.201 0.070 0.735 0.274 0.005 0.761
(3) >65<74 -0.081 0.195 0.030 0.376 -0.079 0.414 0.017 0.857 0.386 0.007 0.681
(4) 75+ 0.058 0.269 0.073 0.222 0.072 0.456 0.084 0.382 0.575 0.010 0.564
(1) >18<40 -0.084 0.186 0.182 0.026 -0.057 0.550 0.173 0.070 2.085 0.036 0.129
(2) >40<65 0.040 0.337 0.104 0.136 0.058 0.545 0.113 0.239 0.791 0.014 0.456
(3) >65<75 -0.030 0.378 -0.013 0.445 -0.032 0.136 -0.018 0.849 0.066 0.001 0.936
(4) 75+ 0.010 0.458 0.077 0.209 0.023 0.813 0.080 0.404 0.357 0.006 0.701
(1) >18<41 -0.037 0.346 0.004 0.483 -0.038 0.695 -0.002 0.983 0.078 0.001 0.925
(2) >40<66 -0.011 0.455 0.053 0.288 -0.002 0.980 0.052 0.586 0.156 0.003 0.856
(3) >65<76 -0.102 0.139 0.076 0.212 -0.093 0.334 0.061 0.525 0.793 0.014 0.455
(4) 75+ 0.091 0.168 0.112 0.118 0.111 0.243 0.129 0.176 1.398 0.025 0.251
-0.008 0.468 0.069 0.234 0.003 0.972 0.069 0.473 0.262 0.005 0.770
0.033 0.364 -0.028 0.383 0.029 0.762 -0.023 0.808 0.090 0.002 0.914
0.005 0.479 0.019 0.419 0.008 0.930 0.021 0.829 0.025 0.000 0.975
Aim 2 : Is there a statistical significance in the age-specific means of Delta  PQI rates with regard to 
PCD and PCMH densities? (n=114)
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PCD PCMH PCD PCMH
Age CatPQI
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PQI 90 (Overall)
PQI 91 (Acute)
PQI 92 (Chronic)
*=p<.05 & **=<.01
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Table 16: Delta PQI Regression—FIPS w/PCMH—PCD/PCMH Density 
 
with PCMH (n=67), even though there is correlation (p<.05) with PCD density with PQI 90 age 
cat 1 (.219) and PQI 91 age cat 3 (-.024); as well, PCMH density shows negative (-.221) 
correlation (p<.05) for the overall Delta PQI 91 (Acute). 
Table 17, regression results for all FIPS (n=114), shows a statistical significance in the 
full model for 2011 PQI 92 (2,114), f=3.775, r2=.063 (p<.05) with positive correlation in PCD 
density r=-.183 (p<.05). There is also statistical significance in the full model for age-specific 
2011 PQI 90 age cat 2 F(2,114), f=4.714, r2=.078 (p<.05) with negative correlation in PCD r=-
.165 (p<.05) and PCMH r=-.197 (p<.05) density; 2011 PQI 92 age cat 2 F(2,114), f=5.597, 
r2=.092 (p<.01) with negative correlation in PCD r=-.194 (p<.05) and PCMH r=-.199 (p<.05) 
density; and 2011 PQI 92 age cat 3 F(2,114), f=2.997, r2=.051 (p<.05) with negative correlation 
in PCD density r=-.189 (p<.05).  
Corr Sig Corr Sig Beta Sig Beta Sig
(1) >18<39 0.219* 0.037 -0.053 0.335 .275* 0.037 -0.154 0.240 2.357 0.069 0.103
(2) >40<64 -0.197 0.055 -0.152 0.110 -0.163 0.219 -0.093 0.482 1.548 0.046 0.221
(3) >65<74 0.009 0.470 -0.111 0.186 0.057 0.668 -0.132 0.326 0.492 0.015 0.613
(4) 75+ 0.155 0.105 0.114 0.179 0.131 0.325 0.066 0.618 0.921 0.028 0.403
(1) >18<40 -0.059 0.318 0.038 0.381 -0.084 0.533 0.068 0.612 0.242 0.008 0.786
(2) >40<65 -0.102 0.205 0.005 0.485 -0.120 0.372 0.048 0.718 0.405 0.012 0.669
(3) >65<75 -.024* 0.024 -0.150 0.113 -0.217 0.100 -0.070 0.589 8.161 0.063 0.123
(4) 75+ -0.166 0.089 -0.109 0.189 -0.146 0.274 -0.056 0.672 1.003 0.030 0.372
(1) >18<41 0.143 0.124 -0.036 0.387 0.180 0.177 -0.102 0.445 0.973 0.029 0.384
(2) >40<66 -0.188 0.064 -0.134 0.139 -0.160 0.229 -0.076 0.566 1.340 0.040 0.269
(3) >65<76 -0.092 0.230 -0.172 0.082 -0.033 0.801 -0.159 0.232 1.004 0.030 0.372
(4) 75+ 0.023 0.427 -0.050 0.343 0.047 0.725 -0.067 0.616 0.143 0.004 0.867
-0.104 0.201 -0.152 0.110 -0.056 0.673 -0.132 0.324 0.849 0.026 0.433
-0.066 0.299 -.221* 0.036 0.017 0.895 -0.227 0.087 1.652 0.049 0.200
0.012 0.463 -0.172 0.082 0.086 0.517 -0.204 0.127 1.198 0.036 0.308
D
e
lt
a
 9
1
 
(A
c
u
te
)
*=p<.05 & **=<.01
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Aim 2 : Is there a statistical significance in the age-specific means of Delta  PQI rates with regard to 
PCD and PCMH densities within communities with PCMHs? (n=67)
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Table 17: 2011 PQI Regression—All FIPS—PCD/PCMH Density 
 
Table 18, regression results for all FIPS with PCMHs (n=67), shows statistical 
significance in the full model for 2011 PQI 92 (2,67), f=5.983, r2=.158 (p<.01) with negative 
correlation in PCMH density r=-.333 (p<.01); and 2011 PQI 90 (2,67), f=3.198, r2=.109 (p<.01) 
with negative correlation in PCMH density r=-.269 (p<.01). There is also statistical significance 
in the full model for age-specific 2011 PQI 90 age cat 2 F(2,67), f=6.219, r2=.163 (p<.01) with 
negative correlation in PCMH density r=-.368 (p<.01); 2011 PQI 90 age cat 3 F(2,67), f=4.826, 
r2=.131 (p<.01) with negative correlation in PCMH density r=-.269 (p<.01); 2011 PQI 92 age cat 
2 F(2,67), f=7.318, r2=.186 (p<.05) with negative correlation in PCMH density r=-.400 (p<.01); 
and 2011 PQI 92 age cat 3 F(2,67), f=6.182, r2=.162 (p<.01) with negative correlation in PCMH 
density r=-.299 (p<.01).  
Corr Sig Corr Sig Beta Sig Beta Sig
(1) >18<39 -0.058 0.268 -.194* 0.019 -0.092 0.330 -.209* 0.028 2.674 0.046 0.073
(2) >40<64 -.165* 0.040 -.197* 0.018 -.201* 0.031 -.229* 0.015 4.714 .078* 0.011
(3) >65<74 -.187* 0.026 -0.086 0.183 -.201* 0.035 -0.118 0.213 2.716 0.047 0.071
(4) 75+ -0.119 0.103 0.017 0.430 -0.120 0.213 0.002 0.981 0.799 0.014 0.452
(1) >18<40 0.007 0.469 -0.130 0.084 -0.014 0.886 -0.132 0.169 0.961 0.017 0.386
(2) >40<65 -0.046 0.315 -0.148 0.058 -0.071 0.456 -0.159 0.096 1.525 0.027 0.222
(3) >65<75 -0.122 0.097 -0.053 0.289 -0.134 0.161 -0.074 0.437 1.153 0.020 0.319
(4) 75+ -0.108 0.126 0.062 0.256 -0.101 0.294 0.046 0.630 0.774 0.014 0.463
(1) >18<41 -0.084 0.188 -.189* 0.022 -0.117 0.215 -.208* 0.028 2.873 0.049 0.061
(2) >40<66 -.194* 0.019 -.199* 0.017 -.231** 0.013 -.236** 0.011 5.597 .092** 0.005
(3) >65<76 -.189* 0.022 -0.093 0.163 -.209* 0.028 -0.126 0.180 2.997 .051* 0.054
(4) 75+ -0.100 0.144 -0.034 0.359 -0.108 0.259 -0.052 0.590 0.710 0.013 0.494
-.166* 0.039 -0.111 0.121 -.188* 0.048 -0.141 0.137 2.717 0.047 0.070
-0.096 0.154 -0.036 0.351 -0.105 0.275 -0.053 -0.555 0.677 0.012 0.510
-.183* 0.026 -0.142 0.066 -.211* 0.026 -0.175 0.062 3.775 .063* 0.026
*=p<.05 & **=<.01
Aim 2:  Is there a statistical significance in the age-specific means of 2011  PQI rates with regard to PCD and 
PCMH densities? (n=114)
PCD PCMH PCD PCMH
F_Value r-Sq Sig
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Table 18: 2011 PQI Regression—FIPS w/PCMH—PCD/PCMH Density 
 
With regard to Specific Aim 3—that PCMH capability composites impact the risk-
adjusted composite PQI rates—the author tested for correlation of the predictor variables 
PCD/population and PCMH capability composites (IVs) against the response variables, 2011 and 
Delta (2008-2011) PQI composite 90, 91, and 92 rates. 
PCD density and PCMH capability composites were used in a simple multiple regression 
analysis to predict 2011 and Delta (2008–2011) risk-adjusted avoidable hospital admission rates 
(PQI) among the counties with PCMH practices within Vermont and North Carolina. The results 
are reported, demonstrate varying strength of the correlations with each of the PQI rates. The 
analysis of the PQI rates was done at two levels: 1) Summary level (no age categories), and 2) 
By four age-specific categories. The 10 PCMH capability composites are used in the regression 
models that follow as a replacement for the PCMH density used in evaluating Specific Aim 2. 
Corr Sig Corr Sig Beta Sig Beta Sig
(1) >18<39 0.080 0.259 -.218* 0.038 0.184 0.158 -.285* 0.031 2.663 0.077 0.077
(2) >40<64 0.021 0.434 -.368** 0.001 0.179 0.151 -.433** 0.001 6.219 0.163** 0.003
(3) >65<74 0.127 0.152 -.269** 0.014 .260* 0.042 -.364** 0.005 4.826 .131** 0.011
(4) 75+ 0.115 0.178 -0.105 0.200 0.176 0.186 -0.169 0.205 1.258 0.038 0.291
(1) >18<40 0.023 0.426 -0.133 0.142 0.082 0.536 -0.163 0.225 0.769 0.023 0.468
(2) >40<65 0.056 0.326 -.219* 0.038 0.157 0.230 -.267* 0.037 2.374 0.069 0.101
(3) >65<75 0.078 0.266 -0.148 0.117 0.152 0.253 -0.203 0.128 1.393 0.042 0.256
(4) 75+ 0.080 0.260 0.002 0.495 0.092 0.495 -0.238 0.812 0.235 0.007 0.791
(1) >18<41 0.094 0.224 -.224* 0.035 0.203 0.119 -.297* 0.024 2.993 0.086 0.057
(2) >40<66 0.006 0.482 -.400** 0.000 0.175 0.154 -.463** 0.000 7.318 0.186** 0.001
(3) >65<76 0.142 0.127 -.299** 0.007 .289* 0.022 -.405** 0.002 6.182 0.162** 0.004
(4) 75+ 0.137 0.134 -.191 0.061 0.239 0.068 -.278* 0.034 3.001 0.086 0.057
0.081 0.257 -.269** 0.014 0.206 0.108 -.344** 0.009 3.198 .109* 0.025
0.074 0.277 -0.102 0.205 0.128 0.338 -0.149 0.266 0.808 0.025 0.450
0.079 0.263 -0.333** 0.003 0.231 0.065 -.419** 0.001 5.983 .158** 0.004
PQI 91 (Acute)
*=p<.05 & **=<.01
PQI 92 (Chronic)
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Aim 2 : Is there a statistical significance in the age-specific means of 2011  PQI rates with regard to PCD and 
PCMH densities within communities with PCMHs? (n=67)
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The results in Table 19 indicate no statistical significance in any of the regression models 
for PCD density and the 10 PCMH capability composites or any of the Delta PQI overall or age-
specific Delta PQI rate means for all FIPS (n=114), even though there is correlation (p<.01-.05) 
with several of the PCMH capability composites amongst several age-specific PQI means. 
Table 20 indicates no statistical significance in any of the regression models for PCD 
density and the 10 PCMH capability composites on any of the overall Delta PQI rate means for 
the FIPS with PCMH (n=67); however, there is statistical significance in the full model for age-
specific Delta PQI age cat 2 F(11,67), f=2.224, r2=.555 (p<.05) with positive correlation in 
information technology (IT) r=.227 (p<.05), clinical data tools (CDT) r=.361 (p<.01), and patient 
communications (PTC) r=.228 (p<.05). 
The results in Table 21 indicate statistical significance in the full models for PCD density 
and the 10 PCMH capability composites for all FIPS (n=114) on 2011 PQI 90, F(11,114), 
f=2.017, r2=.179 (p<.05) with negative correlation on PCD density at r=-.183 (p<.05); and 2011 
PQI 92 F(11,114), f=2.201, r2=.192 (p<.05) with negative correlation on PCD density at r=-.166 
(p<.05) and positive correlation for condition specific care (CSC) r=.153 (p<.05). There is also 
statistical significance in the full models for age-specific 2011 PQI 90 age cat 2 F(11,114), 
f=2.174, r2=.190 (p<.05) with negative correlation on PCD density at r=-.165 (p<.05); 2011 PQI 
90 age cat 3 F(11,114), f=1.868, r2=.168 (p<.05) with negative correlation on PCD density at r=-
.182 (p<.05), and positive correlations for CSC r=.166, ACC r=.175 and PXP r=.166; 2011 PQI 
92 age cat 2 F(11,114), f=2.275, r2=.197 (p<.05) with negative correlation on PCD density at r=-
.194 (p<.05); and 2011 PQI 92 age cat 3 F(11,114), f=1.889, r2=.169 (p<.05) with positive 
correlations on PCD density at r=.189 (p<.05), IT r=.167, CSC r=.188, COC r=.188, ACC 
r=.197, RPT r=.163, and PXP r=.186. 
  
7
9
 
Table 19: Delta PQI Regression—All FIPS—10 PCMH Capability Composites 
 
PQI 90 (Age Cat 4) 0.741 0.074 0.697  
IV 
PQI 90 (Age Cat 1) PQI 90 (Age Cat 2) PQI 90 (Age Cat 3) PQI 90 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.061 0.259 0.000 0.997 0.008 0.466 0.112 0.285 -0.081 0.195 -0.013 0.902 0.058 0.269 0.143 0.177 
  
Aim 3: Is there a statistical significance in the means of Delta PQI rates within all FIPs with regard to PCD densities and 10 PCMH capabilities? (n=114) 
DV F-Value r-Sq Sig 
  
  
PQI 90 (Overall) 0.944 0.092 0.502 
PQI 91 (Acute) 0.773 0.077 0.666 
PQI 92 (Chronic) 0.828 0.082 0.612 
IV 
PQI 90 (Overall) PQI 91 (Acute) PQI 92 (Chronic) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.008 0.468 0.095 0.365 0.033 0.364 0.107 0.311 0.005 0.479 0.088 0.405 
P
C
M
H
 C
ap
ab
il
it
ie
s 
IT 0.243** 0.005 0.228 0.527 0.168* 0.037 0.198 0.587 0.214** 0.011 0.331 0.362 
CSC 0.209** 0.013 0.189 0.815 0.127 0.089 0.061 0.941 0.180* 0.028 0.534 0.511 
CoC 0.231** 0.007 0.468 0.419 0.157 0.048 0.629 0.282 0.195* 0.019 0.461 0.429 
ACC 0.212** 0.012 -0.074 0.897 0.137 0.074 0.102 0.861 0.181* 0.027 -0.058 0.921 
RPT 0.196* 0.019 -0.322 0.461 0.110 0.122 -0.457 0.300 0.162* 0.043 -0.238 0.588 
CDT 0.199* 0.017 -0.206 0.723 0.122 0.099 -0.225 0.701 0.161* 0.043 -0.510 0.385 
NoN 0.244** 0.004 0.231 0.368 0.137 0.073 0.008 0.976 0.202* 0.016 0.131 0.612 
PxP 0.172* 0.034 -0.089 0.735 0.097 0.151 -0.092 0.728 0.136 0.074 -0.096 0.717 
PVS 0.207** 0.013 -0.184 0.696 0.125 0.092 -0.232 0.627 0.173* 0.033 -0.293 0.538 
PTC 0.209** 0.013 0.033 0.880 0.165* 0.040 0.208 0.343 0.167* 0.038 -0.041 0.851 
*=p<.05 & **=<.01   
Aim 3: Is there a statistical significance in the age-specific means of Delta PQI rates within all FIPs with regard to PCD densities and 10 PCMH 
capabilities? (n=114) 
DV F-Value r-Sq Sig 
  
PQI 90 (Age Cat 1) 0.990 0.096 0.461 
PQI 90 (Age Cat 2) 0.901 0.089 0.542 
PQI 90 (Age Cat 3) 0.642 0.065 0.789 
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Table 19: Continued 
P C M H
 
C
a
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IT 0.182* 0.027 0.029 0.935 0.229** 0.007 0.187 0.605 0.202* 0.016 0.266 0.468 0.183* 0.025 0.256 0. 483 
 
CSC 0.167* 0.038 0.569 0.480 0.196* 0.018 -0.019 0.981 0.172* 0.034 -0.077 0.925 0.149 0.056 0.173 0.832 
CoC 0.190* 0.021 0.605 0.296 0.222** 0.009 0.502 0.387 0.179* 0.028 -0.127 0.828 0.168* 0.037 0.485 0.407 
ACC 0.183* 0.026 0.270 0.639 0.199* 0.017 -0.118 0.838 0.173* 0.033 0.094 0.873 0.148 0.058 -0.138 0.813 
RPT 0.152* 0.053 -0.457 0.296 0.185* 0.024 -0.308 0.482 0.164* 0.041 -0.338 0.446 0.142 0.066 -0.062 0.889 
CDT 0.145 0.062 -0.848 0.147 0.189* 0.022 -0.125 0.831 0.173* 0.033 0.207 0.726 0.140 0.068 -0.189 0.748 
NoN 0.201** 0.016 0.191 0.457 0.236** 0.006 0.249 0.334 0.211* 0.012 0.331 0.205 0.163* 0.041 0.046 0.858 
PxP 0.170* 0.035 0.221 0.401 0.166* 0.039 -0.073 0.781 0.158* 0.047 0.036 0.893 0.096 0.155 -0.264 0.321 
PVS 0.154* 0.051 -0.546 0.248 0.202* 0.016 -0.021 0.964 0.162* 0.043 -0.288 0.548 0.149 0.057 -0.075 0.875 
PTC 0.184** 0.025 0.175 0.420 0.191* 0.021 -0.003 0.990 0.186* 0.024 0.110 0.619 0.146 0.060 -0.026 0.905 
DV F-Value r-Sq Sig 
  
PQI 91 (Age Cat 1) 1.72 0.156 0.079 
PQI 91 (Age Cat 2) 0.916 0.09 0.528 
PQI 91 (Age Cat 3) 0.287 0.03 0.987 
PQI 91 (Age Cat 4) 0.856 0.085 0.585 
IV 
PQI 91 (Age Cat 1) PQI 91 (Age Cat 2) PQI 91 (Age Cat 3) PQI 91 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.084 0.186 0.043 0.668 0.040 0.337 0.125 0.235 -0.030 0.378 0.013 0.902 0.010 0.458 0.113 0.283 
P
C
M
H
 C
ap
ab
il
it
ie
s 
IT 0.29** 0.001 -0.134 0.700 0.198* 0.017 0.277 0.444 0.078 0.204 -0.048 0.898 0.216** 0.010 0.055 0.880 
CSC 0.281** 0.001 0.480 0.538 0.148 0.058 -0.292 0.718 0.061 0.258 -0.636 0.447 0.186* 0.024 -0.313 0.700 
CoC 0.310** 0.000 0.807 0.150 0.174* 0.032 0.284 0.624 0.086 0.183 0.159 0.791 0.217** 0.010 0.553 0.342 
ACC 0.295** 0.001 0.052 0.926 0.149 0.057 -0.028 0.961 0.076 0.211 0.181 0.762 0.191* 0.021 -0.064 0.913 
RPT 0.255** 0.003 -0.796 0.061 0.144 0.063 -0.347 0.429 0.060 0.264 -0.387 0.393 0.185* 0.025 -0.204 0.641 
CDT 0.270** 0.002 -0.296 0.598 0.145 0.062 -0.020 0.973 0.081 0.196 0.565 0.349 0.185* 0.024 0.038 0.948 
NoN 0.313** 0.000 0.321 0.196 0.194* 0.019 0.232 0.367 0.080 0.198 0.151 0.569 0.218** 0.010 0.166 0.519 
PxP 0.279** 0.001 0.207 0.414 0.129 0.086 -0.030 0.910 0.070 0.231 0.008 0.976 0.153* 0.052 -0.169 0.522 
PVS 0.271** 0.002 -0.491 0.283 0.154* 0.051 -0.052 0.912 0.063 0.254 -0.047 0.924 0.194* 0.019 0.063 0.895 
PTC 0.284** 0.001 0.198 0.345 0.205** 0.014 0.235 0.282 0.085 0.186 0.159 0.479 0.211** 0.012 0.142 0.515 
DV F-Value r-Sq Sig 
  
PQI 92 (Age Cat 1) 0.457 0.047 0.925 
PQI 92 (Age Cat 2) 0.822 0.081 0.618 
PQI 92 (Age Cat 3) 1.062 0.103 0.400 
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Table 19: Continued 
PQI 92 (Age Cat 4) 0.627 0.063 0.802  
IV 
PQI 92 (Age Cat 1) PQI 92 (Age Cat 2) PQI 92 (Age Cat 3) PQI 92 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.037 0.346 -0.029 0.786 -0.011 0.455 0.092 0.380 -0.102 0.139 -0.025 0.811 0.091 0.168 0.154 0.148 
P
C
M
H
 C
ap
ab
il
it
ie
s 
IT 0.074 0.216 0.103 0.781 0.219** 0.009 0.104 0.775 0.253** 0.003 0.379 0.292 0.131 0.083 0.253 0.490 
CSC 0.061 0.260 0.385 0.642 0.199* 0.017 0.059 0.942 0.219** 0.010 0.150 0.851 0.104 0.134 0.431 0.600 
CoC 0.074 0.216 0.259 0.663 0.223** 0.009 0.556 0.341 0.217** 0.010 -0.281 0.626 0.111 0.120 0.377 0.521 
ACC 0.075 0.214 0.364 0.539 0.204* 0.015 -0.151 0.795 0.213** 0.012 0.035 0.951 0.099 0.148 -0.154 0.793 
RPT 0.059 0.267 -0.111 0.804 0.188* 0.023 -0.248 0.572 0.21** 0.012 -0.270 0.534 0.093 0.162 0.014 0.975 
CDT 0.038 0.343 -0.915 0.127 0.191* 0.021 -0.144 0.806 0.21** 0.012 0.021 0.971 0.090 0.169 -0.267 0.652 
NoN 0.090 0.170 0.086 0.744 0.233** 0.006 0.239 0.355 0.271** 0.002 0.434 0.091 0.106 0.131 -0.020 0.939 
PxP 0.068 0.237 0.168 0.533 0.169* 0.036 -0.082 0.756 0.195* 0.019 0.047 0.858 0.042 0.327 -0.313 0.243 
PVS 0.052 0.292 -0.388 0.424 0.205** 0.014 0.023 0.962 0.206** 0.014 -0.354 0.452 0.100 0.144 -0.108 0.822 
PTC 0.085 0.185 0.130 0.561 0.168* 0.037 -0.106 0.628 0.233** 0.006 0.100 0.644 0.094 0.161 -0.068 0.757 
*=p<.05 & **=<.01   
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Table 20: Delta PQI Regression–FIPS w/PCMH—10 PCMH Capability Composites 
Aim 3: Is there a statistical significance in the means of Delta PQI rates within PCMH FIPs with regard to PCD densities and 10 PCMH capabilities? (n=67) 
DV F-Value r-Sq Sig 
  
  
PQI 90 (Overall) 1.398 0.219 0.200 
PQI 91 (Acute) 0.905 0.153 0.542 
PQI 92 (Chronic) 0.852 0.146 0.590 
IV 
PQI 90 (Overall) PQI 91 (Acute) PQI 92 (Chronic) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.104 0.201 -0.083 0.510 -0.066 0.299 -0.046 0.727 0.012 0.463 0.022 0.869 
P
C
M
H
 C
ap
ab
il
it
ie
s 
IT 0.218* 0.038 0.112 0.462 0.146 0.120 0.072 0.650 0.217 0.039 0.134 0.399 
CSC -0.029 0.407 0.234 0.345 -0.092 0.229 0.134 0.602 0.040 0.374 0.294 0.257 
CoC 0.151 0.111 0.092 0.603 0.106 0.198 0.132 0.477 0.141 0.128 0.080 0.668 
ACC 0.005 0.483 -0.031 0.874 -0.020 0.437 0.049 0.809 0.048 0.349 -0.009 0.965 
RPT -0.086 0.246 -0.116 0.496 -0.146 0.120 -0.157 0.374 -0.045 0.358 -0.074 0.678 
CDT -0.26* 0.017 -0.344* 0.037 -0.255* 0.019 -0.271 0.112 -0.190 0.062 -0.323 0.060 
NoN 0.211* 0.043 0.289 0.079 0.032 0.397 0.061 0.717 0.148 0.116 0.161 0.344 
PxP -0.146 0.118 -0.086 0.513 -0.142 0.125 -0.070 0.610 -0.115 0.178 -0.075 0.584 
PVS -0.020 0.436 -0.281 0.125 -0.080 0.261 -0.238 0.211 0.004 0.487 -0.251 0.188 
PTC 0.077 0.267 -0.001 0.997 0.121 0.164 0.136 0.351 0.040 0.374 -0.061 0.679 
*=p<.05 & **=<.01   
Aim 3: Is there a statistical significance in the age-specific means of Delta PQI rates within PCMH FIPs with regard to PCD densities and 10 PCMH capabilities? (n=67) 
DV F-Value r-Sq Sig 
  
PQI 90 (Age Cat 1) 1.725 0.257 0.092 
PQI 90 (Age Cat 2) 1.241 0.199 0.284 
PQI 90 (Age Cat 3) 0.878 0.149 0.566 
PQI 90 (Age Cat 4) 0.923 0.156 0.525 
IV 
PQI 90 (Age Cat 1) PQI 90 (Age Cat 2) PQI 90 (Age Cat 3) PQI 90 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den 0.143 0.124 0.155 0.210 -0.188 0.064 -0.166 0.196 -0.092 0.230 -0.076 0.563 0.023 0.427 0.035 0.792 
P
C
M
H
 
C
ap
ab
il
it
ie
s 
IT 0.198* 0.054 -0.019 0.898 0.184 0.068 0.103 0.505 0.123 0.162 0.106 0.505 0.207 0.046 0.125 0.427 
CSC 0.129 0.149 0.248 0.305 -0.053 0.335 0.132 0.598 -0.080 0.260 0.093 0.717 -0.023 0.425 0.182 0.478 
CoC 0.313** 0.005 0.217 0.214 0.156 0.104 0.119 0.508 -0.031 0.402 -0.157 0.397 0.128 0.151 0.122 0.508 
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Table 20: Continued 
 
ACC 0.233* 0.029 0.152 0.426 -0.010 0.467 -0.066 0.739 -0.051 0.341 0.055 0.786 -0.02 0.436 -0.058 0.776 
RPT 0.032 0.398 -0.261 0.118 -0.084 0.249 -0.092 0.593 -0.088 0.239 -0.114 0.522 -0.049 0.348 0.011 0.948 
CDT -0.103 0.203 -0.284 0.076 -0.246* 0.022 -0.273 0.101 -0.163 0.093 -0.214 0.209 -0.209* 0.045 -0.271 0.111 
NoN 0.243* 0.024 0.205 0.198 0.207* 0.046 0.272 0.102 0.157 0.102 0.336* 0.051 0.103 0.204 0.103 0.541 
PxP 0.131 0.146 0.143 0.266 -0.124 0.158 -0.065 0.623 -0.065 0.300 0.006 0.966 -0.236* 0.028 -0.213 0.121 
PVS 0.041 0.372 -0.295 0.100 0.010 0.469 -0.177 0.338 -0.113 0.181 -0.289 0.131 -0.011 0.465 -0.171 0.366 
PTC 0.181 0.071 0.140 0.307 0.043 0.365 -0.025 0.859 0.077 0.268 0.060 0.681 0.042 0.367 -0.053 0.716 
DV F-Value r-Sq Sig 
  
PQI 91 (Age Cat 1) 1.698 0.253 0.098 
PQI 91 (Age Cat 2) 2.224 0.555* 0.026 
PQI 91 (Age Cat 3) 0.872 0.149 0.572 
PQI 91 (Age Cat 4) 1.101 0.18 0.378 
IV 
PQI 91 (Age Cat 1) PQI 91 (Age Cat 2) PQI 91 (Age Cat 3) PQI 91 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.059 0.318 -0.046 0.708 -0.102 0.205 -0.082 0.488 -0.243* 0.024 -0.201 0.129 -0.166 0.089 -0.156 0.228 
P
C
M
H
 C
ap
ab
il
it
ie
s 
IT 0.156 0.104 -0.071 0.634 0.227* 0.032 0.137 0.338 -0.075 0.274 -0.041 0.796 0.161 0.097 0.038 0.808 
CSC 0.094 0.226 0.218 0.367 -0.151 0.111 0.043 0.854 -0.243* 0.024 -0.115 0.654 -0.085 0.248 -0.043 0.865 
CoC 0.318** 0.004 0.329 0.062 0.067 0.295 -0.017 0.918 -0.072 0.282 -0.037 0.843 0.184 0.068 0.191 0.295 
ACC 0.190 0.061 0.018 0.926 -0.119 0.169 -0.004 0.984 -0.117 0.172 0.077 0.708 -0.023 0.427 -0.047 0.816 
RPT -0.051 0.342 -0.415* 0.015 -0.123 0.161 -0.120 0.453 -0.188 0.064 -0.117 0.509 -0.047 0.352 -0.055 0.752 
CDT -0.044 0.362 -0.085 0.592 -0.361** 0.001 -0.366* 0.019 -0.199* 0.053 -0.108 0.524 -0.209 0.045 -0.151 0.365 
NoN 0.264* 0.015 0.273 0.089 0.185 0.067 0.315* 0.043 -0.020 0.437 0.169 0.321 0.175 0.078 0.184 0.270 
PxP 0.112 0.183 0.147 0.255 -0.146 0.120 -0.046 0.710 -0.088 0.240 -0.006 0.964 -0.165 0.092 -0.139 0.302 
PVS 0.034 0.391 -0.261 0.144 -0.075 0.274 -0.252 0.144 -0.189 0.063 -0.181 0.340 0.008 0.475 -0.085 0.647 
PTC 0.160 0.097 0.180 0.191 0.228* 0.031 0.197 0.139 0.000 0.498 0.112 0.446 0.150 0.112 0.133 0.357 
DV F-Value r-Sq Sig 
  
PQI 92 (Age Cat 1) 1.203 0.194 0.307 
PQI 92 (Age Cat 2) 0.852 0.146 0.591 
PQI 92 (Age Cat 3) 1.030 0.171 0.433 
PQI 92 (Age Cat 4) 0.877 0.149 0.568 
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Table 20: Continued 
     
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den 0.219* 0.037 0.227 0.079 -0.197 0.055 -0.178 0.180 0.009 0.470 0.006 0.961 0.155 0.105 0.165 0.211 
P
C
M
H
 C
ap
ab
il
it
ie
s 
IT 0.166 0.090 0.009 0.953 0.135 0.138 0.064 0.687 0.215* 0.040 0.156 0.321 0.190 0.062 0.107 0.501 
CSC 0.119 0.168 0.163 0.515 -0.007 0.479 0.122 0.635 0.027 0.415 0.140 0.583 0.044 0.362 0.242 0.349 
CoC 0.223* 0.035 0.069 0.701 0.176 0.078 0.164 0.377 0.015 0.453 -0.186 0.311 0.094 0.224 0.087 0.637 
ACC 0.202* 0.050 0.209 0.296 0.036 0.385 -0.084 0.680 0.000 0.500 0.034 0.867 0.004 0.486 -0.051 0.802 
RPT 0.086 0.244 -0.090 0.601 -0.048 0.349 -0.064 0.718 -0.002 0.494 -0.099 0.570 -0.021 0.434 0.021 0.904 
CDT -0.104 0.201 -0.314 0.060 -0.157 0.102 -0.178 0.295 -0.098 0.216 -0.196 0.242 -0.136 0.137 -0.233 0.172 
NoN 0.183 0.069 0.130 0.433 0.193 0.059 0.218 0.201 0.255* 0.019 0.394* 0.021 0.063 0.306 0.042 0.806 
PxP 0.113 0.181 0.103 0.439 -0.090 0.235 -0.060 0.662 -0.032 0.398 0.013 0.922 -0.234 0.028 -0.235 0.089 
PVS 0.046 0.355 -0.213 0.251 0.050 0.342 -0.100 0.599 -0.037 0.383 -0.266 0.158 0.017 0.446 -0.138 0.468 
PTC 0.159 0.100 0.094 0.507 -0.033 0.397 -0.103 0.481 0.133 0.142 0.052 0.717 0.022 0.431 -0.088 0.550 
*=p<.05 & **=<.01   
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Table 21: 2011 PQI Regression—All FIPS—10 PCMH Capability Composites 
Aim 3: Is there a statistical significance in the means of 2011 PQI rates within all FIPs with regard to PCD densities and 10 PCMH capabilities? (n=114) 
DV F-Value r-Sq Sig 
  
  
PQI 90 (Overall) 2.017 0.179* 0.034 
PQI 91 (Acute) 1.121 0.108 0.353 
PQI 92 (Chronic) 2.201 .192* 0.020 
IV 
PQI 90 (Overall) PQI 91 (Acute) PQI 92 (Chronic) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.166* 0.039 -0.175 0.080 -0.096 0.154 -0.112 0.281 -0.183* 0.026 -0.188 0.059 
P
C
M
H
 
C
ap
ab
il
it
ie
s 
IT 0.120 0.101 0.233 0.497 0.064 0.248 0.137 0.702 0.136 0.074 0.256 0.452 
CSC 0.137 0.074 2.169** 0.006 0.078 0.204 1.786 0.027 0.153* 0.052 2.133** 0.006 
CoC 0.120 0.103 0.418 0.448 0.069 0.231 0.461 0.422 0.133 0.079 0.336 0.539 
 
ACC 0.142 0.066 0.249 0.651 0.079 0.201 -0.102 0.859 0.160 0.044 0.41 0.452 
 
RPT 0.111 0.119 0.025 0.952 0.069 0.232 0.140 0.747 0.122 0.097 -0.024 0.953 
CDT 0.087 0.178 -1.885** 0.001 0.040 0.335 -1.496 0.011 0.103 0.137 -1.879** 0.001 
NoN 0.100 0.145 -0.21 0.390 0.075 0.215 -0.028 0.911 0.101 0.143 -0.294 0.225 
PxP 0.128 0.088 0.288 0.251 0.082 0.193 0.258 0.324 0.140 0.069 0.276 0.267 
PVS 0.092 0.165 -1.112 0.015 0.045 0.319 -0.894 0.058 0.107 0.128 -1.108** 0.014 
PTC 0.077 0.208 -0.154 0.457 0.014 0.442 -0.268 0.215 0.103 0.139 -0.074 0.719 
Aim 3: Is there a statistical significance in the age-specific means of 2011 PQI rates within all FIPs with regard to PCD densities and 10 PCMH capabilities? (n=114) 
DV F-Value r-Sq Sig 
  PQI 90 (Age Cat 1) 1.57 0.145 0.119 
PQI 90 (Age Cat 2) 2.174 .190* 0.021 
PQI 90 (Age Cat 3) 1.868 .168* 0.052 
 
PQI 90 (Age Cat 4) 1.335 0.126 0.216 
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Table 21: Continued 
IV 
PQI 90 (Age Cat 1) PQI 90 (Age Cat 2) PQI 90 (Age Cat 3) PQI 90 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.058 0.268 -0.144 0.156 -0.165* 0.040 -0.198* 0.047 -0.182* 0.026 -0.176 0.080 -0.119 0.103 -0.088 0.393 
P
C
M
H
 C
ap
ab
il
it
ie
s 
IT -0.058 0.269 0.217 0.536 0.091 0.167 0.287 0.400 0.145 0.062 0.214 0.535 0.137 0.073 0.121 0.733 
CSC -0.056 0.277 1.969** 0.013 0.099 0.148 2.416** 0.002 0.166* 0.039 1.872* 0.017 0.158 0.047 1.427 0.074 
CoC -0.088 0.176 0.038 0.946 0.078 0.204 0.481 0.379 0.145 0.062 0.177 0.749 0.158 0.047 0.505 0.375 
ACC -0.062 0.255 0.296 0.598 0.096 0.155 0.090 0.869 0.174* 0.032 0.436 0.431 0.175 0.031 0.285 0.615 
RPT -0.091 0.168 -0.131 0.758 0.068 0.235 -0.028 0.946 0.142 0.066 -0.001 0.998 0.142 0.066 0.067 0.877 
CDT -0.114 0.114 -1.684** 0.004 0.045 0.317 -1.998** 0.000 0.124 0.094 -1.605** 0.005 0.128 0.088 -1.327* 0.022 
NoN -0.069 0.232 -0.134 0.589 0.052 0.290 -0.301 0.216 0.118 0.105 -0.227 0.357 0.131 0.082 -0.125 0.619 
PxP -0.099 0.147 0.014 0.955 0.082 0.194 0.253 0.310 0.166* 0.039 0.333 0.188 0.159 0.045 0.237 0.359 
PVS -0.087 0.179 -0.858 0.064 0.054 0.285 -1.178** 0.009 0.119 0.103 -1.063* 0.020 0.125 0.093 -0.779 0.095 
PTC -0.037 0.349 0.122 0.564 0.068 0.237 -0.053 0.797 0.113 0.116 -0.075 0.717 0.058 0.271 -0.334 0.120 
DV F-Value r-Sq Sig 
  
PQI 91 (Age Cat 1) 0.732 0.073 0.705 
PQI 91 (Age Cat 2) 1.303 0.123 0.234 
PQI 91 (Age Cat 3) 1.115 0.107 0.357 
PQI 91 (Age Cat 4) 0.881 0.087 0.562 
IV 
PQI 91 (Age Cat 1) PQI 91 (Age Cat 2) PQI 91 (Age Cat 3) PQI 91 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den 0.007 0.469 -0.047 0.658 -0.046 0.315 -0.094 0.360 -0.122 0.097 -0.140 0.177 -0.108 0.126 -0.089 0.395 
P
C
M
H
 C
ap
ab
il
it
ie
s 
IT -0.067 0.240 -0.082 0.821 -0.006 0.476 0.043 0.904 0.061 0.260 0.139 0.697 0.114 0.114 0.201 0.578 
CSC -0.058 0.271 1.384 0.092 0.018 0.423 2.246** 0.005 0.079 0.203 1.729* 0.033 0.117 0.107 1.110 0.172 
CoC -0.063 0.253 0.399 0.496 -0.008 0.467 0.357 0.531 0.066 0.242 0.358 0.533 0.124 0.094 0.499 0.390 
ACC -0.056 0.279 0.004 0.995 0.007 0.469 -0.206 0.717 0.084 0.188 0.094 0.870 0.127 0.090 -0.042 0.942 
RPT -0.071 0.225 -0.179 0.685 0.012 0.448 0.274 0.523 0.064 0.248 0.071 0.870 0.109 0.123 0.076 0.862 
 
CDT -0.097 0.152 -1.263* 0.034 -0.030 0.377 -1.696** 0.004 0.048 0.308 -1.337* 0.022 0.094 0.159 -1.085 0.065 
NoN -0.023 0.406 0.159 0.539 0.004 0.483 -0.11 0.663 0.045 0.319 -0.184 0.469 0.117 0.107 -0.003 0.991 
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Table 21: Continued 
 
PxP -0.058 0.270 0.168 0.528 0.013 0.445 0.207 0.424 0.085 0.185 0.266 0.309 0.126 0.091 0.235 0.373 
PVS -0.076 0.212 -0.669 0.163 -0.023 0.404 -1.049* 0.026 0.039 0.340 -0.963* 0.042 0.096 0.154 -0.579 0.223 
PTC -0.057 0.273 -0.006 0.978 -0.013 0.444 -0.134 0.531 0.018 0.423 -0.195 0.367 0.032 0.368 -0.363 0.098 
DV F-Value r-Sq Sig 
  
PQI 92 (Age Cat 1) 1.781 0.161 0.067 
PQI 92 (Age Cat 2) 2.275 .197* 0.016 
PQI 92 (Age Cat 3) 1.889 .169* 0.049 
PQI 92 (Age Cat 4) 1.357 0.128 0.205 
IV 
PQI 92 (Age Cat 1) PQI 92 (Age Cat 2) PQI 92 (Age Cat 3) PQI 92 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.084 0.188 -0.169 0.094 -0.194* 0.019 -0.217* 0.029 0.189* 0.022 -0.173 0.086 -0.100 0.144 -0.065 0.524 
P
C
M
H
 
C
ap
ab
il
i
ti
es
 IT -0.039 0.340 0.366 0.292 0.121 0.100 0.354 0.298 0.167* 0.038 0.222 0.520 0.126 0.090 0.022 0.950 
CSC -0.042 0.330 1.882* 0.017 0.122 0.098 2.247** 0.004 0.188* 0.023 1.741* 0.026 0.160* 0.044 1.471 0.065 
 
CoC -0.084 0.187 -0.223 0.689 0.105 0.133 0.476 0.382 0.165* 0.040 0.074 0.893 0.152* 0.053 0.393 0.489 
ACC -0.053 0.289 0.409 0.462 0.122 0.097 0.201 0.712 0.197* 0.018 0.543 0.327 0.180* 0.027 0.499 0.379 
RPT -0.081 0.195 -0.062 0.882 0.085 0.184 -0.136 0.740 0.163* 0.042 -0.024 0.954 0.142 0.066 0.077 0.858 
CDT -0.097 0.152 -1.552** 0.006 0.071 0.225 -1.92** 0.001 0.146 0.060 -1.558** 0.006 0.130 0.084 -1.283* 0.026 
NoN -0.083 0.189 -0.292 0.238 0.066 0.242 -0.352 0.146 0.139 0.070 -0.224 0.362 0.113 0.116 -0.224 0.375 
PxP -0.100 0.144 -0.074 0.769 0.103 0.139 0.251 0.311 0.186* 0.023 0.333 0.187 0.156* 0.048 0.197 0.445 
PVS -0.074 0.217 -0.779 0.089 0.080 0.200 -1.111** 0.014 0.143 0.064 -1.000* 0.029 0.122 0.098 -0.827 0.077 
PTC -0.015 0.435 0.171 0.414 0.093 0.163 -0.020 0.921 0.143 0.064 -0.015 0.944 0.067 0.241 -0.245 0.251 
*=p<.05 & **=<.01   
 
 88 
The results in Table 22 indicate statistical significance in the full models for PCD density 
and the 10 PCMH capability composites for FIPS with PCMHs (n=67) on 2011 PQI 92, 
F(11,67), f=2.061, r2=.192 (p<.05) with positive correlations on CSC r=.198 (p<.05) and ACC 
r=.214. There is also statistical significance in the full models for age-specific 2011 PQI 90 age 
cat 2 F(11,67), f=1.997, r2=.285 (p<.05) with positive correlations on CSC r=.223 (p<.05); and 
age-specific 2011 PQI 92 age cat 2 F(11,67), f=2.059, r2=.292 (p<.05) with no correlation on any 
of the IVs. 
In addition to evaluating the effect of the 10 individual PCMH capability composites on 
the PQI rates, the author also evaluated the effects of the single composites of MU and MP. The 
MU and MP composites were evaluated as an independent composite because each of the 
composites is an amalgam of the various PCMH elements from the 10 PCMH capability 
composites analyzed. To account for any overlap in the capability composites, the various 
composites were analyzed independently. Just as with the evaluation of the 10 PCMH capability 
composites, the MU and MP composites will independently replace the PCMH density IV in the 
simple regressions that follow.  
The results in Table 23 indicate statistical significance in the regression models for PCD 
density and the MU capability composite for all FIPS (n=114) on Delta PQI 90, F(11,114), 
f=3.637, r2=.062 (p<.05) with positive correlation on MU r=.230 (p<.01). There is also statistical 
significance in the full models for age-specific Delta PQI 90 age cat 2 F(11,114), f=3.431, 
r2=.085 (p<.05) with correlation on MU r=.218 (p<.01); Delta PQI 91 age cat 1 F(11,114), 
f=5.387, r2=.088 (p<.01) with correlation on MU r=.295 (p<.01); Delta PQI 91 age cat 4 
F(11,114), f=3.160, r2=.054 (p<.05) with correlation on MU r=.209 (p<.01); Delta PQI 92 age  
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Table 22: 2011 PQI Regression—FIPS w/PCMH—10 PCMH Capability Composites 
Aim 3: Is there a statistical significance in the means of 2011 PQI rates within PCMH FIPs with regard to PCD densities and 10 PCMH capabilities? (n=67) 
DV F-Value r-Sq Sig 
  
  
PQI 90 (Overall) 1.896 0.275 0.060 
PQI 91 (Acute) 1.074 0.177 0.398 
PQI 92 (Chronic) 2.061 0.192* 0.039 
IV 
PQI 90 (Overall) PQI 91 (Acute) PQI 92 (Chronic) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den 0.081 0.257 0.064 0.597 0.074 0.277 0.053 0.679 0.079 0.263 0.065 0.588 
P
C
M
H
 C
ap
ab
il
it
ie
s 
IT 0.099 0.213 0.039 0.788 0.087 0.242 0.022 0.886 0.090 0.233 0.042 0.770 
CSC 0.211* 0.043 0.711** 0.004 0.190 0.062 0.578* 0.025 0.198* 0.054 0.707** 0.004 
CoC 0.121 0.165 0.037 0.828 0.144 0.123 0.090 0.622 0.091 0.232 0.001 0.995 
ACC 0.217* 0.039 0.116 0.539 0.174 0.079 -0.014 0.944 0.214* 0.041 0.173 0.356 
RPT 0.066 0.299 0.019 0.907 0.113 0.181 0.056 0.748 0.036 0.386 0.004 0.980 
CDT -0.114 0.180 -0.529** 0.001 -0.041 0.370 -0.38* 0.025 -0.139 0.131 -0.554** 0.001 
NoN 0.032 0.399 -0.052 0.742 0.095 0.223 0.029 0.863 -0.010 0.469 -0.093 0.548 
 
PxP 0.115 0.176 0.123 0.333 0.134 0.140 0.119 0.378 0.096 0.220 0.114 0.364 
 PVS -0.019 0.440 -0.489** 0.007 0.007 0.479 -0.376* 0.048 -0.034 0.393 -0.500** 0.005 
PTC -0.024 0.423 -0.132 0.332 -0.064 0.303 -0.195 0.178 -0.001 0.496 -0.084 0.530 
Aim 3: Is there a statistical significance in the age-specific means of 2011 PQI rates within PCMH FIPs with regard to PCD densities and 10 PCMH capabilities? (n=67) 
DV F-Value r-Sq Sig 
  
PQI 90 (Age Cat 1) 1.41 0.220 0.195 
PQI 90 (Age Cat 2) 1.997 0.285* 0.046 
PQI 90 (Age Cat 3) 1.862 0.271 0.065 
PQI 90 (Age Cat 4) 1.323 0.209 0.237 
IV 
PQI 90 (Age Cat 1) PQI 90 (Age Cat 2) PQI 90 (Age Cat 3) PQI 90 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den 0.080 0.259 0.038 0.765 0.021 0.434 -0.017 0.889 0.127 0.152 0.120 0.324 0.115 0.178 0.130 0.305 
P
C
M
H
 
C
ap
ab
il
it
ie
s 
IT 0.206* 0.047 0.082 0.589 0.136 0.136 0.076 0.602 0.057 0.324 0.019 0.898 0.024 0.422 -0.007 0.963 
CSC 0.318** 0.004 0.624** 0.014 0.223* 0.035 0.788** 0.001 0.174 0.080 0.638** 0.009 0.128 0.152 0.481 0.056 
CoC 0.132 0.144 0.009 0.959 0.112 0.184 0.064 0.704 0.060 0.316 -0.047 0.786 0.129 0.149 0.072 0.685 
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Table 22: Continued 
 
ACC 0.242* 0.024 0.121 0.537 0.183 0.069 0.053 0.778 0.200* 0.053 0.191 0.314 0.203 0.050 0.131 0.506 
RPT 0.078 0.264 -0.072 0.671 0.050 0.345 0.009 0.958 0.045 0.359 0.004 0.980 0.044 0.361 0.026 0.879 
CDT -0.014 0.455 -0.323* 0.050 -0.129 0.149 -0.529** 0.001 -0.114 0.178 -0.52** 0.002 -0.084 0.250 -0.415** 0.013 
NoN 0.085 0.246 -0.076 0.641 0.001 0.496 -0.122 0.435 -0.006 0.482 -0.047 0.763 0.028 0.412 -0.003 0.986 
PxP 0.018 0.443 0.004 0.976 0.088 0.240 0.109 0.384 0.129 0.149 0.143 0.260 0.105 0.198 0.099 0.452 
PVS 0.108 0.192 -0.321 0.081 -0.015 0.453 -0.511** 0.005 -0.059 0.318 -0.490** 0.007 -0.035 0.390 -0.359* 0.053 
PTC 0.167 0.089 0.079 0.571 0.041 0.371 -0.061 0.648 -0.016 0.449 -0.089 0.511 -0.155 0.105 -0.247 0.084 
DV F-Value r-Sq Sig 
  
PQI 91 (Age Cat 1) 1.050 0.174 0.417 
PQI 91 (Age Cat 2) 1.390 0.218 0.204 
PQI 91 (Age Cat 3) 1.337 0.211 0.230 
PQI 91 (Age Cat 4) 0.803 0.138 0.636 
IV 
PQI 91 (Age Cat 1) PQI 91 (Age Cat 2) PQI 91 (Age Cat 3) PQI 91 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den 0.023 0.426 -0.019 0.886 0.056 0.326 0.001 0.994 0.078 0.266 0.071 0.573 0.080 0.260 0.087 0.511 
P
C
M
H
 C
ap
ab
il
it
ie
s 
IT 0.168 0.087 -0.017 0.915 0.095 0.223 -0.003 0.987 0.022 0.431 0.002 0.990 0.067 0.295 0.045 0.778 
CSC 0.317** 0.004 0.458 0.075 0.275** 0.012 0.741** 0.004 0.124 0.158 0.622* 0.015 0.097 0.219 0.372 0.154 
CoC 0.284** 0.010 0.210 0.253 0.126 0.155 0.077 0.666 0.052 0.337 0.020 0.911 0.138 0.133 0.099 0.597 
ACC 0.286** 0.009 -0.010 0.960 0.185 0.067 -0.062 0.750 0.137 0.134 0.067 0.734 0.136 0.136 0.010 0.962 
RPT 0.162 0.095 -0.113 0.518 0.184 0.068 0.118 0.486 0.037 0.383 0.042 0.807 0.050 0.343 0.028 0.876 
CDT 0.102 0.205 -0.127 0.445 0.003 0.492 -0.395* 0.018 -0.106 0.197 -0.466** 0.006 -0.068 0.293 -0.315 0.068 
NoN 0.236* 0.027 0.080 0.630 0.085 0.247 -0.042 0.797 -0.019 0.439 -0.039 0.812 0.074 0.277 0.049 0.772 
PxP 0.166 0.090 0.117 0.386 0.141 0.128 0.102 0.438 0.106 0.197 0.119 0.367 0.104 0.201 0.106 0.441 
PVS 0.156 0.104 -0.217 0.247 0.029 0.409 -0.437* 0.019 -0.084 0.250 -0.468** 0.013 -0.009 0.471 -0.262 0.172 
PTC 0.112 0.184 0.015 0.918 0.034 0.392 -0.104 0.457 -0.086 0.244 -0.168 0.237 -0.145 0.120 -0.260 0.081 
DV F-Value r-Sq Sig 
  
PQI 92 (Age Cat 1) 1.568 0.239 0.135 
PQI 92 (Age Cat 2) 2.059 0.292* 0.040 
PQI 92 (Age Cat 3) 1.751 0.259 0.086 
PQI 92 (Age Cat 4) 1.551 0.237 0.140 
  
9
1
 
Table 22: Continued 
IV 
PQI 92 (Age Cat 1) PQI 92 (Age Cat 2) PQI 92 (Age Cat 3) PQI 92 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den 0.094 0.224 0.057 0.649 0.006 0.482 -0.022 0.855 0.142 0.127 0.135 0.273 0.137 0.134 0.156 0.214 
P
C
M
H
 C
ap
ab
il
it
ie
s 
IT 0.190 0.062 0.124 0.408 0.138 0.133 0.098 0.500 0.064 0.304 0.022 0.884 -0.022 0.430 -0.055 0.715 
CSC 0.263* 0.016 0.602* 0.016 0.185 0.067 0.751** 0.002 0.178 0.075 0.587* 0.017 0.137 0.134 0.511* 0.039 
CoC 0.024 0.422 -0.104 0.553 0.094 0.224 0.051 0.763 0.055 0.328 -0.073 0.675 0.092 0.229 0.031 0.858 
ACC 0.174 0.080 0.166 0.391 0.168 0.087 0.093 0.618 0.207* 0.047 0.227 0.237 0.225* 0.034 0.211 0.278 
RPT 0.023 0.426 -0.034 0.838 -0.004 0.488 -0.028 0.860 0.046 0.356 -0.009 0.956 0.039 0.376 0.032 0.850 
CDT -0.069 0.289 -0.366* 0.025 -0.170 0.084 -0.545** 0.001 -0.108 0.193 -0.498** 0.002 -0.078 0.266 -0.437** 0.008 
NoN -0.010 0.467 -0.146 0.364 -0.034 0.394 -0.144 0.352 0.000 0.499 -0.046 0.770 -0.024 0.422 -0.057 0.723 
PxP -0.057 0.324 -0.049 0.703 0.063 0.305 0.106 0.395 0.130 0.148 0.143 0.266 0.093 0.226 0.079 0.544 
PVS 0.063 0.307 -0.319 0.079 -0.032 0.398 -0.504** 0.005 -0.045 0.359 -0.456** 0.012 -0.057 0.324 -0.393* 0.032 
PTC 0.165 0.091 0.097 0.483 0.037 0.384 -0.044 0.739 0.015 0.452 -0.049 0.722 -0.139 0.131 -0.197 0.159 
*=p<.05 & **=<.01   
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Table 23: Delta PQI Regression—All FIPS—MU PCMH Capability Composite 
Aim 3: Is there a statistical significance in the means of Delta PQI rates within all FIPs with regard to PCD densities and Meaningful Use (MU) capabilities 
composite? (n=114) 
DV F-Value r-Sq Sig 
  PQI 90 (Overall) 3.637 0.062* 0.030 
PQI 91 (Acute) 1.799 0.031 0.170 
PQI 92 (Chronic) 2.784 0.048 0.066  
IV 
PQI 90 (Overall) PQI 91 (Acute) PQI 92 (Chronic) 
  
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.008 0.468 0.100 0.320 0.033 0.364 0.109 0.288 0.005 0.479 0.100 0.323 
MU .230** 0.007 .270** 0.008 0.147 0.060 0.190 0.065 .198* 0.017 .238* 0.02 
Aim 3: Is there a statistical significance in the age-specific means of Delta PQI rates within all FIPs with regard to PCD densities and Meaningful Use (MU) 
capabilities composite? (n=114) 
DV F-Value r-Sq Sig 
  PQI 90 (Age Cat 1) 1.908 0.033 0.153 
PQI 90 (Age Cat 2) 3.431 .058* 0.036 
PQI 90 (Age Cat 3) 2.008 0.035 0.139 
 
PQI 90 (Age Cat 4) 2.782 0.048 0.066 
IV 
PQI 90 (Age Cat 1) PQI 90 (Age Cat 2) PQI 90 (Age Cat 3) PQI 90 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.061 0.259 0.014 0.894 0.008 0.466 0.113 0.263 -0.081 0.195 -0.001 0.937 0.058 0.269 0.150 0.141 
MU .182* 0.026 0.187 0.068 .218** 0.010 .263** 0.010 .187* 0.023 0.184 0.074 .170* 0.035 .230* 0.025 
DV F-Value r-Sq Sig 
  
PQI 91 (Age Cat 1) 5.387 .088** 0.006 
PQI 91 (Age Cat 2) 2.588 0.045 0.080 
PQI 91 (Age Cat 3) 0.259 0.005 0.772 
PQI 91 (Age Cat 4) 3.160 .054* 0.046 
IV 
PQI 91 (Age Cat 1) PQI 91 (Age Cat 2) PQI 91 (Age Cat 3) PQI 91 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.084 0.186 0.040 0.687 0.040 0.337 0.130 0.201 -0.030 0.378 -0.003 0.979 0.010 0.458 0.111 0.273 
MU .295** 0.001 .311** 0.002 .174* 0.032 .226* 0.027 0.068 0.236 0.067 0.517 .209** 0.013 .253** 0.013 
DV F-Value r-Sq Sig 
  
PQI 92 (Age Cat 1) 0.301 0.005 0.741 
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Table 23: Continued 
PQI 92 (Age Cat 2) 3.157 .054* 0.046 
 PQI 92 (Age Cat 3) 3.317 .056* 0.040 
PQI 92 (Age Cat 4) 2.105 0.037 0.127 
 IV 
PQI 92 (Age Cat 1) PQI 92 (Age Cat 2) PQI 92 (Age Cat 3) PQI 92 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.037 0.346 -0.010 0.923 -0.011 0.455 0.090 0.373 -0.102 0.139 -0.009 0.928 0.091 0.168 0.164 0.109 
MU 0.073 0.221 0.069 0.506 .217** 0.010 .253** 0.014 .237** 0.006 .234* 0.022 0.118 0.106 0.183 0.074 
*=p<.05 & **=<.01   
 94 
cat 2 F(11,114), f=3.157, r2=.054 (p<.01) with correlation on MU r=.217 (p<.01); and Delta PQI 
92 age cat 3 F(11,114), f=3.157, r2=.054 (p<.01) with correlation on MU r=.217 (p<.01). 
The results in Table 24 indicate no statistical significance in the regression models for 
PCD density and the MU capability composite for FIPS with PCMH (n=67) on any of the overall 
or age-specific Delta PQI rates, even though there is varying correlation with PCD and/or MU 
capability composite on a few of the PQI rates.  
The results in Table 25 indicate no statistical significance in the regression models for 
PCD density and the MU capability composite for all FIPS (n=114) on any of the 2011 PQI rates 
for the overall or age-specific 2011 PQI rates, even though there is varying correlation with PCD 
and/or MU capability composite on a few of the PQI rates. 
The results in Table 26 indicate no statistical significance in the regression models for 
PCD density and the MU capability composite for FIPS with PCMHs (n=67) on the overall 2011 
PQI rates. There is statistical significance in the full models for age-specific 2011 PQI 91 age cat 
1 F(11,114), f=3.207, r2=.091 (p<.05) with positive correlation on MU r=.300 (p<.01). 
The results in Table 27 indicate statistical significance in the full models for MP 
capability composite for all FIPS (n=114) on Delta PQI 90, F(11,114), f=3.256, r2=.056 (p<.05) 
with positive correlation on MP r=.218 (p<.01). There is also statistical significance in the full 
models for age-specific Delta PQI 90 age cat 2 F(11,114), f=3.203, r2=.053 (p<.05) with 
correlation on MP r=.204 (p<.05); and Delta PQI 91 age cat 1 F(11,114), f=1.387, r2=.085 
(p<.01) with correlation on MP r=.289 (p<.01). 
The results in Table 28 indicate no statistical significance in the full models for PCD 
density and the MP capability composite for FIPS with PCMHs (n=67) on any of the overall or  
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Table 24: Delta PQI Regression—FIPS w/PCMH—MU PCMH Capability Composite 
Aim 3: Is there a statistical significance in the means of Delta PQI rates within PCMH FIPs with regard to PCD densities and Meaningful Use (MU) 
capabilities composite? (n=67) 
DV F-Value r-Sq Sig 
  
PQI 90 (Overall) 1.350 0.040 0.266 
PQI 91 (Acute) 0.212 0.007 0.809 
PQI 92 (Chronic) 0.947 0.029 0.393 
IV 
PQI 90 (Overall) PQI 91 (Acute) PQI 92 (Chronic) 
  
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.104 0.201 -1.943 0.272 -0.066 0.299 -0.075 0.557 0.012 0.463 -0.022 0.862 
MU 0.149 0.115 7.342 0.165 0.034 0.392 0.049 0.702 0.168 0.087 0.172 0.175 
Aim 3: Is there a statistical significance in the age-specific means of Delta PQI rates within PCMH FIPs with regard to PCD densities and Meaningful 
Use (MU) capabilities composite? (n=67) 
DV F-Value r-Sq Sig   
PQI 90 (Age Cat 1) 2.543 0.074 0.087 
 
PQI 90 (Age Cat 2) 2.127 0.062 0.128 
PQI 90 (Age Cat 3) 0.329 0.010 0.721 
PQI 90 (Age Cat 4) 0.706 0.022 0.498 
IV 
PQI 90 (Age Cat 1) PQI 90 (Age Cat 2) PQI 90 (Age Cat 3) PQI 90 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den 0.143 0.124 0.098 0.430 -0.188 0.064 -0.220 0.079 -0.092 0.230 -0.100 0.433 0.023 0.427 -0.006 0.962 
MU .254* 0.019 0.235 0.060 0.125 0.157 0.168 0.178 0.024 0.425 0.043 0.735 0.147 0.118 0.148 0.245 
DV F-Value r-Sq Sig 
  
PQI 91 (Age Cat 1) 1.790 0.053 0.175 
PQI 91 (Age Cat 2) 0.611 0.019 0.546 
 PQI 91 (Age Cat 3) 2.971 0.085 0.058 
PQI 91 (Age Cat 4) 1.671 0.05 0.196 
IV 
PQI 91 (Age Cat 1) PQI 91 (Age Cat 2) PQI 91 (Age Cat 3) PQI 91 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.059 0.318 -0.103 0.409 -0.102 0.205 -0.120 0.344 -.243* 0.024 -0.211 0.089 -0.166 0.089 -0.196 0.120 
MU .207* 0.047 0.227 0.072 0.069 0.289 0.093 0.465 -.205* 0.048 -0.164 0.182 0.113 0.181 0.151 0.228 
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Table 24: Continued 
DV F-Value r-Sq Sig 
  
PQI 92 (Age Cat 1) 2.806 0.081 0.068 
PQI 92 (Age Cat 2) 2.329 0.068 0.106 
PQI 92 (Age Cat 3) 0.823 0.025 0.443 
PQI 92 (Age Cat 4) 1.325 0.040 0.273 
IV 
PQI 92 (Age Cat 1) PQI 92 (Age Cat 2) PQI 92 (Age Cat 3) PQI 92 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den 0.219* 0.037 0.184 0.138 -0.197 0.055 -0.231 0.065 0.009 0.470 -0.022 0.861 0.155 0.105 0.131 0.299 
MU 0.220* 0.037 0.184 0.138 0.129 0.149 0.174 0.162 0.157 0.102 0.161 0.205 0.153 0.109 0.127 0.312 
*=p<.05 & **=<.01   
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Table 25: 2011 PQI Regression—All FIPS—MU PCMH Capability Composite 
Aim 3: Is there a statistical significance in the means of 2011 PQI rates within all FIPs with regard to PCD densities and Meaningful Use 
(MU) capabilities composite? (n=114) 
DV F-Value r-Sq Sig 
  
PQI 90 (Overall) 1.921 0.032 0.167 
PQI 91 (Acute) 0.586 0.01 0.558 
PQI 92 (Chronic) 2.268 0.039 0.108 
IV 
PQI 90 (Overall) PQI 91 (Acute) PQI 92 (Chronic) 
  
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -.166* 0.039 -0.137 0.182 -0.096 0.154 -0.082 0.430 -.183* 0.026 -0.150 0.143 
MU 0.127 0.090 0.072 0.481 0.070 0.231 0.037 0.719 0.143 0.065 0.083 0.414  
Aim 3: Is there a statistical significance in the age-specific means of 2011 PQI rates within all FIPs with regard to PCD densities and Meaningful Use 
(MU) capabilities composite? (n=114) 
DV F-Value r-Sq Sig 
  
PQI 90 (Age Cat 1) 0.692 0.012 0.503 
PQI 90 (Age Cat 2) 1.590 0.028 0.209 
PQI 90 (Age Cat 3) 2.372 0.041 0.098 
PQI 90 (Age Cat 4) 1.502 0.026 0.227 
IV 
PQI 90 (Age Cat 1) PQI 90 (Age Cat 2) PQI 90 (Age Cat 3) PQI 90 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.058 0.268 -0.100 0.335 -0.165* 0.040 -0.153 0.138 -.182* 0.026 -0.144 0.159 -0.119 0.103 -0.071 0.487 
MU -0.063 0.252 -0.103 0.320 0.091 0.168 0.030 0.768 .154* 0.051 0.097 0.343 0.149 0.057 0.120 0.242 
DV F-Value r-Sq Sig 
  PQI 91 (Age Cat 1) 0.238 0.004 0.789 
PQI 91 (Age Cat 2) 0.132 0.002 0.876 
PQI 91 (Age Cat 3) 0.860 0.015 0.426 
 
PQI 91 (Age Cat 4) 1.02 0.018 0.364 
IV 
PQI 91 (Age Cat 1) PQI 91 (Age Cat 2) PQI 91 (Age Cat 3) PQI 91 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den 0.007 0.469 -0.021 0.841 -0.046 0.315 -0.053 0.609 -0.122 0.097 -0.115 0.264 -0.108 0.126 -0.073 0.476 
MU -0.062 0.255 -0.071 0.495 0.002 0.490 -0.019 0.856 0.064 0.250 0.018 0.862 0.116 0.109 0.087 0.398 
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Table 25: Continued 
DV F-Value r-Sq Sig 
  
PQI 92 (Age Cat 1) 0.846 0.015 0.432 
PQI 92 (Age Cat 2) 2.279 0.039 0.107 
PQI 92 (Age Cat 3) 2.816 0.048 0.064 
PQI 92 (Age Cat 4) 1.309 0.023 0.274 
IV 
PQI 92 (Age Cat 1) PQI 92 (Age Cat 2) PQI 92 (Age Cat 3) PQI 92 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.084 0.188 -0.123 0.235 -.194* 0.019 -0.174 0.088 -.189* 0.022 -0.140 0.169 -0.100 0.144 -0.051 0.622 
MU -0.049 0.303 -0.098 0.344 0.118 0.106 0.048 0.637 .178* 0.029 0.123 0.228 0.145 0.062 0.124 0.227 
*=p<.05 & **=<.01                                 
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Table 26: 2011 PQI Regression—FIPS w/PCMH—MU PCMH Capability Composite 
Aim 3: Is there a statistical significance in the means of 2011 PQI rates within PCMH FIPs with regard to PCD densities and Meaningful Use (MU) 
capabilities composite? (n=67) 
DV F-Value r-Sq Sig   
PQI 90 (Overall) 0.969 0.029 0.385 
 PQI 91 (Acute) 0.801 0.024 0.453 
PQI 92 (Chronic) 0.817 0.025 0.446 
IV 
PQI 90 (Overall) PQI 91 (Acute) PQI 92 (Chronic) 
  
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den 0.081 0.257 0.051 0.686 0.074 0.277 0.046 0.714 0.079 0.263 0.052 0.682 
MU 0.164 0.092 0.154 0.224 0.150 0.114 0.141 0.268 0.149 0.114 0.139 0.273  
Aim 3: Is there a statistical significance in the age-specific means of 2011 PQI rates within PCMH FIPs with regard to PCD densities and 
Meaningful Use (MU) capabilities composite? (n=67) 
DV F-Value r-Sq Sig 
  
PQI 90 (Age Cat 1) 2.990 0.085 0.057 
PQI 90 (Age Cat 2) 1.180 0.036 0.314 
PQI 90 (Age Cat 3) 0.796 0.024 0.456 
PQI 90 (Age Cat 4) 0.541 0.107 0.585 
IV 
PQI 90 (Age Cat 1) PQI 90 (Age Cat 2) PQI 90 (Age Cat 3) PQI 90 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den 0.080 0.259 0.024 0.841 0.021 0.434 -0.017 0.895 0.127 0.152 0.109 0.388 0.115 0.178 0.103 0.419 
MU 0.291** 0.008 .287* 0.022 0.188 0.064 0.191 0.132 0.113 0.182 0.092 0.470 0.080 0.259 0.060 0.635 
DV F-Value r-Sq Sig 
  
PQI 91 (Age Cat 1) 3.207 .091* 0.047 
PQI 91 (Age Cat 2) 1.236 0.037 0.297 
 PQI 91 (Age Cat 3) 0.215 0.007 0.807 
PQI 91 (Age Cat 4) 0.422 0.013 0.658 
IV 
PQI 91 (Age Cat 1) PQI 91 (Age Cat 2) PQI 91 (Age Cat 3) PQI 91 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den 0.023 0.426 -0.037 0.764 0.056 0.326 0.020 0.876 0.078 0.266 0.073 0.570 0.080 0.260 0.064 0.615 
MU .300** 0.007 .307** 0.014 0.192 0.060 0.188 0.137 0.040 0.374 0.026 0.839 0.095 0.222 0.083 0.515 
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Table 26: Continued 
DV F-Value r-Sq Sig 
  
PQI 92 (Age Cat 1) 1.963 0.058 0.149 
PQI 92 (Age Cat 2) 0.957 0.029 0.389 
PQI 92 (Age Cat 3) 1.033 0.031 0.362 
PQI 92 (Age Cat 4) 0.634 0.019 0.534  
IV 
PQI 92 (Age Cat 1) PQI 92 (Age Cat 2) PQI 92 (Age Cat 3) PQI 92 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den 0.094 0.224 0.050 0.686 0.006 0.482 -0.028 0.824 0.142 0.127 0.120 0.340 0.137 0.134 0.133 .298 
MU .235* 0.028 0.226 0.073 0.168 0.087 0.174 0.171 0.132 0.144 0.108 0.392 0.050 0.343 0.024 0.847 
*=p<.05 & **=<.01   
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Table 27: Delta PQI Regression—All FIPS—MP PCMH Capability Composite 
Aim 3: Is there a statistical significance in the means of Delta PQI rates within all FIPs with regard to PCD densities and Must Pass (MP) capabilities 
composite? (n=114) 
DV F-Value r-Sq Sig 
  
PQI 90 (Overall) 3.256 0.056* 0.042 
PQI 91 (Acute) 1.773 0.031 0.175 
PQI 92 (Chronic) 2.388 0.041 0.097 
IV 
PQI 90 (Overall) PQI 91 (Acute) PQI 92 (Chronic) 
  
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.008 0.468 0.099 0.330 0.033 0.364 0.111 0.281 0.005 0.479 0.097 0.343 
MP 0.218** 0.010 0.259** 0.012 0.144 0.063 0.190 0.067 0.183* 0.026 0.223* 0.031  
Aim 3: Is there a statistical significance in the age-specific means of Delta PQI rates within all FIPs with regard to PCD densities and Must Pass (MP) 
capabilities composite? (n=114) 
DV F-Value r-Sq Sig   
PQI 90 (Age Cat 1) 1.700 0.030 0.187 
 
PQI 90 (Age Cat 2) 3.024 0.052* 0.053 
PQI 90 (Age Cat 3) 1.909 0.033 0.153 
PQI 90 (Age Cat 4) 2.459 0.042 0.090 
IV 
PQI 90 (Age Cat 1) PQI 90 (Age Cat 2) PQI 90 (Age Cat 3) PQI 90 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.061 0.259 0.012 0.908 0.008 0.466 0.111 0.276 -0.081 0.195 -0.007 0.943 0.058 0.269 0.148 0.150 
MP 0.172* 0.034 0.177 0.088 0.204* 0.015 .249* 0.016 0.182* 0.026 0.179 0.083 .156* 0.049 .217* 0.036 
DV F-Value r-Sq Sig 
  PQI 91 (Age Cat 1) 1.203 .085** 0.007 
PQI 91 (Age Cat 2) 2.283 0.040 0.107 
PQI 91 (Age Cat 3) 0.408 0.007 0.666 
 
PQI 91 (Age Cat 4) 2.964 0.051 0.056 
IV 
PQI 91 (Age Cat 1) PQI 91 (Age Cat 2) PQI 91 (Age Cat 3) PQI 91 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.084 0.186 0.042 0.674 0.040 0.337 0.128 0.212 -0.030 0.378 0.007 0.948 0.010 0.458 0.112 0.273 
MP 0.289** 0.001 0.306** 0.003 0.161* 0.044 .214* 0.039 0.085 0.184 0.088 0.398 0.201* 0.016 .247* 0.017 
DV F-Value r-Sq Sig 
  
PQI 92 (Age Cat 1) 0.231 0.004 0.794 
  
1
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Table 27: Continued 
PQI 92 (Age Cat 2) 2.801 0.048 0.065 
 PQI 92 (Age Cat 3) 2.847 0.049 0.062 
PQI 92 (Age Cat 4) 1.833 0.032 0.165 
IV 
PQI 92 (Age Cat 1) PQI 92 (Age Cat 2) PQI 92 (Age Cat 3) PQI 92 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.037 0.346 -0.014 0.895 -0.011 0.455 0.088 0.386 -0.102 0.139 -0.014 0.893 0.091 0.168 0.161 0.120 
MP 0.063 0.252 0.057 0.582 .204* 0.015 .240* 0.020 .221** 0.009 .215* 0.037 0.103 0.138 0.169 0.102 
*=p<.05 & **=<.01   
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Table 28: Delta PQI Regression—FIPS w/PCMH—MP PCMH Capability Composite 
Aim 3: Is there a statistical significance in the means of Delta PQI rates within PCMH FIPs with regard to PCD densities and Must Pass 
(MP) capabilities composite? (n=67) 
DV F-Value r-Sq Sig 
  
PQI 90 (Overall) 0.386 0.012 0.681 
PQI 91 (Acute) 0.143 0.004 0.867 
PQI 92 (Chronic) 0.115 0.004 0.891 
IV 
PQI 90 (Overall) PQI 91 (Acute) PQI 92 (Chronic) 
  
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.104 0.201 -0.107 0.394 -0.066 0.299 -0.067 0.596 0.012 0.463 0.006 0.961 
MP 0.023 0.426 0.033 0.791 0.006 0.479 0.013 0.920 0.060 0.316 0.059 0.640 
Aim 3: Is there a statistical significance in the age-specific means of Delta PQI rates within PCMH FIPs with regard to PCD densities and Must 
Pass (MP) capabilities composite? (n=67) 
DV F-Value r-Sq Sig 
  
PQI 90 (Age Cat 1) 2.103 0.062 0.130 
PQI 90 (Age Cat 2) 1.168 0.035 0.318 
PQI 90 (Age Cat 3) 0.024 0.001 0.976 
PQI 90 (Age Cat 4)       
IV 
PQI 90 (Age Cat 1) PQI 90 (Age Cat 2) PQI 90 (Age Cat 3) PQI 90 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den 0.143 0.124 0.124 0.310 -0.188 0.064 -0.187 0.134 -0.092 0.230 -0.089 0.478 0.023 0.427 0.021 0.866 
MP .215* 0.040 0.204 0.099 -0.020 0.434 -0.002 0.984 -0.034 0.393 -0.025 0.840 0.018 0.444 0.016 0.902 
DV F-Value r-Sq Sig 
  PQI 91 (Age Cat 1) 1.177 0.035 0.315 
PQI 91 (Age Cat 2) 0.545 0.017 0.583 
PQI 91 (Age Cat 3) 2.315 0.067 0.107 
 
PQI 91 (Age Cat 4) 0.978 0.03 0.381 
IV 
PQI 91 (Age Cat 1) PQI 91 (Age Cat 2) PQI 91 (Age Cat 3) PQI 91 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.059 0.318 -0.076 0.542 -0.102 0.205 -0.095 0.449 -.243* 0.024 -0.234 0.058 -0.166 0.089 -0.170 0.173 
MP 0.173 0.081 0.180 0.150 -0.088 0.238 -0.080 0.525 -0.114 0.179 -0.093 0.448 0.029 0.408 0.045 0.718 
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Table 28: Continued 
DV F-Value r-Sq Sig   
PQI 92 (Age Cat 1) 2.586 0.075 0.083 
 
PQI 92 (Age Cat 2) 1.324 0.040 0.273 
PQI 92 (Age Cat 3) 0.026 0.001 0.975 
PQI 92 (Age Cat 4) 0.806 0.025 0.451 
IV 
PQI 92 (Age Cat 1) PQI 92 (Age Cat 2) PQI 92 (Age Cat 3) PQI 92 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den .219* 0.037 0.204 0.096 -0.197 0.055 -0.200 0.109 0.009 0.470 0.007 0.957 0.155 0.105 0.061 0.625 
MP 0.183 0.069 0.164 0.179 0.014 0.455 0.033 0.792 0.028 0.413 0.027 0.831 0.029 0.408 0.139 0.267 
*=p<.05 & **=<.01   
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age-specific Delta PQI rates, even though there is varying correlation with PCD and/or MP 
capability composite on a few of the PQI rates. 
The results in Table 29 indicate no statistical significance in the full models for PCD 
density and the MP capability composite for all FIPS (n=114) on any of the overall or age-
specific 2011 PQI rates, even though there is varying correlation with PCD and/or MP capability 
composite on a few of the PQI rates.  
The results in Table 30 indicate no statistical significance in the full models for PCD 
density and the MP capability composite for FIPS with PCMHs (n=67) on any of the overall or 
age-specific 2011 PQI rates, even though there is varying correlation with the MP capability 
composite on a few of the PQI rates. 
Summary of Aims Supported by Analysis 
Table 31 provides a summary of the statistical evidence to support the specific aims of 
this study. As the table indicates, there are mixed results by specific aim and associated sub-aims 
depending on each of the 300 regression models evaluated. There is stronger statistical 
significance to suggest an association between the post-measurement (2011 PQI rates) and the 
PCMH density or PCMH capabilities; and less statistical significance to support an association 
between the Delta PQI rates and the PCD/PCMH densities or capabilities evaluated in the 
models. The only uniformly accepted null hypothesis among all the aims was the ratio of 
PCD/PCMH densities with the Delta PQI rates as noted in Table 31. All other aims as noted in 
Table 31 were supported by statistical evidence to demonstrate association with the risk-adjusted 
avoidable hospital admissions (PQI rates) with varying degrees of significance among select 
summary-level PQI rates and select age-specific PQI rates within the 114 counties evaluated. 
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Table 29: 2011 PQI Regression—All FIPS—MP PCMH Capability Composite 
Aim 3: Is there a statistical significance in the means of 2011 PQI rates within all FIPs with regard to PCD densities and Must Pass (MP) capabilities 
composite? (n=114) 
DV F-Value r-Sq Sig 
  
PQI 90 (Overall) 1.733 0.03 0.182 
PQI 91 (Acute) 0.558 0.01 0.574 
 
PQI 92 (Chronic) 2.162 0.037 0.120 
IV 
PQI 90 (Overall) PQI 91 (Acute) PQI 92 (Chronic) 
  
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -.166* 0.039 -0.141 0.171 -0.096 0.154 -0.085 0.415 -0.183* 0.026 -0.154 0.135 
MP 0.117 0.107 0.059 0.568 0.063 0.252 0.028 0.786 0.133 0.078 0.070 0.495 
Aim 3: Is there a statistical significance in the age-specific means of 2011 PQI rates within all FIPs with regard to PCD densities and Must Pass (MP) 
capabilities composite? (n=114) 
DV F-Value r-Sq Sig 
  
PQI 90 (Age Cat 1) 1.025 0.018 0.362 
PQI 90 (Age Cat 2) 1.553 0.027 0.216 
PQI 90 (Age Cat 3) 2.291 0.04 0.106 
PQI 90 (Age Cat 4) 1.483 0.026 0.231 
IV 
PQI 90 (Age Cat 1) PQI 90 (Age Cat 2) PQI 90 (Age Cat 3) PQI 90 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.058 0.268 -0.113 0.274 -.165* 0.040 -0.159 0.124 -.182* 0.026 -0.146 0.157 -0.119 0.103 -0.070 0.498 
MP -0.086 0.181 -0.133 0.200 0.079 0.202 0.013 0.898 0.149 0.057 0.088 0.388 0.148 0.058 0.119 0.248 
DV F-Value r-Sq Sig 
  
PQI 91 (Age Cat 1) 0.356 0.006 0.701 
PQI 91 (Age Cat 2) 0.149 0.003 0.862 
PQI 91 (Age Cat 3) 0.867 0.015 0.423 
PQI 91 (Age Cat 4) 0.963 0.017 0.385 
IV 
PQI 91 (Age Cat 1) PQI 91 (Age Cat 2) PQI 91 (Age Cat 3) PQI 91 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den 0.007 0.469 -0.029 0.784 -0.046 0.315 -0.057 0.587 -0.122 0.097 -0.113 0.275 -0.108 0.126 -0.075 0.470 
MP -0.076 0.212 -0.087 0.402 -0.004 0.485 -0.027 0.797 0.069 0.234 0.022 0.834 0.111 0.119 0.778 0.438 
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Table 29: Continued 
DV F-Value r-Sq Sig 
  
PQI 92 (Age Cat 1) 1.186 0.021 0.309 
PQI 92 (Age Cat 2) 2.206 0.038 0.115 
 PQI 92 (Age Cat 3) 2.660 0.046 0.074 
PQI 92 (Age Cat 4) 1.366 0.024 0.259 
IV 
PQI 92 (Age Cat 1) PQI 92 (Age Cat 2) PQI 92 (Age Cat 3) PQI 92 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den -0.084 0.188 -0.137 0.186 -.194* 0.019 -0.181 0.079 -.189* 0.022 -0.143 0.162 -0.100 0.144 -0.047 0.652 
MP -0.073 0.220 -0.130 0.212 0.105 0.134 0.030 0.772 .169* 0.036 0.110 0.282 0.149 0.057 0.130 0.210 
*=p<.05 & **=<.01   
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Table 30: 2011 PQI Regression—FIPS w/PCMH—MP PCMH Capability Composite 
Aim 3: Is there a statistical significance in the means of 2011 PQI rates within PCMH FIPs with regard to PCD densities and Must Pass (MP) 
capabilities composite? (n=67) 
DV F-Value r-Sq Sig 
  
PQI 90 (Overall) 0.605 0.019 0.549 
PQI 91 (Acute) 1.569 0.047 0.216 
PQI 92 (Chronic) 0.769 0.023 0.468 
IV 
PQI 90 (Overall) PQI 91 (Acute) PQI 92 (Chronic) 
  
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den 0.079 0.263 0.069 0.583 0.080 0.259 0.062 0.617 0.021 0.434 0.006 0.959 
MP 0.118 0.171 0.111 0.374 .207* 0.046 0.202 0.105 0.153 0.108 0.152 0.224 
Aim 3: Is there a statistical significance in the age-specific means of 2011 PQI rates within PCMH FIPs with regard to PCD densities and Must 
Pass (MP) capabilities composite? (n=114) 
DV F-Value r-Sq Sig 
  
PQI 90 (Age Cat 1) 1.569 0.047 0.216 
PQI 90 (Age Cat 2) 0.769 0.023 0.468 
PQI 90 (Age Cat 3) 0.776 0.024 0.465 
PQI 90 (Age Cat 4) 0.649 0.002 0.526  
IV 
PQI 90 (Age Cat 1) PQI 90 (Age Cat 2) PQI 90 (Age Cat 3) PQI 90 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den 0.080 0.259 0.119 0.340 0.021 0.434 0.006 0.959 0.127 0.152 0.119 0.34 0.115 0.178 0.107 0.393 
MP .207* 0.046 0.087 0.487 0.153 0.108 0.152 0.224 0.098 0.215 0.087 0.487 0.093 0.228 0.083 0.509 
DV F-Value r-Sq Sig 
 PQI 91 (Age Cat 1) 2.819 0.081 0.067 
PQI 91 (Age Cat 2) 1.534 0.046 0.224 
PQI 91 (Age Cat 3) 0.394 0.012 0.676 
 
PQI 91 (Age Cat 4) 0.378 0.012 0.687 
IV 
PQI 91 (Age Cat 1) PQI 91 (Age Cat 2) PQI 91 (Age Cat 3) PQI 91 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den 0.023 0.426 -0.003 0.978 0.056 0.326 0.037 0.764 0.078 0.266 0.070 0.575 0.080 0.260 0.073 0.559 
MP .285** 0.010 0.285* 0.021 .211* 0.044 0.207 0.096 0.085 0.246 0.079 0.530 0.080 0.261 0.073 0.562 
DV F-Value r-Sq Sig 
  
PQI 92 (Age Cat 1) 0.776 0.024 0.464 
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Table 30: Continued 
PQI 92 (Age Cat 2) 0.446 0.014 0.642 
 PQI 92 (Age Cat 3) 0.868 0.026 0.425 
PQI 92 (Age Cat 4) 0.815 0.025 0.447 
IV 
PQI 92 (Age Cat 1) PQI 92 (Age Cat 2) PQI 92 (Age Cat 3) PQI 92 (Age Cat 4) 
Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig Corr Sig Beta Sig 
PCD Den 0.094 0.224 0.083 0.507 0.006 0.482 -0.005 0.967 0.142 0.127 0.134 0.283 0.137 0.134 0.13 0.298 
MP 0.130 0.147 0.122 0.328 0.117 0.173 0.118 0.349 0.093 0.228 0.080 0.519 0.090 0.235 0.078 0.532 
*=p<.05 & **=<.01   
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Table 31: Summary of Specific Aims Supported 
Specific Aims 
PQI Regression Models w/Statistical Significance 
2011 PQI Rates Delta PQI Rates 
n=114 n=67 n=114 n=67 
Specific Aim 1: Is there literature to support the 
measurement framework? 
Yes 
Specific Aim 2: Communities with higher PCMH-
recognized practice concentrations among primary care 
practices will have lower risk-adjusted avoidable 
hospital admission rates. 
Mixed 
   -- Sub-Aim 1. Are risk-adjusted PQI rates affected by 
PCD density? (summary-level PQI rates) 
92 No No No 
  -- Sub-Aim 1A: By age-specific PQI rates 90-AC2, 92-AC2/3 No No No 
   -- Sub-Aim 2. Are risk-adjusted PQI rates affected by 
PCMH density? (summary-level PQI rates) 
No 90/92 No No 
  -- Sub-Aim 2A: By age-specific PQI rates 90-AC2, 92-AC2 90-AC2/3, 92-AC2/3 No No 
Specific Aim (3): The use of technology and care 
coordination will have a greater correlation on risk-
adjusted avoidable hospital admission rates than other 
PCMH capabilities. 
Mixed 
   -- Sub-Aim 1: Do the 10 PCMH capability composites 
affect risk-adjusted PQI rates? (summary-level) 
90 (PCD-), 92 (PCD-
/CSC+) 
92 (CSC+/ACC+) No No 
  -- Sub-Aim 1A: By age-specific PQI rates 
90-AC2 (PCD-), 90-AC3 
(PCD-
/CSC+/ACC+/PXP+), 
92-AC2 (PCD-), 92-AC3 
(PCD+/IT+/CSC+/COC
+/ACC+/RPT+/PXP) 
90-AC2 (CSC+), 92-
AC 2 
No 
91-AC2 
(IT+/CDT+/PTC+
)  
   -- Sub-Aim 2: Do MU capability composites affect 
risk-adjusted PQI rates?  (summary-level) 
No No 90 No 
  -- Sub-Aim 2A: By age-specific PQI rates No 91-AC1 
90-AC2, 91-
AC1/4, 92-AC 2/3 
No 
   -- Sub-Aim 3: Do MP capability composites affect 
risk-adjusted PQI rates?  (summary-level) 
No No 90 No 
  -- Sub-Aim 2A: By age-specific PQI rates No No 90-AC2, 91-AC1 No 
(+) = Positive Correlation // (-) = Negative Correlation 
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Chapter Summary 
This chapter presents the statistical descriptions and analyses of the combined data sets 
used in this study. The chapter began with a descriptive analyses of the data sets, followed by a 
means comparison to establish differences in the risk-adjusted means. Then the author conducted 
a simple multiple regression analysis to ascertain the strength of the independent and dependent 
variable relationships. 
The descriptive analyses established that in 2011, there were ~7.8M adults (≥18 years 
old) living within the 114 counties (14 in Vermont and 100 in North Carolina) with ~18% of the 
total population >65 years of age and accounted for ~35% of the discharges.  
The AHRQ state inpatient datasets (SID) used for this study indicated that the total 
number of discharges from 2008-2011 dropped (~24K) by ~2% across all 114 FIPS, but 
Vermont had double the drop in total discharges at ~4% vs North Carolina at ~2%; means 
comparison test confirmed a statistically significant difference (p<.05) in means across all PQI 
rates between FIPS with vs without PCMHs. 
The regression analysis provided statistical evidence to support the specific aims with 
varying degrees of relationships noted among the variables of interest. There were mixed results 
in terms of which IVs showed predictive strength in the full models and among the various PQI 
rates (summary-level vs. age-specific). Table 31 summarizes the statistical analysis results with a 
depiction of those aims/sub-aims that are supported (or not) by the analyses conducted in this 
chapter. 
Based on these results from Chapter 5, the author provides implications, conclusions, and 
recommendations for further research in Chapter 6. 
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Chapter 6: Conclusion and Recommendations 
 
 
Practice and Policy Implications 
The results from this study help provide policy makers a generalizable, scientifically-
based, outcome-based measure to gauge the contributions of recognized patient-centered medical 
home primary care practices on a community, state, and national scale. This finding is of 
particular importance as the nation recently, April 2015, signed into law the Medicare Access 
and CHIP Reauthorization Act of 2015 (MACRA) to repeal the Sustainable Growth Rate (SGR) 
formula that was aimed at reducing payments to primary care practices.  
The new MACRA law establishes provider reimbursement to the very type of practice 
transformation defined by the NCQA PCMH evaluation standards(Carey, 2015)(Carey, 2015). 
As part of the agreement to repeal the SGR, the MACRA now puts into place economic 
incentives for providers to adopt the core tenets of the PCMH capabilities, instead of facing steep 
(~22%) fee-for-service (FFS) cuts. For exchange in staving off the reduction in fees and to 
receive additional incentive payments, practices must demonstrate transformation as a patient-
centered, team-based practice.  
These accountable care entities (e.g., primary care practices with an attributable and 
accountable patient population) will be measured on achieving a variety of (yet to be defined) 
specified levels of patient health quality indicators. These new payment models will need to 
establish evaluation metrics that measure the effectiveness of these non-traditional team-based 
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organizations to ensure value is achieved for the fees established. The results of this study could 
serve as an effective evaluation model and scientific basis of a fee-for-value payment structure.  
In evaluating the PCD/PCMH density effect (Specific Aim 2), the PCD and PCMH ratios 
were not statistically significant (p>.05) variables contributing to the regression model for the 
Delta PQI rates in all counties, or even counties with PCMHs. This finding is significant as it 
indicates that while PCD density as reported in previous research impacts a reduction in overall 
hospital utilization (reduced admissions), it does not appear to have the same impact on the 
disease-specific conditions as measured by the AHRQ PQI rates. In addition, the results of this 
study indicate that fewer patients per doctor (PCD density) had an inverse relationship with PQI 
rates, meaning PQI rates were higher in counties instead of lower where there were more doctors 
per patient. One could infer from this finding that more doctors within a county does not lead to 
increased access to better primary care, just more access; possibly indicating higher utilization of 
the overall services within the system and an indicator of volume versus value health care.  
As noted earlier, the PQI condition-specific rates are known to be cost-drivers, because 
they indicate inappropriate utilization of more expensive inpatient health care when not managed 
properly. As well as PCD density, PCMH density was not a statistically significant variable on 
the Delta PQI rates for any of the FIPS. This result indicates that PCD and PCMH density are not 
predictive variables with regard to the change experienced in these rates from 2008 to 2011. 
However, the 2011 PQI rates (the end point of the change in rates after PCMH intervention) did 
show statistical strength in the predictive models for both the PCD and PCMH density. The PCD 
and PCMH density showed predictive strength for all FIPS on the summary-level 2011 PQI 92 
(Chronic) rates with PCD density demonstrating negative correlation. In addition, the PCD and 
PCMH density showed even more predictive strength for the FIPS with PCMHs (n=67) on the 
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summary-level 2011 PQI 90 (~11%) and PQI 92 (~16%) with PCMH density demonstrating 
negative correlation. The full models for age-specific 2011 PQI 90 and 92 showed statistical 
significance for age categories 2 and 3 in both PQIs with PCMH density demonstrating negative 
correlation. This is an important finding as it infers support for the current direction of policies 
aimed at PCMH practice transformation to reduce the total cost of care. For every hospital 
admission avoided, there was an average savings of ~$10,600 (Weiss, Barrett, & Steiner, 2015). 
Avoiding preventable hospitalizations is an important step towards the triple aim of 
reducing total cost of care and improving overall health of the community. The regression 
analysis in this study showed that where PCMHs are present in the community, the affect was 
lower avoidable admissions related to chronic conditions (PQI 92), accounting for ~16-19% of 
the variation in the mean PQI rate for ages 39–74. Community planners now have evidence to 
work with primary care teams in their communities to target the PCMH density growth among 
PCDs to achieve the greatest impact on the outcomes of avoidable hospital admissions for these 
age groups. These early results are also encouraging in that they may also indicate that the 
correlation of impact on these younger age groups may signal avoidance of chronic conditions at 
later stages in life by growing densities of PCMHs within communities. 
In addition to supporting recent legislation to pay practices to make the PCMH 
transformation a priority, the results of this study’s third aim provides support in deciding which 
of the PCMH capabilities have the most impact on avoidable ambulatory specific 
hospitalizations. The 10 PCMH composite capabilities cover a range of functions expected of a 
primary care practice to demonstrate transformation as a patient-centered medical home. These 
10 composite capabilities were used with the PCD density in place of the PCMH density 
regression model to determine the strength of these IVs on the PQI rates. In addition to the 10 
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PCMH capabilities, the MU and MP capability composites were also independently used with 
PCD density in place of the PCMH density regression model. The results of this study’s results 
could aide policy makers in targeting specific PCMH capabilities to base incentives around that 
demonstrated predictive correlation with reducing the risk-adjusted PQI rates. 
In summary, the results of this study provide policy makers with an outcome-based 
primary care performance measurement framework to support additional reforms to the currently 
proposed movement from a fee-for-service incentive model to a value-based incentive model. 
Theoretical Implications 
With regard to the General Systems Theory implications, there is evidence to support that 
changes to the primary care subsystem of the total health care system have an impact on the 
outcomes of health care quality for the populations within communities where densities of 
recognized PCMHs exist. There is also evidence to support the Donabedian conceptual model of 
quality improvement by which good structure and process begets more appropriate utilization of 
health care resources and better health outcomes as measured by the PCMH capabilities 
(structure/process) effect on the PQI rates. Although there were mixed results on the effect that 
changes to the primary care subsystem may have on the Delta PQI rates in this study, there is 
statistical significance in supporting the impact that PCMH densities within communities 
experienced lower levels of risk-adjusted avoidable hospital admissions. 
Contributions to Health Services Research 
The main contributions of this study reside in its use of validated measurement 
instruments (AHRQ PQI Rates and NCQA Recognition Program), use of accessible secondary 
data sets, and strength in its generalizability and repeatability as a measurement framework for 
monitoring changes to the health care ecosystem. The results of this study contribute to the on-
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going research regarding the structure and process of the primary care delivery system in terms 
of the capabilities that have an effect on specific outcomes-based measures. Published research 
on the subject of primary care delivery were focused on individual practice locations with an 
assigned panel or enrolled population. This study extended prior research regarding the impact of 
doctor/patient ratios on access to care with a focus on specific care conditions known to be 
preventable by PCMH primary care management practices. This study demonstrated an 
evaluation/measurement framework to help further the understanding of the PCMH model and 
its impact on an outcomes-based measure. This evaluation framework informs future research in 
the continued study of primary care-based health care reform initiatives.  
Limitations of the Study 
Although this study offers supporting evidence that increased PCMH densities are having 
an impact on the reduction of avoidable hospitalizations related to ambulatory care sensitive 
conditions, there are still unexplained reductions in the same outcome measurement within 
communities that do not have any recognized PCMH practices. In this study, the 47 FIPS 
without PCMHs experienced greater reductions in PQI rates than the 67 FIPS with PCMHs. 
However, the 67 FIPS with PCMHs started in 2008 with better PQI rates than the 47 FIPs 
without PCMHs. One possible co-variant that is unexplained by the model proposed in this study 
is the assumption that populations living within the communities (FIPS) are the only patients 
utilizing the resources within those communities. The assumption that patients access care within 
their county boundaries does not likely hold true, particularly for those counties that are 
bordering states where the imaginary county lines do not necessarily represent where people 
access care. 
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This study is also limited in terms of the potential bias regarding the self-selection of 
practices that chose to become recognized versus not become recognized. For example, there 
may very well be practices that have adopted the PCMH model of delivering care, but this study 
has no visibility into that possibility. The participating practice that self-elected to become 
recognized may have also been operating as a PCMH practice prior to recognition. This 
limitation and possible phenomenon could also explain why the 67 FIPS that had PCMHs were 
already performing better on PQI rates than the 47 FIPS that did not have any FIPS by 2011. As 
well, there are limitations into the controllability of the intervention model. 
In addition to the lack of visibility into the actual practice site capabilities before the 
PCMH recognition, there are other local and state environmental factors that may have impacted 
the reduction in the PQI rates. For example, there are many state and payer led initiatives to 
reduce the utilization of expensive hospital care, regardless of PCMH recognition status. The 
identified limitations in this study may explain the lack of statistical significance to support the 
impact of the PCMH density on the Delta PQI rates. 
Areas of Future Research 
While the findings of this study offer policy makers and healthcare decision makers 
additional guidance on primary care transformation, this study also highlights the need for 
additional research to determine other environmental factors that may not be detected by this 
proposed measurement framework. It may be useful to conduct controlled studies where the 
practices are pre-measured on their actual level of PCMH transformation and the outcome 
predictor of avoidable hospital admissions is monitored for attribution to the population within 
that community of evaluation. Such a study would need to be inclusive enough in terms of scope 
as to not replicate the many smaller studies that have preceded this study.  
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As well, the results of this study could be better informed by conducting a follow-up 
study within NC and VT to understand how the changes in the PCMH evaluation model (there 
are now two more versions (2011 and 2014) since this study’s evaluation) may have impacted 
the 114 counties under evaluation in this study. Since 2011, both states have added many more 
NCQA recognized PCMH practices (NC at ~25% and VT at ~65% of all doctors in each state); a 
follow-on study should be conducted to determine if increased densities within counties resulted 
in furthering a sustained or increased reduction in risk-adjusted PQI rates. It’s also probable that 
these increased PCMH densities may help to determine which of the PCMH capabilities may 
now correlate with PQI rates in terms of association, whereas this study may have not have had 
enough counties with significant PCMH density to detect such an association.  
In addition to the two states evaluated in this study, there are another 46 states 
participating in the AHRQ HCUP program. To further evaluate this model, it would be important 
to look at other states in a similar study to determine if the results of this study are repeatable and 
generalizable within those states evaluated. 
In addition to the adult PQIs evaluated in this study, there are also pediatric PQIs 
produced by AHRQ. The results of this study could be further evaluated using the same 
measurement framework for the pediatric populations within these states. 
Conclusions 
The US government, through recent legislation, is placing greater emphasis on the 
transformative affects that primary care practices can have on the cost, quality, and access to 
care. This study provides empirical evidence that increasing numbers of recognized PCMH 
practices are having a positive impact on avoiding preventable ambulatory care sensitive 
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condition (ACSC) hospital admissions within their respective communities. Specifically, this 
study resulted in the following statistically significant findings: 
1. Decreased patients per doctor (PCD Density) was inversely related to PQI rates, and 
most models indicated no correlation on the change in avoidable hospitalizations 
(Delta PQI rates) or lower 2011 PQI rates 
2. Increased PCMH densities are related to lower rates of avoidable hospitalizations, 
specific to chronic care conditions (2011 PQI 92); mainly affecting ages 40-64 (~16-
18% predictive model) 
3. Increased PCMH capabilities scores for Information Technology (IT), Clinical Data 
Tools (CDT), and Patient Communication Preferences (PTC) are related to reductions 
in avoidable hospitalizations for acute care conditions (Delta PQI 91); mainly 
affecting ages 40–64 (~55% predictive model) 
4. Increased scores on MU capabilities are related to reductions in avoidable 
hospitalizations for both acute and chronic care conditions (Delta PQI 90/91/92); 
affecting all ages >18 (~5-9% predictive model) 
5. Increased scores on NCQA MP capabilities are related to reductions in avoidable 
hospitalizations for overall and acute care conditions (Delta PQI 90/91); mainly 
affecting ages 18–39 (~6-8% predictive model) 
Although the above conclusions are inferred from the statistical significance of the 
models evaluated, it is also noteworthy to mention there were mixed results among the models. 
The threats to validity and limitations to the study are likely contributing causes to the mixed 
results obtained in this study. For example, the 67 counties with PCMHs in 2011 had overall 
lower 2008 PQI rates than the 47 counties that did not have recognized PCMHs by endo of 2011. 
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There is also a probability that the PCMH capabilities models may show statistical significance 
for change scores across all 114 counties versus the 67 counties with PCMHs because the total 
number of counties with PCMHs are just too small and the larger number of counties provides 
for the variation needed to determine a difference in change scores or overall rates. 
In addition to aiding policy makers with a model to evaluate community-wide health 
system performance based on outcomes of care, this evaluation framework also provides 
healthcare decision makers a method to determine which PCMH capabilities may be more 
influential in affecting avoidable ACSC hospital admissions within age-specific populations. 
This is particularly true of the recurrent age group of 40–64 that showed statistical significance 
in several of the models. This finding could indicate that age group is more responsive to the 
effects of the PCMH model in terms of behavior change and avoiding onset of chronic 
conditions; or could also be an indicator that this age group was most affected by the economic 
downturn and unemployment (or loss of insurance) during the same time period. 
The results of this study build upon and extend the General Systems Theory, Donabedian 
QI, and Chronic Care Models in determining that effectively structured primary care, as 
evaluated by the NCQA recognition program, can produce better outcomes for patients and 
reduce utilization of more expensive ambulatory sensitive inpatient care at a community-level. 
This study also provides recommendations for future research which includes a call to 
reproduce this model in other states and include more counties in the study; conduct a follow-on 
study within NC and VT to determine if increased densities or the updated PCMH capabilities 
has additional effect; conduct a controlled-study of the model to better control for 
patient/practice attribution and actual capabilities used in each model; and include or control for 
other confounding environmental factors (e.g., unemployment, economics) that may be 
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influencing the PQI rates to further the understanding of this study’s limitations and threats to the 
validity of the research design presented.
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ST FIPS Total Docs Rec Docs Pop-2011 Rec Doc Den Doc Den 
NC 37001 65 4  117,179  0.06  1,803  
NC 37003 1 0  28,946  0.00 28,946  
NC 37019 27 2  90,057  0.07  3,335  
NC 37021 243 48  192,698  0.20  793  
NC 37023 38 0  70,799  0.00  1,863  
NC 37025 131 73  133,316  0.56  1,018  
NC 37027 18 3  64,390  0.17  3,577  
NC 37035 87 22  118,314  0.25  1,360  
NC 37037 6 3  50,562  0.50  8,427  
NC 37049 78 0  80,659  0.00  1,034  
NC 37051 211 6  238,208  0.03  1,129  
NC 37053 1 0  18,545  0.00 18,545  
NC 37057 30 16  125,121  0.53  4,171  
NC 37059 5 5  32,123  1.00  6,425  
NC 37063 805 65  209,568  0.08  260  
NC 37065 10 0  42,764  0.00  4,276  
NC 37067 518 93  268,153  0.18  518  
NC 37069 10 1  46,466  0.10  4,647  
NC 37071 119 39  158,437  0.33  1,331  
NC 37073 0 0  9,331  0.00  9,331  
NC 37081 395 47  378,755  0.12  959  
NC 37087 25 0  47,795  0.00  1,912  
NC 37089 72 6  86,345  0.08  1,199  
NC 37093 4 3  34,679  0.75  8,670  
NC 37097 96 4  121,752  0.04  1,268  
NC 37101 37 1  125,782  0.03  3,400  
NC 37103 12 0  7,957  0.00  663  
NC 37109 24 11  60,990  0.46  2,541  
NC 37115 2 0  16,658  0.00  8,329  
NC 37119 871 307  705,963  0.35  811  
NC 37127 43 5  73,645  0.12  1,713  
NC 37129 216 22  164,076  0.10  760  
NC 37133 75 1  132,461  0.01  1,766  
NC 37135 398 67  105,156  0.17  264  
NC 37137 3 0  10,866  0.00  3,622  
NC 37141 7 0  41,486  0.00  5,927  
NC 37145 12 1  30,730  0.08  2,561  
NC 37147 211 25  130,058  0.12  616  
NC 37151 28 2  108,211  0.07  3,865  
NC 37157 33 0  73,361  0.00  2,223  
NC 37159 75 14  105,842  0.19  1,411  
NC 37169 10 10  37,279  1.00  3,728  
NC 37179 54 19  145,012  0.35  2,685  
NC 37183 508 142  689,848  0.28  1,358  
NC 37191 43 0  93,285  0.00  2,169  
NC 37197 6 3  29,677  0.50  4,946  
NC 37013 14 0  37,426  0.00  2,673  
NC 37029 0 0  7,546  0.00  7,546  
NC 37031 25 1  54,872  0.04  2,195  
NC 37045 61 13  75,097  0.21  1,231  
NC 37055 7 0  27,562  0.00  3,937  
NC 37077 17 15  47,015  0.88  2,766  
NC 37083 22 0  41,899  0.00  1,905  
NC 37085 18 6  86,261  0.33  4,792  
NC 37099 24 0  32,101  0.00  1,338  
NC 37105 27 2  43,816  0.07  1,623  
NC 37107 29 0  45,341  0.00  1,563  
NC 37111 6 0  35,571  0.00  5,929  
NC 37125 83 3  70,548  0.04  850  
NC 37131 2 0  17,429  0.00  8,715  
NC 37139 16 0  31,319  0.00  1,957  
NC 37143 1 0  10,806  0.00 10,806  
NC 37153 18 3  35,370  0.17  1,965  
NC 37155 53 0  98,763  0.00  1,863  
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ST FIPS Total Docs Rec Docs Pop-2011 Rec Doc Den Doc Den 
NC 37161 22 4  52,896  0.18  2,404  
NC 37165 22 1  27,018  0.05  1,228  
NC 37167 27 3  47,068  0.11  1,743  
NC 37171 32 11  56,967  0.34  1,780  
NC 37175 16 3  27,015  0.19  1,688  
NC 37177 0 0  3,569  0.00  3,569  
NC 37181 14 4  34,019  0.29  2,430  
NC 37189 25 1  42,174  0.04  1,687  
NC 37193 21 5  54,113  0.24  2,577  
NC 37195 38 0  61,627  0.00  1,622  
NC 37005 1 0  8,904  0.00  8,904  
NC 37007 3 0  20,924  0.00  6,975  
NC 37009 2 0  22,068  0.00 11,034  
NC 37011 4 2  14,521  0.50  3,630  
NC 37015 1 0  16,670  0.00 16,670  
NC 37017 9 9  27,141  1.00  3,016  
NC 37033 1 0  18,820  0.00 18,820  
NC 37039 3 0  22,215  0.00  7,405  
NC 37041 6 0  11,624  0.00  1,937  
NC 37043 0 0  8,658  0.00  8,658  
NC 37047 20 17  44,576  0.85  2,229  
NC 37061 10 2  44,665  0.20  4,467  
NC 37075 0 0  6,937  0.00  6,937  
NC 37079 3 3  16,632  1.00  5,544  
NC 37091 6 0  19,055  0.00  3,176  
NC 37095 0 0  4,767  0.00  4,767  
NC 37113 10 0  27,622  0.00  2,762  
NC 37117 8 0  18,982  0.00  2,373  
NC 37121 3 0  12,549  0.00  4,183  
NC 37123 3 3  21,127  1.00  7,042  
NC 37149 4 0  16,579  0.00  4,145  
NC 37163 7 0  47,798  0.00  6,828  
NC 37173 8 0  10,821  0.00  1,353  
NC 37185 0 0  16,703  0.00 16,703  
NC 37187 4 0  10,079  0.00  2,520  
NC 37199 4 0  14,240  0.00  3,560  
VT 50007 194 73  124,795  0.38  643  
VT 50011 15 8  36,812  0.53  2,454  
VT 50013 0 0  5,608  0.00  5,608  
VT 50003 22 12  29,546  0.55  1,343  
VT 50009 3 3  5,154  1.00  1,718  
VT 50017 9 9  23,093  1.00  2,566  
VT 50021 36 17  49,518  0.47  1,376  
VT 50023 46 33  47,456  0.72  1,032  
VT 50027 54 24  45,985  0.44  852  
VT 50001 16 16  29,051  1.00  1,816  
VT 50005 21 21  24,347  1.00  1,159  
VT 50015 8 8  19,266  1.00  2,408  
VT 50019 12 10  21,663  0.83  1,805  
VT 50025 18 6  35,706  0.33  1,984  
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PCMH Capability Composites by FIPS
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ST FIPS MU MP IT CSC CoC ACC RPT CDT NoN PxP PVS PTC 
NC 37001 42.50 38.00 23.25 13.50 15.00 6.50 6.00 6.00 2.25 3.00 4.00 2.00 
NC 37003 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37005 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37007 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37009 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37011 43.75 36.00 17.00 16.00 15.50 6.50 9.00 6.00 2.25 3.00 4.00 1.00 
NC 37013 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37015 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37017 33.21 37.46 12.25 11.83 18.96 6.71 7.75 6.00 2.00 3.00 2.67 1.67 
NC 37019 43.88 41.25 21.88 15.50 17.50 7.75 9.00 6.00 2.63 1.50 4.00 1.50 
NC 37021 42.04 40.48 18.29 14.92 17.79 7.77 7.63 6.00 1.88 2.50 4.00 1.67 
NC 37023 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37025 41.26 34.83 17.50 13.39 16.80 6.04 7.50 5.68 2.17 2.76 3.26 1.42 
NC 37027 49.00 41.38 24.75 15.00 19.38 8.38 9.00 6.00 2.25 3.00 4.00 1.50 
NC 37029 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37031 24.00 26.75 3.75 13.00 7.00 5.25 7.50 6.00 0.00 3.00 3.00 2.00 
NC 37033 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37035 38.67 35.06 17.61 12.61 17.78 6.56 6.67 5.33 2.00 2.33 3.44 0.78 
NC 37037 46.25 34.00 21.25 14.00 15.50 5.50 9.00 6.00 2.25 3.00 3.00 2.00 
NC 37039 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37041 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37043 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37045 42.42 37.75 17.42 14.83 18.50 6.92 7.50 6.00 2.25 3.00 2.67 1.33 
NC 37047 28.00 32.71 7.73 14.15 11.06 6.27 6.23 6.00 1.10 3.00 3.15 1.15 
NC 37049 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37051 27.63 22.88 14.38 9.00 10.38 3.38 3.75 3.00 1.50 3.00 3.50 1.50 
NC 37053 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37055 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37057 43.75 39.38 19.58 14.67 19.17 6.71 9.00 6.00 2.38 3.00 3.50 2.00 
NC 37059 44.00 40.75 21.75 15.00 20.00 7.75 9.00 6.00 2.25 3.00 4.00 2.00 
NC 37061 42.25 40.50 20.00 16.00 15.00 6.50 9.00 6.00 2.25 3.00 4.00 2.00 
NC 37063 39.63 35.98 17.93 13.25 16.61 7.30 6.54 5.57 1.88 2.79 3.71 1.50 
NC 37065 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37067 40.18 37.28 17.03 13.94 18.85 6.85 7.50 5.40 1.99 2.63 3.90 1.70 
NC 37069 42.50 40.75 17.25 15.00 20.00 7.75 9.00 6.00 1.50 3.00 4.00 2.00 
NC 37071 40.41 37.52 17.30 13.86 17.63 7.17 8.53 5.63 2.02 2.81 3.88 1.75 
NC 37073 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37075 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37077 31.08 27.63 16.38 8.92 13.13 5.29 3.00 6.00 1.13 1.50 1.33 1.50 
NC 37079 38.00 32.44 20.25 10.38 17.75 4.56 6.75 4.50 2.06 2.25 3.00 2.00 
NC 37081 41.93 38.75 18.53 14.10 18.32 7.01 8.65 5.65 2.38 3.00 3.35 1.88 
NC 37083 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37085 38.54 32.21 16.96 12.33 17.33 5.54 6.50 5.00 0.25 2.00 3.17 0.17 
NC 37087 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37089 42.00 39.50 17.50 15.00 17.50 6.50 6.00 6.00 0.00 1.50 4.00 2.00 
NC 37091 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37093 47.25 38.00 20.83 15.33 17.42 7.33 8.00 6.00 2.25 2.50 3.33 2.00 
NC 37095 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37097 36.50 39.75 10.50 14.00 20.00 7.75 9.00 6.00 3.00 3.00 4.00 0.00 
NC 37099 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37101 46.75 41.88 21.88 15.50 18.75 8.38 9.00 6.00 2.63 3.00 4.00 1.00 
NC 37103 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37105 45.13 37.88 18.25 15.50 17.25 6.63 9.00 6.00 2.63 3.00 3.50 2.00 
NC 37107 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37109 39.85 37.25 15.50 14.60 16.90 6.75 9.00 6.00 2.85 3.00 3.20 1.60 
NC 37111 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37113 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37115 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37117 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37119 40.38 38.18 16.80 14.22 18.63 7.05 8.46 5.92 2.47 3.00 3.39 1.76 
NC 37121 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37123 39.88 37.38 14.00 13.75 18.75 7.13 6.00 6.00 2.63 2.25 4.00 1.00 
NC 37125 35.63 32.38 16.38 9.63 19.50 6.50 4.88 4.50 1.31 1.50 3.50 1.50 
NC 37127 42.25 41.50 21.00 16.00 15.00 9.00 7.50 6.00 3.00 0.00 3.00 1.00 
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ST FIPS MU MP IT CSC CoC ACC RPT CDT NoN PxP PVS PTC 
NC 37129 39.13 34.13 17.38 12.00 20.00 5.88 5.63 4.50 1.69 0.00 3.00 2.00 
NC 37131 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37133 30.75 41.50 8.75 16.00 15.00 9.00 4.50 6.00 0.00 3.00 4.00 0.00 
NC 37135 43.79 39.11 19.36 15.50 18.32 6.54 7.50 6.00 2.46 2.57 3.43 1.57 
NC 37137 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37139 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37141 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37143 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37145 49.00 40.50 22.75 15.00 20.00 9.00 7.50 6.00 3.00 3.00 4.00 1.00 
NC 37147 45.25 40.00 20.50 15.50 18.25 7.25 8.25 6.00 2.63 3.00 3.00 2.00 
NC 37149 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37151 41.50 39.63 18.75 14.50 17.50 7.13 9.00 6.00 2.63 3.00 3.00 2.00 
NC 37153 47.50 40.25 20.50 16.00 19.00 7.75 8.50 6.00 2.25 2.00 3.00 2.00 
NC 37155 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37157 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37159 43.80 39.70 20.30 15.50 20.00 6.50 8.70 6.00 2.40 3.00 4.00 2.00 
NC 37161 48.25 38.00 21.25 16.00 19.00 6.50 4.50 6.00 3.00 3.00 4.00 1.00 
NC 37163 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37165 47.75 40.75 22.25 15.00 20.00 7.75 7.50 6.00 3.00 3.00 4.00 2.00 
NC 37167 40.38 40.25 14.63 15.00 19.50 7.25 9.00 6.00 2.25 3.00 4.00 0.50 
NC 37169 50.00 39.00 23.00 16.00 20.00 6.50 7.50 6.00 2.25 3.00 4.00 2.00 
NC 37171 41.92 40.33 19.25 15.00 18.33 7.33 9.00 6.00 2.75 3.00 4.00 2.00 
NC 37173 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37175 37.00 26.00 19.00 12.00 8.50 2.00 4.50 6.00 1.50 0.00 4.00 1.00 
NC 37177 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37179 41.50 39.05 18.10 15.10 19.75 6.25 7.50 6.00 2.55 3.00 3.80 2.00 
NC 37181 46.50 39.50 23.25 15.00 17.50 6.50 6.00 6.00 1.50 3.00 4.00 2.00 
NC 37183 40.13 37.73 17.56 14.31 16.56 7.32 6.94 5.89 2.26 2.61 3.22 1.06 
NC 37185 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37187 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37189 18.50 30.00 14.00 3.00 15.00 4.00 6.00 6.00 0.00 3.00 0.00 0.00 
NC 37191 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37193 45.00 41.75 18.00 16.00 20.00 7.75 9.00 6.00 3.00 3.00 4.00 2.00 
NC 37195 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
NC 37197 41.00 39.25 14.00 15.00 20.00 7.75 7.50 6.00 3.00 3.00 4.00 2.00 
NC 37199 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
VT 50001 32.90 35.85 10.50 13.80 16.35 7.75 4.80 6.00 2.40 3.00 3.20 0.60 
VT 50003 42.25 38.00 18.38 14.25 18.46 6.75 7.50 6.00 2.38 2.75 3.67 1.00 
VT 50005 43.00 34.95 17.30 14.00 15.20 6.55 8.40 6.00 3.00 3.00 4.00 2.00 
VT 50007 38.98 33.92 15.92 12.65 16.60 6.77 7.73 5.54 2.71 2.65 4.00 1.69 
VT 50009 41.50 38.25 17.00 13.50 19.00 6.75 9.00 6.00 3.00 3.00 4.00 2.00 
VT 50011 44.81 36.44 20.88 13.25 19.88 7.13 6.56 5.25 2.53 2.25 4.00 2.00 
VT 50013 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
VT 50015 47.13 41.25 20.88 15.50 19.38 7.75 8.25 6.00 3.00 3.00 4.00 2.00 
VT 50017 32.63 36.50 10.25 12.00 19.38 6.50 9.00 6.00 3.00 1.50 4.00 2.00 
VT 50019 49.50 41.75 22.88 16.00 20.00 7.75 9.00 6.00 3.00 3.00 4.00 2.00 
VT 50021 42.88 35.71 20.42 12.67 19.00 7.96 5.25 5.00 2.50 2.50 4.00 2.00 
VT 50023 34.65 29.71 14.71 10.85 16.21 4.73 7.25 5.50 1.75 2.88 3.33 1.08 
VT 50025 45.08 39.58 19.58 14.67 19.17 6.92 8.00 6.00 2.50 3.00 4.00 2.00 
VT 50027 40.35 34.28 17.60 12.75 17.85 6.18 6.30 5.40 2.70 2.40 4.00 0.60 
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PQI Rates by Age Category by FIPS 
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ST FIPS AGE CAT PQI90-08 PQI91-08 PQI92-08 PQI90-11 PQI91-11 PQI92-11 Delta-90 Delta-91 Delta-92 
NC 37001 1 0.929370 1.156550 0.787170 0.867290 0.775300 0.928100 -0.062080 -0.381250 0.140930 
NC 37001 2 1.222550 1.116000 1.270150 0.990980 0.794640 1.075460 -0.231570 -0.321360 -0.194690 
NC 37001 3 1.235640 1.231160 1.245340 1.030320 0.911220 1.094950 -0.205320 -0.319940 -0.150390 
NC 37001 4 1.123690 1.236220 1.041160 0.791720 0.771380 0.809010 -0.331970 -0.464840 -0.232150 
NC 37003 1 0.995250 1.658710 0.611850 1.079950 1.666100 0.739780 0.084700 0.007390 0.127930 
NC 37003 2 1.057210 1.476360 0.894270 1.094610 1.412900 0.957470 0.037400 -0.063460 0.063200 
NC 37003 3 1.234930 1.337100 1.207460 0.927400 0.996520 0.889670 -0.307530 -0.340580 -0.317790 
NC 37003 4 1.109680 1.346310 1.006950 0.980450 0.938550 1.020860 -0.129230 -0.407760 0.013910 
NC 37005 1 2.195740 4.309050 1.056210 1.698480 3.034500 0.978910 -0.497260 -1.274550 -0.077300 
NC 37005 2 1.123710 1.912230 0.816600 0.882890 1.687030 0.568300 -0.240820 -0.225200 -0.248300 
NC 37005 3 1.071870 1.943870 0.655780 0.968260 1.794070 0.569440 -0.103610 -0.149800 -0.086340 
NC 37005 4 1.553040 2.305060 1.033460 0.981990 1.404880 0.676230 -0.571050 -0.900180 -0.357230 
NC 37007 1 1.568530 1.090160 1.840210 1.207740 0.594020 1.547420 -0.360790 -0.496140 -0.292790 
NC 37007 2 1.340690 1.123130 1.421470 0.991260 1.001300 0.980290 -0.349430 -0.121830 -0.441180 
NC 37007 3 1.405190 1.398630 1.433250 0.994170 1.241890 0.871870 -0.411020 -0.156740 -0.561380 
NC 37007 4 1.015860 0.982520 1.112630 0.584970 0.535790 0.626990 -0.430890 -0.446730 -0.485640 
NC 37009 1 1.106860 1.712500 0.734060 1.224490 1.975580 0.756990 0.117630 0.263080 0.022930 
NC 37009 2 0.917460 1.294510 0.760100 0.921100 1.625660 0.614610 0.003640 0.331150 -0.145490 
NC 37009 3 1.280450 1.813410 1.027580 1.004450 1.690940 0.628300 -0.276000 -0.122470 -0.399280 
NC 37009 4 1.166130 1.393900 1.074440 1.214810 1.634300 0.854690 0.048680 0.240400 -0.219750 
NC 37011 1 1.464520 1.954890 1.221850 0.938360 1.693440 0.548360 -0.526160 -0.261450 -0.673490 
NC 37011 2 1.250790 2.759750 0.683380 1.197860 1.987040 0.889460 -0.052930 -0.772710 0.206080 
NC 37011 3 1.654240 3.159620 0.993650 1.281130 1.677750 1.085990 -0.373110 -1.481870 0.092340 
NC 37011 4 1.829260 3.204260 1.055050 1.706000 2.483370 1.145040 -0.123260 -0.720890 0.089990 
NC 37013 1 1.272930 1.488600 1.139950 0.921380 0.727920 1.047740 -0.351550 -0.760680 -0.092210 
NC 37013 2 1.137680 1.178260 1.129170 1.075080 1.054400 1.085570 -0.062600 -0.123860 -0.043600 
NC 37013 3 1.259850 1.076290 1.393570 0.814060 0.757340 0.845640 -0.445790 -0.318950 -0.547930 
NC 37013 4 1.221540 1.246690 1.304790 0.805570 0.720710 0.875390 -0.415970 -0.525980 -0.429400 
NC 37015 1 1.611550 1.288610 1.805410 1.164620 0.710270 1.424390 -0.446930 -0.578340 -0.381020 
NC 37015 2 1.056210 1.397100 0.917460 1.023040 1.491570 0.835170 -0.033170 0.094470 -0.082290 
NC 37015 3 1.451760 1.942220 1.208280 0.883920 1.022900 0.814430 -0.567840 -0.919320 -0.393850 
NC 37015 4 1.163580 1.536100 0.889530 0.952020 1.094280 0.850550 -0.211560 -0.441820 -0.038980 
NC 37017 1 0.769270 0.938610 0.682250 1.072490 1.223420 0.999300 0.303220 0.284810 0.317050 
NC 37017 2 0.946460 1.126600 0.870550 0.996030 1.196590 0.911670 0.049570 0.069990 0.041120 
NC 37017 3 1.004140 1.164860 0.925900 1.038720 1.286890 0.916160 0.034580 0.122030 -0.009740 
NC 37017 4 1.037720 1.269120 0.877220 1.184100 1.414060 1.019540 0.146380 0.144940 0.142320 
NC 37019 1 1.127520 0.994300 1.211540 1.105240 1.277890 0.996710 -0.022280 0.283590 -0.214830 
NC 37019 2 0.878550 0.923570 0.857600 0.769120 0.796300 0.756110 -0.109430 -0.127270 -0.101490 
NC 37019 3 1.009970 0.962180 1.039090 0.754260 0.805460 0.726330 -0.255710 -0.156720 -0.312760 
NC 37019 4 1.182740 1.322970 1.098160 0.860240 1.017590 0.733210 -0.322500 -0.305380 -0.364950 
NC 37021 1 0.903310 1.023430 0.833420 0.859900 0.835820 0.876000 -0.043410 -0.187610 0.042580 
NC 37021 2 0.816030 0.955540 0.753270 0.765770 0.791450 0.749960 -0.050260 -0.164090 -0.003310 
NC 37021 3 0.877260 0.991910 0.816230 0.832690 0.852600 0.820420 -0.044570 -0.139310 0.004190 
NC 37021 4 0.758550 0.803070 0.729030 0.624350 0.637810 0.618770 -0.134200 -0.165260 -0.110260 
NC 37023 1 0.905950 1.334900 0.642460 0.866580 0.681880 0.983360 -0.039370 -0.653020 0.340900 
NC 37023 2 0.948980 1.162840 0.858610 0.813090 1.109690 0.684830 -0.135890 -0.053150 -0.173780 
NC 37023 3 0.961640 0.984510 0.959980 0.848260 0.975450 0.779290 -0.113380 -0.009060 -0.180690 
NC 37023 4 0.953420 0.957270 0.985310 0.734070 0.736690 0.731880 -0.219350 -0.220580 -0.253430 
NC 37025 1 2.049930 1.689820 2.282710 1.298270 1.035330 1.469900 -0.751660 -0.654490 -0.812810 
NC 37025 2 1.852710 1.753570 1.905140 1.303850 1.371960 1.276620 -0.548860 -0.381610 -0.628520 
NC 37025 3 2.228420 2.178910 2.259680 1.554600 1.397950 1.647490 -0.673820 -0.780960 -0.612190 
NC 37025 4 1.569550 1.494610 1.632060 1.455560 1.351150 1.545450 -0.113990 -0.143460 -0.086610 
NC 37027 1 1.206670 1.093840 1.279390 1.169830 0.822420 1.389020 -0.036840 -0.271420 0.109630 
NC 37027 2 1.071660 1.226230 1.005360 0.982280 0.932710 1.003160 -0.089380 -0.293520 -0.002200 
NC 37027 3 1.178650 1.408210 1.063570 0.984590 1.037760 0.955790 -0.194060 -0.370450 -0.107780 
NC 37027 4 1.129990 1.251610 1.046080 0.967860 1.072250 0.881650 -0.162130 -0.179360 -0.164430 
NC 37029 1 1.089880 2.029550 0.453280 1.256650 1.374250 1.168040 0.166770 -0.655300 0.714760 
NC 37029 2 1.127060 0.868020 1.250210 0.646880 0.890960 0.535840 -0.480180 0.022940 -0.714370 
NC 37029 3 1.204140 0.892230 1.386860 0.537060 0.265280 0.695900 -0.667080 -0.626950 -0.690960 
NC 37029 4 0.853540 0.798450 0.903450 1.301100 0.692550 1.836560 0.447560 -0.105900 0.933110 
NC 37031 1 1.442220 1.377460 1.478530 1.392410 0.849480 1.750760 -0.049810 -0.527980 0.272230 
NC 37031 2 1.320250 1.271610 1.347470 0.859990 0.847330 0.868870 -0.460260 -0.424280 -0.478600 
NC 37031 3 1.418100 1.145700 1.578460 1.113560 1.069610 1.140350 -0.304540 -0.076090 -0.438110 
NC 37031 4 1.457220 1.282320 1.618080 1.059860 0.903580 1.196050 -0.397360 -0.378740 -0.422030 
 138 
ST FIPS AGE CAT PQI90-08 PQI91-08 PQI92-08 PQI90-11 PQI91-11 PQI92-11 Delta-90 Delta-91 Delta-92 
NC 37033 1 0.964010 1.267640 0.779880 0.329400 0.247330 0.380860 -0.634610 -1.020310 -0.399020 
NC 37033 2 0.579750 0.612170 0.566700 0.560250 0.680700 0.508660 -0.019500 0.068530 -0.058040 
NC 37033 3 0.457450 0.493440 0.438490 0.619860 0.695400 0.579060 0.162410 0.201960 0.140570 
NC 37033 4 0.553510 0.481270 0.621530 0.591070 0.804590 0.407870 0.037560 0.323320 -0.213660 
NC 37035 1 0.875590 0.710930 0.978150 0.922860 0.747740 1.032320 0.047270 0.036810 0.054170 
NC 37035 2 1.029850 1.068010 1.012890 0.895260 0.937660 0.875090 -0.134590 -0.130350 -0.137800 
NC 37035 3 1.126680 1.081300 1.160070 0.910890 0.909240 0.911090 -0.215790 -0.172060 -0.248980 
NC 37035 4 0.909200 1.011860 0.846030 0.804550 0.811840 0.800270 -0.104650 -0.200020 -0.045760 
NC 37037 1 0.617890 0.871050 0.455470 0.792030 0.657680 0.875700 0.174140 -0.213370 0.420230 
NC 37037 2 0.676460 0.754540 0.641460 0.591090 0.593960 0.588830 -0.085370 -0.160580 -0.052630 
NC 37037 3 0.890000 0.951570 0.864110 0.501300 0.371420 0.572390 -0.388700 -0.580150 -0.291720 
NC 37037 4 0.852240 0.921630 0.818820 0.601660 0.684670 0.531790 -0.250580 -0.236960 -0.287030 
NC 37039 1 0.859250 1.411020 0.515560 1.317000 0.758850 1.671140 0.457750 -0.652170 1.155580 
NC 37039 2 0.669820 0.881480 0.577820 0.672630 0.932070 0.559760 0.002810 0.050590 -0.018060 
NC 37039 3 0.563410 0.744460 0.465830 0.444460 0.546550 0.389350 -0.118950 -0.197910 -0.076480 
NC 37039 4 0.832750 1.069710 0.635940 0.472830 0.586910 0.377850 -0.359920 -0.482800 -0.258090 
NC 37041 1 1.324600 1.793360 1.026500 1.328600 0.600880 1.799330 0.004000 -1.192480 0.772830 
NC 37041 2 1.422090 1.414180 1.427460 1.031550 1.372920 0.883190 -0.390540 -0.041260 -0.544270 
NC 37041 3 1.275690 1.320660 1.251730 1.264250 1.346110 1.220220 -0.011440 0.025450 -0.031510 
NC 37041 4 1.010550 1.156500 0.883140 0.955480 1.023970 0.896000 -0.055070 -0.132530 0.012860 
NC 37043 1 0.619990 1.293070 0.201590 0.249500 0.652120 0.000000 -0.370490 -0.640950 -0.201590 
NC 37043 2 0.435310 0.839650 0.260020 0.330380 0.544750 0.236960 -0.104930 -0.294900 -0.023060 
NC 37043 3 0.705610 0.566610 0.780500 0.245930 0.351430 0.189140 -0.459680 -0.215180 -0.591360 
NC 37043 4 0.526730 0.468640 0.576260 0.278220 0.346030 0.221990 -0.248510 -0.122610 -0.354270 
NC 37045 1 1.331480 1.043840 1.519260 1.718130 1.283270 2.002780 0.386650 0.239430 0.483520 
NC 37045 2 1.337660 1.450290 1.290370 1.456320 1.355580 1.502370 0.118660 -0.094710 0.212000 
NC 37045 3 1.201450 1.211330 1.201530 1.323610 1.298540 1.338240 0.122160 0.087210 0.136710 
NC 37045 4 1.281090 1.358800 1.223410 1.035100 1.072650 1.001570 -0.245990 -0.286150 -0.221840 
NC 37047 1 1.701690 1.745420 1.695540 0.600070 0.727780 0.535650 -1.101620 -1.017640 -1.159890 
NC 37047 2 1.337350 1.478540 1.274110 0.935960 1.200270 0.827520 -0.401390 -0.278270 -0.446590 
NC 37047 3 1.127810 1.253730 1.066440 0.849820 0.943900 0.802400 -0.277990 -0.309830 -0.264040 
NC 37047 4 0.980490 1.096330 0.912190 0.699400 0.761260 0.657260 -0.281090 -0.335070 -0.254930 
NC 37049 1 1.236770 1.561570 1.046750 1.074580 1.264540 0.963990 -0.162190 -0.297030 -0.082760 
NC 37049 2 1.520170 1.503400 1.521610 1.069860 0.932640 1.118700 -0.450310 -0.570760 -0.402910 
NC 37049 3 1.370100 1.136000 1.523920 0.857530 0.743860 0.913820 -0.512570 -0.392140 -0.610100 
NC 37049 4 1.236660 1.286950 1.315660 0.645610 0.572920 0.708290 -0.591050 -0.714030 -0.607370 
NC 37051 1 1.033840 0.739010 1.223720 1.469710 0.903320 1.834240 0.435870 0.164310 0.610520 
NC 37051 2 1.344470 0.964370 1.516680 1.537110 1.225890 1.671470 0.192640 0.261520 0.154790 
NC 37051 3 1.421200 1.105870 1.633680 1.494080 1.272190 1.614790 0.072880 0.166320 -0.018890 
NC 37051 4 1.229640 1.122100 1.429050 1.161540 1.086020 1.225840 -0.068100 -0.036080 -0.203210 
NC 37053 1 1.032090 0.698270 1.256080 0.357690 0.000000 0.602410 -0.674400 -0.698270 -0.653670 
NC 37053 2 0.579780 0.507000 0.617290 0.516440 0.336440 0.604270 -0.063340 -0.170560 -0.013020 
NC 37053 3 0.983260 0.432140 1.309940 0.528780 0.369320 0.624030 -0.454480 -0.062820 -0.685910 
NC 37053 4 1.076760 1.001780 1.142550 0.800350 0.663840 0.920690 -0.276410 -0.337940 -0.221860 
NC 37055 1 0.485050 0.595460 0.406610 0.619780 0.911080 0.416200 0.134730 0.315620 0.009590 
NC 37055 2 0.542600 0.764570 0.440050 0.429070 0.423190 0.434120 -0.113530 -0.341380 -0.005930 
NC 37055 3 0.847820 0.906050 0.815630 0.519850 0.621590 0.460460 -0.327970 -0.284460 -0.355170 
NC 37055 4 1.068560 1.318990 0.839670 0.888720 1.073300 0.718800 -0.179840 -0.245690 -0.120870 
NC 37057 1 1.284100 1.254450 1.303860 1.000170 0.948000 1.033120 -0.283930 -0.306450 -0.270740 
NC 37057 2 1.212550 1.345750 1.149710 0.999850 1.162550 0.926450 -0.212700 -0.183200 -0.223260 
NC 37057 3 1.359340 1.480050 1.294060 1.014780 1.213260 0.910550 -0.344560 -0.266790 -0.383510 
NC 37057 4 1.241240 1.326730 1.184580 0.934940 1.087420 0.821980 -0.306300 -0.239310 -0.362600 
NC 37059 1 1.835120 1.819210 1.836660 1.326460 0.946660 1.577330 -0.508660 -0.872550 -0.259330 
NC 37059 2 1.275880 1.498130 1.177590 0.935610 0.959020 0.927980 -0.340270 -0.539110 -0.249610 
NC 37059 3 1.822120 1.998950 1.727470 1.101170 1.107800 1.098550 -0.720950 -0.891150 -0.628920 
NC 37059 4 1.526560 1.903060 1.200100 1.279830 1.211020 1.339070 -0.246730 -0.692040 0.138970 
NC 37061 1 0.652780 0.764450 0.597420 0.678910 0.561120 0.751940 0.026130 -0.203330 0.154520 
NC 37061 2 1.102560 1.164040 1.081220 0.866610 1.073270 0.780840 -0.235950 -0.090770 -0.300380 
NC 37061 3 1.057440 1.608920 0.811520 1.063590 1.216750 0.987100 0.006150 -0.392170 0.175580 
NC 37061 4 0.906740 1.148460 0.789680 0.860410 1.033880 0.735850 -0.046330 -0.114580 -0.053830 
NC 37063 1 0.827830 0.727370 0.893690 0.666820 0.488920 0.781830 -0.161010 -0.238450 -0.111860 
NC 37063 2 1.135170 0.772140 1.298740 1.003290 0.696100 1.136330 -0.131880 -0.076040 -0.162410 
NC 37063 3 1.237470 1.066630 1.363160 0.991470 0.750900 1.121790 -0.246000 -0.315730 -0.241370 
NC 37063 4 0.883630 0.891160 0.939750 0.716840 0.718760 0.715160 -0.166790 -0.172400 -0.224590 
 139 
ST FIPS AGE CAT PQI90-08 PQI91-08 PQI92-08 PQI90-11 PQI91-11 PQI92-11 Delta-90 Delta-91 Delta-92 
NC 37065 1 1.807810 1.543990 1.984170 1.892340 1.190920 2.319980 0.084530 -0.353070 0.335810 
NC 37065 2 1.766380 1.671750 1.801060 1.774520 1.558130 1.846790 0.008140 -0.113620 0.045730 
NC 37065 3 1.584550 1.633370 1.580620 1.283680 1.403890 1.222740 -0.300870 -0.229480 -0.357880 
NC 37065 4 1.347760 1.725160 1.108560 1.221330 1.574190 0.960730 -0.126430 -0.150970 -0.147830 
NC 37067 1 1.222840 1.137990 1.277300 1.202470 1.088440 1.275950 -0.020370 -0.049550 -0.001350 
NC 37067 2 1.301230 1.385340 1.262760 1.274880 1.161010 1.322510 -0.026350 -0.224330 0.059750 
NC 37067 3 1.301420 1.181780 1.365980 1.238960 1.242420 1.236470 -0.062460 0.060640 -0.129510 
NC 37067 4 1.247280 1.326030 1.182940 1.163970 1.263970 1.081110 -0.083310 -0.062060 -0.101830 
NC 37069 1 1.064810 0.957180 1.131780 1.302580 0.510910 1.796750 0.237770 -0.446270 0.664970 
NC 37069 2 1.432960 0.997690 1.625930 0.721490 0.439920 0.842110 -0.711470 -0.557770 -0.783820 
NC 37069 3 1.601320 1.294480 1.808270 0.705300 0.534760 0.797530 -0.896020 -0.759720 -1.010740 
NC 37069 4 1.242270 1.167060 1.398110 0.823650 0.681710 0.943920 -0.418620 -0.485350 -0.454190 
NC 37071 1 1.098300 1.299440 0.973550 1.251220 1.206700 1.283220 0.152920 -0.092740 0.309670 
NC 37071 2 1.295040 1.452650 1.239040 1.397760 1.563480 1.327120 0.102720 0.110830 0.088080 
NC 37071 3 1.189760 1.248580 1.186470 1.277670 1.373690 1.225810 0.087910 0.125110 0.039340 
NC 37071 4 1.007520 1.106020 0.985490 1.173870 1.282460 1.080130 0.166350 0.176440 0.094640 
NC 37073 1 0.375570 0.502110 0.300590 0.493880 0.263250 0.633760 0.118310 -0.238860 0.333170 
NC 37073 2 0.802140 0.375350 0.970860 0.385780 0.120460 0.491280 -0.416360 -0.254890 -0.479580 
NC 37073 3 1.331320 1.277650 1.357030 0.758330 0.664240 0.804330 -0.572990 -0.613410 -0.552700 
NC 37073 4 0.657880 0.684430 0.642480 0.465670 0.392950 0.527150 -0.192210 -0.291480 -0.115330 
NC 37075 1 0.322830 0.604220 0.168940 1.081420 1.812350 0.681330 0.758590 1.208130 0.512390 
NC 37075 2 0.858130 1.421970 0.633880 0.406800 0.897760 0.213920 -0.451330 -0.524210 -0.419960 
NC 37075 3 0.390970 0.373870 0.398430 0.592520 1.133830 0.329280 0.201550 0.759960 -0.069150 
NC 37075 4 0.743930 0.976080 0.574930 0.490500 0.640450 0.381530 -0.253430 -0.335630 -0.193400 
NC 37077 1 0.985910 0.781670 1.109090 0.723650 0.844760 0.650660 -0.262260 0.063090 -0.458430 
NC 37077 2 1.307100 1.287190 1.324940 0.892640 0.795870 0.932520 -0.414460 -0.491320 -0.392420 
NC 37077 3 1.487320 1.408390 1.570940 1.216530 1.283780 1.179590 -0.270790 -0.124610 -0.391350 
NC 37077 4 1.353500 1.414680 1.425060 1.077420 1.015200 1.131510 -0.276080 -0.399480 -0.293550 
NC 37079 1 0.823060 1.195230 0.632710 0.616280 0.497850 0.683770 -0.206780 -0.697380 0.051060 
NC 37079 2 1.411070 0.591540 1.713730 1.097370 1.022380 1.117730 -0.313700 0.430840 -0.596000 
NC 37079 3 1.078870 1.162050 1.050580 1.130440 1.383030 1.005700 0.051570 0.220980 -0.044880 
NC 37079 4 1.051420 1.235730 0.969880 1.009680 1.213130 0.860730 -0.041740 -0.022600 -0.109150 
NC 37081 1 0.940870 0.966090 0.926940 0.928280 0.838980 0.987720 -0.012590 -0.127110 0.060780 
NC 37081 2 1.049570 1.020750 1.061560 1.027090 1.044300 1.019150 -0.022480 0.023550 -0.042410 
NC 37081 3 1.004320 1.087670 0.959040 1.020030 1.116920 0.968910 0.015710 0.029250 0.009870 
NC 37081 4 0.962340 0.997340 0.933000 0.937880 1.042680 0.848860 -0.024460 0.045340 -0.084140 
NC 37083 1 1.656960 1.723770 1.642480 1.212000 1.461680 1.084550 -0.444960 -0.262090 -0.557930 
NC 37083 2 2.076790 1.447510 2.332400 1.676790 1.311180 1.806900 -0.400000 -0.136330 -0.525500 
NC 37083 3 1.812720 1.547720 2.010400 1.392490 1.306490 1.431890 -0.420230 -0.241230 -0.578510 
NC 37083 4 1.321240 1.362110 1.433090 1.313780 1.217750 1.394670 -0.007460 -0.144360 -0.038420 
NC 37085 1 1.022830 0.880350 1.113120 1.054860 0.964760 1.112280 0.032030 0.084410 -0.000840 
NC 37085 2 1.521250 1.419480 1.574890 1.513860 1.366840 1.575210 -0.007390 -0.052640 0.000320 
NC 37085 3 1.927820 1.910930 2.001450 1.575690 1.722870 1.494950 -0.352130 -0.188060 -0.506500 
NC 37085 4 1.461440 1.680470 1.411240 1.544630 1.550980 1.541900 0.083190 -0.129490 0.130660 
NC 37087 1 1.336390 1.628360 1.146950 1.588640 1.734090 1.491200 0.252250 0.105730 0.344250 
NC 37087 2 1.192510 1.657750 0.984900 1.165480 1.306260 1.101330 -0.027030 -0.351490 0.116430 
NC 37087 3 1.246730 1.417430 1.151410 1.123750 1.237390 1.060060 -0.122980 -0.180040 -0.091350 
NC 37087 4 1.148730 1.365100 0.967590 1.107610 1.119050 1.101940 -0.041120 -0.246050 0.134350 
NC 37089 1 1.237280 1.184720 1.270290 0.889220 0.729380 0.989470 -0.348060 -0.455340 -0.280820 
NC 37089 2 0.955340 1.177070 0.860490 0.714950 0.863530 0.649220 -0.240390 -0.313540 -0.211270 
NC 37089 3 0.901470 0.793350 0.972640 0.689170 0.686050 0.690540 -0.212300 -0.107300 -0.282100 
NC 37089 4 0.836060 0.856860 0.862760 0.634430 0.726780 0.557690 -0.201630 -0.130080 -0.305070 
NC 37091 1 2.230100 1.929320 2.421810 0.519780 0.194810 0.706670 -1.710320 -1.734510 -1.715140 
NC 37091 2 2.682910 3.245650 2.452360 0.616160 0.538600 0.641720 -2.066750 -2.707050 -1.810640 
NC 37091 3 2.541560 3.436900 2.122150 0.696330 0.877670 0.606870 -1.845230 -2.559230 -1.515280 
NC 37091 4 2.397710 2.814950 2.232480 0.909940 0.889900 0.930510 -1.487770 -1.925050 -1.301970 
NC 37093 1 0.677450 0.599660 0.728100 0.726150 0.529830 0.852210 0.048700 -0.069830 0.124110 
NC 37093 2 1.186120 0.721730 1.387400 1.128630 0.826960 1.258360 -0.057490 0.105230 -0.129040 
NC 37093 3 1.191050 0.908710 1.356550 1.694700 0.910960 2.117990 0.503650 0.002250 0.761440 
NC 37093 4 1.016160 0.957330 1.093470 1.193440 0.837410 1.491670 0.177280 -0.119920 0.398200 
NC 37095 1 0.788100 0.390470 0.997140 0.390700 0.000000 0.591570 -0.397400 -0.390470 -0.405570 
NC 37095 2 0.786240 1.096930 0.664520 0.895260 1.148720 0.792390 0.109020 0.051790 0.127870 
NC 37095 3 1.045320 1.323280 0.936190 1.364190 1.397190 1.346260 0.318870 0.073910 0.410070 
NC 37095 4 1.142720 1.491960 0.991630 0.888170 0.884630 0.896210 -0.254550 -0.607330 -0.095420 
 140 
ST FIPS AGE CAT PQI90-08 PQI91-08 PQI92-08 PQI90-11 PQI91-11 PQI92-11 Delta-90 Delta-91 Delta-92 
NC 37097 1 1.506500 1.772880 1.319930 1.271260 1.338830 1.219090 -0.235240 -0.434050 -0.100840 
NC 37097 2 1.605050 1.619300 1.620510 1.368300 1.307380 1.401340 -0.236750 -0.311920 -0.219170 
NC 37097 3 1.681860 1.655340 1.754230 1.466570 1.403010 1.505200 -0.215290 -0.252330 -0.249030 
NC 37097 4 1.577080 1.422380 1.863670 1.374820 1.269140 1.464670 -0.202260 -0.153240 -0.399000 
NC 37099 1 1.274890 1.547760 1.102790 0.574490 0.543000 0.596410 -0.700400 -1.004760 -0.506380 
NC 37099 2 0.756410 1.133750 0.592200 0.569040 0.798230 0.469340 -0.187370 -0.335520 -0.122860 
NC 37099 3 0.731200 1.048350 0.558580 0.476840 0.531010 0.447540 -0.254360 -0.517340 -0.111040 
NC 37099 4 0.955560 1.102960 0.833420 0.597970 0.787150 0.438460 -0.357590 -0.315810 -0.394960 
NC 37101 1 0.992760 1.148560 0.895760 0.936180 0.972120 0.913850 -0.056580 -0.176440 0.018090 
NC 37101 2 1.195420 1.172520 1.211540 1.121910 1.178390 1.095750 -0.073510 0.005870 -0.115790 
NC 37101 3 1.510480 1.357350 1.632440 1.428580 1.393160 1.447030 -0.081900 0.035810 -0.185410 
NC 37101 4 1.479830 1.481620 1.614250 1.208480 1.301830 1.132440 -0.271350 -0.179790 -0.481810 
NC 37103 1 1.748540 3.327840 0.761250 1.388220 1.797790 1.133150 -0.360320 -1.530050 0.371900 
NC 37103 2 1.493080 1.632910 1.435520 1.175340 1.451240 1.055450 -0.317740 -0.181670 -0.380070 
NC 37103 3 2.472400 1.962790 2.851350 1.570520 1.163230 1.790770 -0.901880 -0.799560 -1.060580 
NC 37103 4 1.650770 1.672670 1.820100 0.837530 0.541170 1.085120 -0.813240 -1.131500 -0.734980 
NC 37105 1 1.044810 1.067660 1.032910 1.214040 0.947690 1.384630 0.169230 -0.119970 0.351720 
NC 37105 2 1.401210 1.227270 1.485830 1.584930 1.451600 1.641640 0.183720 0.224330 0.155810 
NC 37105 3 1.407880 1.203300 1.561680 1.640900 1.448790 1.744930 0.233020 0.245490 0.183250 
NC 37105 4 1.250180 1.207050 1.367790 1.204300 1.242020 1.172450 -0.045880 0.034970 -0.195340 
NC 37107 1 2.075550 2.020050 2.134900 1.646330 1.531260 1.729910 -0.429220 -0.488790 -0.404990 
NC 37107 2 1.884840 1.905170 1.894800 1.327830 1.222580 1.359620 -0.557010 -0.682590 -0.535180 
NC 37107 3 1.539690 1.820290 1.463290 1.249130 1.229350 1.256620 -0.290560 -0.590940 -0.206670 
NC 37107 4 1.309800 1.450830 1.363600 1.165000 1.198090 1.146650 -0.144800 -0.252740 -0.216950 
NC 37109 1 1.029940 0.856670 1.137110 1.052160 1.308400 0.885700 0.022220 0.451730 -0.251410 
NC 37109 2 1.295270 1.348190 1.272240 1.241150 1.277020 1.223290 -0.054120 -0.071170 -0.048950 
NC 37109 3 1.265710 1.117200 1.353850 1.222590 1.163880 1.253890 -0.043120 0.046680 -0.099960 
NC 37109 4 1.276320 1.251490 1.322980 1.162830 1.245300 1.095990 -0.113490 -0.006190 -0.226990 
NC 37111 1 1.247710 1.394730 1.159870 1.399160 1.195070 1.530570 0.151450 -0.199660 0.370700 
NC 37111 2 0.877460 1.203370 0.739760 0.941660 1.081040 0.882140 0.064200 -0.122330 0.142380 
NC 37111 3 1.008880 1.014060 1.023870 0.950910 0.991780 0.929170 -0.057970 -0.022280 -0.094700 
NC 37111 4 0.982480 1.010260 1.014480 0.794290 0.860380 0.736290 -0.188190 -0.149880 -0.278190 
NC 37113 1 0.841620 0.567740 1.017150 1.008190 0.577400 1.284920 0.166570 0.009660 0.267770 
NC 37113 2 0.432520 0.591770 0.363830 0.731770 0.654640 0.766590 0.299250 0.062870 0.402760 
NC 37113 3 0.446270 0.495370 0.422510 0.544380 0.642770 0.490660 0.098110 0.147400 0.068150 
NC 37113 4 0.668850 0.743120 0.636200 0.635800 0.732940 0.553110 -0.033050 -0.010180 -0.083090 
NC 37115 1 0.760370 1.307300 0.415140 1.175830 1.712640 0.837760 0.415460 0.405340 0.422620 
NC 37115 2 0.719910 0.769010 0.699550 0.564090 0.544120 0.573550 -0.155820 -0.224890 -0.126000 
NC 37115 3 0.941350 0.550640 1.155480 0.709500 0.788060 0.667070 -0.231850 0.237420 -0.488410 
NC 37115 4 0.644950 0.483440 0.781550 0.766400 0.798820 0.736840 0.121450 0.315380 -0.044710 
NC 37117 1 1.372160 1.687840 1.207840 1.119810 1.106850 1.142490 -0.252350 -0.580990 -0.065350 
NC 37117 2 1.816850 1.538330 1.914100 1.126710 1.061480 1.149050 -0.690140 -0.476850 -0.765050 
NC 37117 3 1.621900 1.811010 1.530620 0.818400 1.030040 0.723200 -0.803500 -0.780970 -0.807420 
NC 37117 4 1.690860 2.200470 1.342150 0.786730 1.103530 0.589050 -0.904130 -1.096940 -0.753100 
NC 37119 1 0.785140 0.724880 0.823470 0.740380 0.597010 0.831630 -0.044760 -0.127870 0.008160 
NC 37119 2 0.897540 0.904310 0.893260 0.902100 0.841400 0.927120 0.004560 -0.062910 0.033860 
NC 37119 3 1.023060 0.986180 1.042610 0.882580 0.878960 0.884100 -0.140480 -0.107220 -0.158510 
NC 37119 4 1.102280 1.155430 1.060850 0.890320 0.954570 0.836990 -0.211960 -0.200860 -0.223860 
NC 37121 1 1.799980 2.641810 1.288810 1.006100 1.006570 1.008020 -0.793880 -1.635240 -0.280790 
NC 37121 2 1.726390 2.691920 1.332920 1.239090 1.741210 1.021670 -0.487300 -0.950710 -0.311250 
NC 37121 3 1.489110 2.254750 1.119970 1.223390 1.469540 1.090490 -0.265720 -0.785210 -0.029480 
NC 37121 4 1.151210 1.517780 0.941400 0.984850 0.973220 0.995480 -0.166360 -0.544560 0.054080 
NC 37123 1 0.701660 0.737500 0.689210 1.257200 0.684720 1.594550 0.555540 -0.052780 0.905340 
NC 37123 2 0.971950 1.134820 0.902440 0.782270 0.748960 0.789790 -0.189680 -0.385860 -0.112650 
NC 37123 3 1.144140 1.224450 1.104360 0.750410 0.889390 0.681830 -0.393730 -0.335060 -0.422530 
NC 37123 4 0.903410 0.939950 0.882660 0.683430 0.615300 0.738940 -0.219980 -0.324650 -0.143720 
NC 37125 1 1.091530 1.016340 1.139170 1.018780 0.985640 1.039990 -0.072750 -0.030700 -0.099180 
NC 37125 2 0.941930 0.906470 0.956020 1.126130 0.914840 1.216650 0.184200 0.008370 0.260630 
NC 37125 3 0.907270 1.010810 0.850510 0.725100 0.618320 0.782780 -0.182170 -0.392490 -0.067730 
NC 37125 4 0.773540 0.730540 0.811210 0.693300 0.698100 0.690430 -0.080240 -0.032440 -0.120780 
NC 37127 1 1.367480 1.286470 1.418810 1.548810 1.095830 1.835610 0.181330 -0.190640 0.416800 
NC 37127 2 1.332440 1.209560 1.394440 1.241650 1.273850 1.225830 -0.090790 0.064290 -0.168610 
NC 37127 3 1.105310 1.237290 1.056300 1.129630 1.225810 1.076870 0.024320 -0.011480 0.020570 
NC 37127 4 1.025590 1.132040 1.005720 1.313240 1.335860 1.296390 0.287650 0.203820 0.290670 
 141 
ST FIPS AGE CAT PQI90-08 PQI91-08 PQI92-08 PQI90-11 PQI91-11 PQI92-11 Delta-90 Delta-91 Delta-92 
NC 37129 1 0.724180 0.551660 0.834960 0.703470 0.565940 0.792260 -0.020710 0.014280 -0.042700 
NC 37129 2 0.728250 0.695510 0.742090 0.730700 0.704600 0.741690 0.002450 0.009090 -0.000400 
NC 37129 3 0.841610 0.850120 0.836990 0.729130 0.743690 0.721250 -0.112480 -0.106430 -0.115740 
NC 37129 4 0.834530 0.801720 0.862260 0.807180 0.825650 0.791500 -0.027350 0.023930 -0.070760 
NC 37131 1 2.528700 1.334890 3.226320 1.308090 1.142640 1.414030 -1.220610 -0.192250 -1.812290 
NC 37131 2 1.459170 1.346330 1.506400 1.120300 1.475960 0.975110 -0.338870 0.129630 -0.531290 
NC 37131 3 1.324550 1.232040 1.406000 0.941360 0.898080 0.960580 -0.383190 -0.333960 -0.445420 
NC 37131 4 1.095630 1.358310 0.980930 1.006250 0.879220 1.109000 -0.089380 -0.479090 0.128070 
NC 37133 1 0.621250 0.398900 0.756520 0.502030 0.356070 0.592030 -0.119220 -0.042830 -0.164490 
NC 37133 2 1.256870 1.177320 1.289480 1.105550 0.974800 1.160610 -0.151320 -0.202520 -0.128870 
NC 37133 3 1.468390 1.159990 1.637530 1.080090 1.113980 1.061090 -0.388300 -0.046010 -0.576440 
NC 37133 4 1.402710 1.423710 1.404570 1.086490 1.008780 1.152970 -0.316220 -0.414930 -0.251600 
NC 37135 1 0.426240 0.396230 0.445770 0.433860 0.353790 0.484190 0.007620 -0.042440 0.038420 
NC 37135 2 0.726960 0.845610 0.675840 0.561670 0.567100 0.555560 -0.165290 -0.278510 -0.120280 
NC 37135 3 1.025180 1.131270 0.992390 0.555440 0.596620 0.532990 -0.469740 -0.534650 -0.459400 
NC 37135 4 1.050750 1.196890 1.030260 0.829960 0.921940 0.762840 -0.220790 -0.274950 -0.267420 
NC 37137 1 1.668830 1.460970 1.791840 1.341410 0.872780 1.629360 -0.327420 -0.588190 -0.162480 
NC 37137 2 1.115040 1.015020 1.159300 0.639280 0.385890 0.749320 -0.475760 -0.629130 -0.409980 
NC 37137 3 0.817340 0.682720 0.901770 0.723520 0.524010 0.832720 -0.093820 -0.158710 -0.069050 
NC 37137 4 1.359120 1.094680 1.692380 0.588940 0.621420 0.563180 -0.770180 -0.473260 -1.129200 
NC 37139 1 0.915780 0.903320 0.932990 0.851160 0.606010 0.999390 -0.064620 -0.297310 0.066400 
NC 37139 2 1.187360 1.033490 1.238720 0.754230 0.532100 0.834800 -0.433130 -0.501390 -0.403920 
NC 37139 3 1.222020 1.310520 1.176660 0.798000 0.835500 0.778250 -0.424020 -0.475020 -0.398410 
NC 37139 4 0.960350 1.097350 0.862920 0.747780 0.824830 0.693090 -0.212570 -0.272520 -0.169830 
NC 37141 1 0.982350 0.910740 1.027060 0.718940 0.825150 0.652740 -0.263410 -0.085590 -0.374320 
NC 37141 2 0.900890 1.014630 0.850410 0.814770 0.969890 0.746550 -0.086120 -0.044740 -0.103860 
NC 37141 3 1.124880 1.137540 1.118410 0.869330 0.851620 0.878430 -0.255550 -0.285920 -0.239980 
NC 37141 4 1.054210 1.093210 1.034850 0.979250 1.069270 0.906400 -0.074960 -0.023940 -0.128450 
NC 37143 1 2.052650 2.008260 2.081450 0.588810 0.505950 0.641470 -1.463840 -1.502310 -1.439980 
NC 37143 2 1.346040 1.462390 1.294870 0.943200 0.535660 1.119200 -0.402840 -0.926730 -0.175670 
NC 37143 3 1.572570 1.360540 1.694460 0.704700 0.900760 0.597870 -0.867870 -0.459780 -1.096590 
NC 37143 4 1.258300 1.040380 1.461550 0.873600 0.912320 0.842890 -0.384700 -0.128060 -0.618660 
NC 37145 1 1.066080 1.416380 0.845560 1.156030 1.194720 1.131840 0.089950 -0.221660 0.286280 
NC 37145 2 1.266460 1.284420 1.260290 1.245620 1.249290 1.242150 -0.020840 -0.035130 -0.018140 
NC 37145 3 1.626790 1.522600 1.712720 1.340120 1.113060 1.462830 -0.286670 -0.409540 -0.249890 
NC 37145 4 1.544830 1.445200 1.682450 1.362980 1.449340 1.292250 -0.181850 0.004140 -0.390200 
NC 37147 1 0.767850 0.696690 0.816780 1.058850 0.838200 1.207310 0.291000 0.141510 0.390530 
NC 37147 2 1.339110 1.044590 1.470030 1.506700 1.167770 1.657700 0.167590 0.123180 0.187670 
NC 37147 3 1.489160 1.394950 1.543350 1.225330 1.160700 1.261530 -0.263830 -0.234250 -0.281820 
NC 37147 4 1.189860 1.058770 1.300630 1.129730 0.982850 1.252420 -0.060130 -0.075920 -0.048210 
NC 37149 1 1.073340 0.395720 1.498050 0.408000 0.419360 0.399650 -0.665340 0.023640 -1.098400 
NC 37149 2 0.860050 1.047320 0.776480 0.512960 0.798110 0.385760 -0.347090 -0.249210 -0.390720 
NC 37149 3 0.735890 0.762660 0.723190 0.622730 0.701800 0.578770 -0.113160 -0.060860 -0.144420 
NC 37149 4 0.980160 1.167500 0.824520 0.768460 0.997460 0.569600 -0.211700 -0.170040 -0.254920 
NC 37151 1 1.039240 1.261780 0.902500 0.752740 0.891300 0.667340 -0.286500 -0.370480 -0.235160 
NC 37151 2 0.896430 1.112120 0.806150 0.872400 1.278090 0.697220 -0.024030 0.165970 -0.108930 
NC 37151 3 0.971250 1.189950 0.867020 0.902380 1.209880 0.736250 -0.068870 0.019930 -0.130770 
NC 37151 4 0.994190 1.132090 0.936740 0.810090 0.918330 0.719800 -0.184100 -0.213760 -0.216940 
NC 37153 1 2.218840 1.857550 2.443950 2.218320 1.604800 2.585690 -0.000520 -0.252750 0.141740 
NC 37153 2 2.105240 1.829400 2.208630 2.240810 1.901900 2.356360 0.135570 0.072500 0.147730 
NC 37153 3 2.166890 2.187180 2.207260 2.011420 1.712420 2.153040 -0.155470 -0.474760 -0.054220 
NC 37153 4 1.240000 1.283240 1.259240 1.246470 1.181120 1.302360 0.006470 -0.102120 0.043120 
NC 37155 1 1.503640 1.706860 1.405830 2.000770 1.820740 2.125860 0.497130 0.113880 0.720030 
NC 37155 2 1.706270 1.484430 1.780920 2.007620 1.778720 2.082540 0.301350 0.294290 0.301620 
NC 37155 3 1.645660 1.688610 1.630010 1.816270 1.587560 1.923820 0.170610 -0.101050 0.293810 
NC 37155 4 1.293490 1.266260 1.335620 1.484480 1.579250 1.422140 0.190990 0.312990 0.086520 
NC 37157 1 1.654300 2.104510 1.375500 1.155180 1.098040 1.193850 -0.499120 -1.006470 -0.181650 
NC 37157 2 1.631870 1.624960 1.645370 1.521310 1.701720 1.442720 -0.110560 0.076760 -0.202650 
NC 37157 3 1.824300 1.826090 1.866810 1.886670 1.982950 1.834410 0.062370 0.156860 -0.032400 
NC 37157 4 1.606750 1.834700 1.536560 1.675500 1.901770 1.484340 0.068750 0.067070 -0.052220 
NC 37159 1 1.446490 1.059230 1.696540 1.210950 1.384440 1.103970 -0.235540 0.325210 -0.592570 
NC 37159 2 1.067330 1.174240 1.022220 1.092270 1.186740 1.052560 0.024940 0.012500 0.030340 
NC 37159 3 1.091780 1.258550 1.001450 0.963640 1.081900 0.899490 -0.128140 -0.176650 -0.101960 
NC 37159 4 0.972760 1.090800 0.871000 0.794970 0.914030 0.691140 -0.177790 -0.176770 -0.179860 
 142 
ST FIPS AGE CAT PQI90-08 PQI91-08 PQI92-08 PQI90-11 PQI91-11 PQI92-11 Delta-90 Delta-91 Delta-92 
NC 37161 1 0.686250 0.654130 0.711630 1.023340 1.003760 1.045680 0.337090 0.349630 0.334050 
NC 37161 2 0.780470 0.759840 0.787270 0.923380 0.891430 0.929410 0.142910 0.131590 0.142140 
NC 37161 3 0.714230 0.892400 0.639590 0.790580 0.854860 0.757770 0.076350 -0.037540 0.118180 
NC 37161 4 0.677140 0.907800 0.544980 0.717770 0.880940 0.598470 0.040630 -0.026860 0.053490 
NC 37163 1 1.102100 0.950600 1.200890 0.889200 0.805440 0.944810 -0.212900 -0.145160 -0.256080 
NC 37163 2 1.268130 1.054410 1.373860 1.175500 1.212260 1.161040 -0.092630 0.157850 -0.212820 
NC 37163 3 1.034790 0.918860 1.120070 1.173680 1.273900 1.119420 0.138890 0.355040 -0.000650 
NC 37163 4 0.862260 0.781630 0.979560 1.265390 1.294450 1.237560 0.403130 0.512820 0.258000 
NC 37165 1 1.554240 1.446640 1.632350 1.775530 2.160530 1.578160 0.221290 0.713890 -0.054190 
NC 37165 2 2.067280 1.689330 2.201900 1.894720 1.560060 2.011210 -0.172560 -0.129270 -0.190690 
NC 37165 3 1.190610 0.908300 1.327570 1.343270 1.025170 1.495360 0.152660 0.116870 0.167790 
NC 37165 4 1.205150 0.996600 1.477430 1.163140 1.044680 1.260490 -0.042010 0.048080 -0.216940 
NC 37167 1 1.070840 1.674110 0.695210 0.844460 1.097490 0.686340 -0.226380 -0.576620 -0.008870 
NC 37167 2 1.221260 1.688920 1.017670 0.930430 0.902780 0.940950 -0.290830 -0.786140 -0.076720 
NC 37167 3 1.176310 1.233120 1.144870 0.920110 1.080000 0.833050 -0.256200 -0.153120 -0.311820 
NC 37167 4 1.121200 1.143040 1.105230 0.941570 0.788410 1.071410 -0.179630 -0.354630 -0.033820 
NC 37169 1 0.969150 1.210800 0.812810 1.313360 1.215730 1.372130 0.344210 0.004930 0.559320 
NC 37169 2 1.150720 1.301770 1.082470 1.254660 1.374820 1.199800 0.103940 0.073050 0.117330 
NC 37169 3 1.349430 1.606680 1.206120 0.963420 1.129960 0.870770 -0.386010 -0.476720 -0.335350 
NC 37169 4 1.272200 1.272560 1.281860 1.127810 1.170200 1.094760 -0.144390 -0.102360 -0.187100 
NC 37171 1 1.314020 1.525040 1.185810 1.088630 1.164840 1.043700 -0.225390 -0.360200 -0.142110 
NC 37171 2 1.186250 1.372530 1.115210 1.328220 1.408260 1.297130 0.141970 0.035730 0.181920 
NC 37171 3 1.290610 1.355010 1.283930 1.463560 1.466580 1.476660 0.172950 0.111570 0.192730 
NC 37171 4 1.181510 1.119100 1.323570 1.172500 1.098510 1.265830 -0.009010 -0.020590 -0.057740 
NC 37173 1 2.454060 2.579770 2.380200 1.585190 1.560570 1.604330 -0.868870 -1.019200 -0.775870 
NC 37173 2 1.907380 2.185540 1.788910 1.027740 1.276760 0.919620 -0.879640 -0.908780 -0.869290 
NC 37173 3 1.457290 1.840660 1.249140 0.961180 1.159570 0.854330 -0.496110 -0.681090 -0.394810 
NC 37173 4 1.863640 2.745190 1.132020 0.977440 1.483430 0.556520 -0.886200 -1.261760 -0.575500 
NC 37175 1 1.578120 1.292920 1.757280 0.906910 0.427740 1.207700 -0.671210 -0.865180 -0.549580 
NC 37175 2 0.487350 0.618950 0.429640 0.635070 0.712430 0.600440 0.147720 0.093480 0.170800 
NC 37175 3 0.513310 0.649750 0.443810 0.479670 0.689070 0.365270 -0.033640 0.039320 -0.078540 
NC 37175 4 0.559990 0.683420 0.478530 0.543770 0.659680 0.447480 -0.016220 -0.023740 -0.031050 
NC 37177 1 0.184230 0.000000 0.279070 0.347430 0.515530 0.263700 0.163200 0.515530 -0.015370 
NC 37177 2 0.537580 0.745240 0.454530 1.032010 1.190980 0.963910 0.494430 0.445740 0.509380 
NC 37177 3 0.712300 0.721030 0.706780 0.776570 1.087290 0.622710 0.064270 0.366260 -0.084070 
NC 37177 4 0.828960 0.807750 0.852910 0.817920 0.642990 0.951750 -0.011040 -0.164760 0.098840 
NC 37179 1 0.799170 0.832350 0.771610 0.947330 1.070410 0.857490 0.148160 0.238060 0.085880 
NC 37179 2 1.068330 1.070560 1.070180 0.936180 1.016580 0.901230 -0.132150 -0.053980 -0.168950 
NC 37179 3 1.349410 1.421300 1.308520 1.166620 1.309350 1.084340 -0.182790 -0.111950 -0.224180 
NC 37179 4 1.665700 1.659890 1.667080 1.305220 1.362770 1.250510 -0.360480 -0.297120 -0.416570 
NC 37181 1 1.566880 1.343500 1.714400 1.456180 1.615590 1.382380 -0.110700 0.272090 -0.332020 
NC 37181 2 1.609700 1.295460 1.741780 1.292170 1.212870 1.314500 -0.317530 -0.082590 -0.427280 
NC 37181 3 1.185090 1.231030 1.200380 1.047090 1.006240 1.065050 -0.138000 -0.224790 -0.135330 
NC 37181 4 0.915010 0.928440 0.983920 1.008020 1.161270 0.897370 0.093010 0.232830 -0.086550 
NC 37183 1 0.680700 0.552490 0.765010 0.689830 0.428240 0.867120 0.009130 -0.124250 0.102110 
NC 37183 2 0.811600 0.697800 0.869910 0.694170 0.524600 0.778480 -0.117430 -0.173200 -0.091430 
NC 37183 3 1.094460 1.030160 1.136700 0.878280 0.688920 0.992200 -0.216180 -0.341240 -0.144500 
NC 37183 4 1.199520 1.070750 1.327070 0.969150 0.803990 1.117770 -0.230370 -0.266760 -0.209300 
NC 37185 1 0.756200 0.632070 0.831800 1.331070 0.883810 1.588640 0.574870 0.251740 0.756840 
NC 37185 2 0.716350 0.660010 0.736470 0.665890 0.653720 0.665810 -0.050460 -0.006290 -0.070660 
NC 37185 3 0.555380 0.632020 0.525230 0.656220 0.659110 0.653440 0.100840 0.027090 0.128210 
NC 37185 4 0.533820 0.504380 0.585200 0.574680 0.720680 0.468180 0.040860 0.216300 -0.117020 
NC 37187 1 0.577890 0.997100 0.343930 1.440480 1.256280 1.563790 0.862590 0.259180 1.219860 
NC 37187 2 0.896210 1.096880 0.812900 0.862280 1.084530 0.770300 -0.033930 -0.012350 -0.042600 
NC 37187 3 1.123910 1.024130 1.173740 1.250160 1.180220 1.283390 0.126250 0.156090 0.109650 
NC 37187 4 0.936410 1.181000 0.768510 1.254600 1.454020 1.113220 0.318190 0.273020 0.344710 
NC 37189 1 0.389200 0.569480 0.290430 0.214900 0.312050 0.161610 -0.174300 -0.257430 -0.128820 
NC 37189 2 0.460450 0.728720 0.355300 0.495230 0.713390 0.407510 0.034780 -0.015330 0.052210 
NC 37189 3 0.535110 0.582660 0.517900 0.583470 0.805340 0.474930 0.048360 0.222680 -0.042970 
NC 37189 4 0.949490 1.115720 0.911170 0.800980 1.011260 0.646280 -0.148510 -0.104460 -0.264890 
NC 37191 1 1.335930 0.791210 1.686220 1.117640 0.791170 1.328960 -0.218290 -0.000040 -0.357260 
NC 37191 2 1.436400 1.022500 1.619110 1.357660 1.107480 1.468840 -0.078740 0.084980 -0.150270 
NC 37191 3 1.274890 1.017110 1.418190 1.267010 1.179930 1.315860 -0.007880 0.162820 -0.102330 
NC 37191 4 1.091510 0.888620 1.261460 0.886040 0.812510 0.945960 -0.205470 -0.076110 -0.315500 
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NC 37193 1 1.190590 1.853310 0.777110 1.153580 1.225110 1.111610 -0.037010 -0.628200 0.334500 
NC 37193 2 1.248780 1.698360 1.055930 1.354770 1.740080 1.190990 0.105990 0.041720 0.135060 
NC 37193 3 1.103880 1.076220 1.124310 1.289390 1.439470 1.214580 0.185510 0.363250 0.090270 
NC 37193 4 1.172090 1.256120 1.118070 1.199070 1.315970 1.112370 0.026980 0.059850 -0.005700 
NC 37195 1 0.929850 1.019760 0.889540 1.173560 0.724370 1.442870 0.243710 -0.295390 0.553330 
NC 37195 2 1.014580 0.969190 1.033160 1.074740 1.117150 1.051070 0.060160 0.147960 0.017910 
NC 37195 3 1.087510 1.215640 1.055570 0.826240 1.024110 0.728380 -0.261270 -0.191530 -0.327190 
NC 37195 4 0.869670 0.971360 0.862500 0.965680 1.142950 0.836570 0.096010 0.171590 -0.025930 
NC 37197 1 0.976780 1.131570 0.875460 1.411710 2.064690 0.990520 0.434930 0.933120 0.115060 
NC 37197 2 1.675280 2.127490 1.480490 1.492930 1.715190 1.399660 -0.182350 -0.412300 -0.080830 
NC 37197 3 1.772020 1.677050 1.850810 1.570930 1.183900 1.799630 -0.201090 -0.493150 -0.051180 
NC 37197 4 1.363360 1.132980 1.617760 1.429050 1.418230 1.487650 0.065690 0.285250 -0.130110 
NC 37199 1 1.534460 2.069980 1.202740 2.229910 2.379160 2.142110 0.695450 0.309180 0.939370 
NC 37199 2 1.157200 1.857740 0.860430 1.017400 1.052300 1.003570 -0.139800 -0.805440 0.143140 
NC 37199 3 1.148820 1.345150 1.069980 0.807130 0.680290 0.877160 -0.341690 -0.664860 -0.192820 
NC 37199 4 1.246420 1.577310 1.057470 1.085080 1.319210 0.883240 -0.161340 -0.258100 -0.174230 
VT 50001 1 0.926390 0.346410 1.322540 0.819310 0.993400 0.692190 -0.107080 -0.115340 -0.098800 
VT 50001 2 0.465870 0.786410 0.316920 0.457990 0.505650 0.437820 -0.007880 -0.003850 -0.011910 
VT 50001 3 0.922720 1.120460 0.807030 0.729780 0.966550 0.591420 -0.192940 -0.179810 -0.206070 
VT 50001 4 1.424480 1.992200 0.894300 0.955730 1.290700 0.636880 -0.468750 -0.464170 -0.473320 
VT 50003 1 1.127890 1.048800 1.175820 0.568050 0.695060 0.477620 -0.559840 -0.568100 -0.551570 
VT 50003 2 1.270650 1.714720 1.068790 0.666360 0.957240 0.533570 -0.604290 -0.602640 -0.605930 
VT 50003 3 1.579570 1.706210 1.507560 1.202220 1.035260 1.300760 -0.377350 -0.369780 -0.384910 
VT 50003 4 1.575290 1.896700 1.277610 1.435890 1.461820 1.407550 -0.139400 -0.137560 -0.141230 
VT 50005 1 0.480500 0.672180 0.360610 0.037590 0.000000 0.061240 -0.442910 -0.104370 -0.439760 
VT 50005 2 0.384570 0.401550 0.376670 0.069110 0.091470 0.059340 -0.315460 -0.220290 -0.317930 
VT 50005 3 0.564380 0.765500 0.455330 0.097670 0.139600 0.075070 -0.466710 -0.340860 -0.477150 
VT 50005 4 0.730880 0.975590 0.525150 0.122010 0.151460 0.097070 -0.608870 -0.587840 -0.608910 
VT 50007 1 0.607800 0.808870 0.461950 0.411280 0.503400 0.343190 -0.196520 -0.196340 -0.196700 
VT 50007 2 0.538810 0.794230 0.420650 0.527640 0.702300 0.447630 -0.011170 -0.008680 -0.013650 
VT 50007 3 0.720290 0.960100 0.578670 0.726400 0.801150 0.683170 0.006110 0.012690 -0.000480 
VT 50007 4 0.848580 0.828700 0.862430 0.819860 0.770810 0.862000 -0.028720 -0.026620 -0.030830 
VT 50009 1 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.032660 
VT 50009 2 0.521440 0.741830 0.428580 0.117570 0.202610 0.082220 -0.403870 -0.180600 -0.411120 
VT 50009 3 0.276080 0.136450 0.346180 0.000000 0.000000 0.000000 -0.276080 0.000000 -0.293880 
VT 50009 4 0.300640 0.314540 0.292060 0.026150 0.059700 0.000000 -0.274490 0.000000 -0.281720 
VT 50011 1 0.672510 0.982680 0.453340 0.519290 0.598590 0.460810 -0.153220 -0.155790 -0.150670 
VT 50011 2 0.519400 0.831070 0.374870 0.604450 0.758860 0.534580 0.085050 0.090050 0.080060 
VT 50011 3 0.960190 1.697590 0.524460 0.990560 1.163150 0.890540 0.030370 0.043370 0.017370 
VT 50011 4 1.282970 1.827720 0.777150 1.306850 1.725090 0.913720 0.023880 0.026900 0.020870 
VT 50013 1 0.450410 1.067220 0.000000 0.476320 0.561790 0.409480 0.025910 0.000000 0.052260 
VT 50013 2 0.433740 0.607450 0.351860 0.662980 0.603540 0.699210 0.229240 0.230460 0.228030 
VT 50013 3 0.949260 1.599090 0.550130 0.316680 0.499060 0.205280 -0.632580 -0.445410 -0.649390 
VT 50013 4 1.665510 1.614760 1.709560 1.512330 1.754190 1.267460 -0.153180 -0.159290 -0.147070 
VT 50015 1 0.932680 0.484910 1.230930 1.716230 1.089430 2.131830 0.783550 0.783780 0.783310 
VT 50015 2 0.557850 0.991040 0.359710 0.720690 1.330600 0.441430 0.162840 0.166590 0.159090 
VT 50015 3 0.628880 1.018410 0.404570 0.896630 1.427760 0.590290 0.267750 0.298600 0.236890 
VT 50015 4 0.988630 1.227370 0.771790 1.441530 1.849800 1.065850 0.452900 0.469740 0.436070 
VT 50017 1 0.478620 0.831930 0.239210 0.293150 0.483860 0.163090 -0.185470 -0.050500 -0.181030 
VT 50017 2 0.296330 0.456270 0.223420 0.431580 0.556880 0.375090 0.135250 0.140380 0.130110 
VT 50017 3 0.894110 1.156280 0.743470 0.520150 0.591930 0.479260 -0.373960 -0.364230 -0.383690 
VT 50017 4 0.875990 1.056730 0.710270 0.694230 0.819350 0.579580 -0.181760 -0.179320 -0.184200 
VT 50019 1 0.667050 0.902270 0.529920 1.030700 1.278670 0.886740 0.363650 0.357680 0.369630 
VT 50019 2 0.493050 0.619350 0.438200 0.499020 0.501440 0.494530 0.005970 0.007630 0.004300 
VT 50019 3 0.707570 0.838690 0.639050 0.213910 0.300000 0.169550 -0.493660 -0.479540 -0.507780 
VT 50019 4 0.806960 0.888100 0.748260 0.258150 0.339610 0.194180 -0.548810 -0.546310 -0.551320 
VT 50021 1 1.270370 0.919380 1.501400 1.402600 1.301970 1.463530 0.132230 0.125100 0.139360 
VT 50021 2 0.731130 0.886420 0.661890 1.058460 1.088750 1.048200 0.327330 0.328740 0.325930 
VT 50021 3 1.381680 1.734670 1.178090 1.348860 1.618770 1.193540 -0.032820 -0.023830 -0.041820 
VT 50021 4 1.415020 1.434320 1.392580 1.371220 1.531750 1.219470 -0.043800 -0.043150 -0.044460 
VT 50023 1 0.698160 0.825570 0.605910 0.696320 1.019400 0.468800 -0.001840 -0.006310 0.002630 
VT 50023 2 0.705110 0.905610 0.613850 0.646290 0.622940 0.660790 -0.058820 -0.055680 -0.061950 
VT 50023 3 1.032350 1.469120 0.774530 0.724730 0.722450 0.727340 -0.307620 -0.300490 -0.314760 
VT 50023 4 1.058520 1.325790 0.801530 1.054370 1.209740 0.902420 -0.004150 -0.000610 -0.007690 
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VT 50025 1 0.749370 0.845290 0.680060 0.488140 0.880120 0.218230 -0.261230 -0.268460 -0.254000 
VT 50025 2 0.499380 0.731100 0.393800 0.520530 0.674660 0.450800 0.021150 0.023380 0.018930 
VT 50025 3 1.065120 1.240680 0.964580 0.699410 0.710350 0.693920 -0.365710 -0.352220 -0.379220 
VT 50025 4 1.002930 1.197690 0.823800 0.891360 1.039200 0.753790 -0.111570 -0.108730 -0.114410 
VT 50027 1 0.637970 0.851540 0.488740 0.300050 0.402310 0.228330 -0.337920 -0.318890 -0.333760 
VT 50027 2 0.428260 0.619100 0.340630 0.427830 0.605490 0.346270 -0.000430 0.000990 -0.001850 
VT 50027 3 0.528520 0.687800 0.436320 0.584830 0.666280 0.537950 0.056310 0.066080 0.046540 
VT 50027 4 0.928900 1.147290 0.726510 0.901860 1.075620 0.740910 -0.027040 -0.024530 -0.029570 
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